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ABSTRACT 
Toxoplasma gondii is an intracellular obligate parasite of phylum 
Apicomplexa.  Toxoplasma is able to infect any nucleated cell including up to one 
third of the world’s population.  Within its hosts, the asexual life cycle of 
Toxoplasma consists of two distinct forms; a rapidly growing form called 
tachyzoite and a latent cyst encapsulated form called bradyzoite.  Although 
tachyzoites can be removed by the host’s immune system, parasites can convert to 
bradyzoites thereby evading the host’s immune response.  If the host’s immune 
system becomes weakened, bradyzoites are able to reconvert to tachyzoites.  Taken 
together, these observations suggest Toxoplasma contains intricate gene regulation 
mechanisms that could be shared by other intracellular parasites.  MicroRNAs 
(miRNAs) are crucial genetic effectors involved in numerous gene regulation 
mechanisms in eukaryotes.  Although a post-transcriptional gene silencing can be 
observed in Toxoplasma the roles and functions of Tg-miRNAs are still elusive.  In 
this work an engineered dual luciferase reporter system was used to examine and 
standardize the ability of long and short double-stranded RNA to control gene 
expression in Toxoplasma.  The effects of endogenous Tg-miRNAs were also 
evaluated based on (i) their abundance and (ii) the number of binding sites within a 
transcript.  Tg-miRNA effectiveness can be altered by use of miRNA mimics and 
inhibitors.  Also a genetic knockdown system that exploits and directs Tg-miRNAs 
for loss-of-function analysis of essential and non-essential genes was developed.  
To further our understanding of miRNA induced gene silencing on parasite cell 
biology, a model gene target was selected for the most abundant Tg-miR-60a.  The 
vi 
 
locus of the Ubiquitin-like protease 1 (Ulp1) contains the highest number of 
predicted Tg-miR-60a binding sites.  The antisense RNA expresses a likely 
precursor of Tg-miR-60a suggesting TgUlp1 expression could be self-regulating.  
Ulp1 activity is required for the first and last step in the SUMOylation pathway.  
TgUlp1 is able to compliment the function of yeast Ulp1 and exhibits cleavage 
activity in vitro.  Knockout of TgUlp1 is detrimental to parasite egress and 
survival.  Since a miR-60a inhibitor or antisense RNA can alter TgUlp1 expression 
and activity, a TgUlp1-SF line was created to study the effects of miR-60a and its 
effects on total protein SUMOylation to demonstrate the importance of proper 
gene regulation by miRNAs.  Furthermore, Toxoplasma Argonaute, the core 
protein of RNA-induced gene silencing that is required for a gene silencing effect, 
is expressed as two isoforms from the same locus, suggesting alternative 
translational starts sites.  Overall, this dissertation reveals the importance of proper 
gene regulation directed by non-coding RNAs in Toxoplasma that could lead to the 
development of anti-Toxoplasma therapeutic. 
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CHAPTER 1 
General Introduction 
1.1.  Toxoplasma gondii, the one and only 
Over 100 years ago in 1908, one of the most successful parasitic protozoans was 
discovered in the tissue of a rodent, the gundi, at the Pasteur Institute in Tunis by Charles 
Nicolle and Louis Manceaux, and in that same year in the tissue of a rabbit in Sao Paulo, 
Brazil by Alfonso Splendore (Splendore 1908). It was originally mis-identified as 
Leishmania, another unicellular eukaryotic parasite by both laboratories (Duby 2008).  
However, Nicolle later realized that he discovered a new organism and named it 
Toxoplasma gondii, based on the parasite’s morphology; toxo “bow” and plasma “life” 
and the host. 
Later Toxoplasma was isolated from birds by Sabin and Olitsky in 1973 and was 
discovered to be identical to the human isolates.  This lead to further investigations of 
Toxoplasma isolates from humans and animals (Sabin and Olitsky 1973).  Furthermore, 
an in-depth study of the genetic differences among 275 isolates worldwide resulted in the 
grouping of three dominant clonal lineages within North American called type I, II and 
III.  Type I parasites are highly virulent, while type II and III are most commonly found 
within humans and animals, respectively (Dubey 2002, Montoya and Liesenfeld 2004).  
Toxoplasma infection occurs worldwide with the largest range of hosts despite the fact 
that Toxoplasma gondii is the only one species of its genus (Duby 2008).  Although great 
advances have been made in the last 50 years to prevent Toxoplasma infection, today one 
third of the world’s population has been estimated to become infected by Toxoplasma 
(Flint 2005).   Typically infection does not produce any clinical symptoms, however, 
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severe disease can be observed in congenitally infected children and immunosuppressed 
individuals, including patients undergoing chemotherapy or by acquired immune 
deficiency syndrome (AIDS, Dubey 1996). 
1.2.  The life cycle of Toxoplasma gondii 
As an intracellular parasite, Toxoplasma spends most of its life cycle within the 
cells of its host.  The life cycle proceeds in two stages; sexual reproduction within the gut 
of felines and asexual reproduction within its host.  In the asexual stage, the parasite can 
alternate between two forms called tachyzoite and bradyzoite (Figure 1.1.). 
1.2.1.  Sexual reproduction 
In 1965, William Hutchison pursued the theory of a fecal transmission route for 
Toxoplasma via cats after researchers reported no evidence of the parasite within canine 
fecal samples ten years prior.  Hutchison not only discovered the oocyst form of the 
parasite but also its definitive host (Hutchison 1965).  Later it was discovered that 
Toxoplasma undergoes sexual reproduction and genetic crossing within the epithelial 
cells of the feline small intestine (Frenkel et al., 1970, Hutchison et al., 1970, Ferguson et 
al., 1974).  The oocysts are shed for up to 21 days in the feces of infected felines and able 
to survive in the environment for up to 18 months (Frenkel 1975).  Sporulation usually 
occurs between 1-21 days, and the oocyst-containing sprorzoites have been found to be 
the most significant source of infection for the intermediate hosts (Figure 1.1., Montoya 
and Liesenfeld 2004).  Despite the parasite’s promiscuous ability to infect any nucleated 
cells including mammal and bird, felines remain the only definitive host for sexual 
reproduction. 
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Figure 1.1.  Toxoplasma gondii life cycle.  Sexual reproduction takes place within the gut 
of felines.  Cats then shed oocysts that can be taken up by any warm-blooded animal.  
Acute infection occurs by the rapidly growing tachyzoites.  An attack by the host’s 
immune system induces tachyzoite convert to a slow growing cyst-encapsulated 
bradyzoite.  Immune suppression allows the bradyzoite to reconvert to tachyzoites.  If a 
cat ingests bradyzoites cyst infected tissue, the parasites re-enter the sexual life cycle.  
(Adapted from Black and Boothroyd, 2000) 
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1.2.2.  Asexual reproduction: A tale of two forms 
The proliferative form of Toxoplasma called the tachyzoite, was the stage 
observed by Nicolle and Manceaux in the gundi.  Tachyzoites are crescent shaped 
approximately 2 by 6 m with a pointed anterior and a rounded posterior end.  This small 
“banana-like” structure is the rapidly growing form of Toxoplasma.  Tachyzoites are able 
to divide rapidly by a process called endodyogeny, where two daughter parasites form 
within the parent parasite (Glodman et al., 1958).  Rapid parasite growth causes a strong 
inflammatory response by the host’s immune system, and the tachyzoites can easily be 
cleared (Figure 1.1).  However, Toxoplasma is able to avoid an immune system attack by 
converting to an encysted slow-growing, dormant form called bradyzoite.  This form does 
not cause harm to the host or elicit a host immune response.  The cyst wall also makes the 
parasite less susceptible to destruction.  Although the parasite in the bradyzoite form 
continues to grow, the growth is slower than that of the tachyzoite form that the parasite 
remain intracellular and dormant (Montoya and Liesenfeld 2004).  In individuals with a 
weakened immune system, bradyzoites could be released from their cysts and convert 
back to the rapidly growing tachyzoite form.  When bradyzoite tissue cysts from infected 
animals are eaten, the parasites are released within a new host and re-enter the asexual 
life cycle (Figure 1.1., Dubey et al., 1998, Black and Boothroyd, 2000). 
1.3.  Lytic cycle 
As an intracellular parasite, Toxoplasma must invade a host cell to survive.  
Tachyzoites move through the extracellular environment by gliding motion until 
attachment to a host cell (Figure 1.2.).  Once attached, the parasite enters by penetrating 
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through the host cell membrane or by phagocytosis (Dubey et al., 1998).  Once inside, the 
parasite is surrounded by a parasitophorous vacuole (PV) derived from parasite and host 
cell lipids and membrane proteins (Dubey et al., 1998).  The parasite can then undergo 
multiple rounds of replication while remaining within the PV (Figure 1.2.).  Rapid growth 
is achieved because Toxoplasma is auxotrophic and sequesters materials from the host 
cell such as amino acids, nucleotides, sugars, cholesterol and lipids which requires less 
energy (Laliberte and Carruthers, 2008).  Growth rates have been shown to be directly 
related to parasite virulence.  Type I parasites are highly virulent where types II and III 
are avirulent in mice (Weiss and Kim 2007).  After multiple rounds of replication, the PV 
fills with parasites and causes the host cell to lyse (Figure 1.2.), and allow the parasite to 
initiate the next round of infection, the lytic cycle.   The destruction of the infected host 
cell is the serious consequence of toxoplasmosis (Blader et al., 2015). 
1.4.  Toxoplasma infection 
Toxoplasma infection occurs through the ingestion of tissue cysts or sporulated 
oocysts from infected meat or from the environment such as contaminated water or soil 
(Dubey and Jones, 2008).  Toxoplasma has been found in animals worldwide, regardless 
of environmental or habitat (Dubey and Jones, 2008).  This is especially a concern for 
human health and consumption of contaminated animals and products.  Tachyzoites can 
spread throughout the hosts system and can be transmitted to a pregnant host’s offspring 
(Montoya and Liesenfeld, 2004).  Congenital toxoplasmosis can cause severe 
complications to fetal development including mental retardation, blindness, and brain 
lesions and in the most severe cases, can cause abortion or stillbirth (Montoya and 
Liesenfeld, 2004).  Initial Toxoplasma infection mimics flu-like symptoms.  Persisting 
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Figure 1.2.  Toxoplasma gondii lytic cycle.  Extracellular parasites attach and invade a 
new host cell.  The intracellular parasites become surrounded by a parasitophorous 
vacuole where they undergo multiple rounds of replication.  Once the host cell fills with 
parasites it ruptures releasing free tachyzoites that are able to invade a new host cell.  
(Adapted from Gubbles, 2014) 
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Toxoplasma infection can cause neurological and behavioral changes, and has been 
linked to psychological disorders such as depression, schizophrenia and suicidal behavior 
(Flegr, 2013, Dubey, 1996).  The most interesting behavioral change has been found in 
rodents, where infected rats display an attraction to the scent of feline urine thereby 
leading them to be consumed by the parasite’s definitive host, completing its life cycle 
(Berdoy et al., 2000, Dubey 1996, Montoya and Liesenfeld, 2004). 
1.5.  The model Apicomplexan 
Toxoplasma is a member of the phylum Apicomplexa that includes other 
important pathogenic genus such as Plasmodium, the cause of malaria, Cryptosporidium, 
a water borne parasite and Eimeria, Neospora, and Theleria all of which are important 
zoonotic parasites (Montoya and Liesenfeld 2004).  Among intracellular parasites, 
Toxoplasma is the most experimentally tractable organism and is amenable to genetic 
manipulation with reliable protocols for both forward and reverse genetics.  These 
include high transient transfection efficacy and expression of epitope tags, reporter 
constructs and heterologous proteins.  The genomic sequences for type I, II, and III 
parasite strains are available (toxodb.org) with regular updates (Gajria et al., 2008).  
Furthermore, Toxoplasma can be used as an expression system to study biological 
functions of other apicomplexan parasites that cannot be expressed in other organisms 
(Soete et al., 1999, Weiss and Kim 2007).  Toxoplasma has also been widely used as a 
model to study host-parasite interactions, basic biology of host immune response, and 
mouse models (Weiss and Kim 2007).  Toxoplasma is a unique model organism for 
intracellular parasitic research. 
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1.6.  Gene regulation 
The regulation of gene expression is vital to the survival of all organisms.  The 
levels of gene products, both functional proteins and RNAs, can be modulated at the level 
of transcription, post-transcription, translation and post-translation.  Transcription 
regulation is the control of DNA expression orchestrated via chromatin modifications, 
transcription factors such as enhancers and repressors, and promoter activity (Bell et al., 
2011, Bruce et al., 2007).  Post-transcriptional regulation is the control of gene 
expression at the RNA level via RNA editing, intron splicing and addition of 5’ cap and 
poly(A) tail; interactions with RNA binding proteins for nuclear export and processing; 
and non-coding RNAs for mRNA degradation or translational repression (Bruce et al., 
2007).  Within this complex network of controlled gene expression, my work focuses on 
post-transcriptional gene regulation via non-coding RNAs, which is another layer of the 
control of gene regulation. Thus this section is focused upon the current knowledge of 
post-transcriptional gene regulation. 
1.6.1.  Post-transcriptional gene regulation by RNA interference 
In 1998 Fire and Mello published one of the most influential discoveries in 
science that described the RNA interference (RNAi) pathway in Caenorhabditis elegans.  
The study began with an investigation of antisense RNA function in modulating the 
expression level of endogenous genes at the mRNA level.  Double-stranded RNA 
(dsRNA) molecules were found to be more potent and specific at interfering with genes 
than antisense RNA (Fire at al., 1998).  English and Jones (1998) described a gene 
silencing effect caused by integration of T-DNA transposons in tobacco plants that 
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caused heritable epigenetic changes to promote drug resistance.  Shortly thereafter, 
Chuang and Meyerowitz (2000) reported that in Arabidopsis thaliana, RNA duplexes 
were able to induce significant gene-specific down-regulation when compared to single-
stranded sense or antisense alone.  The study confirmed the dsRNA-mediated 
interference (Chuang and Meyerowitz, 2000).  RNA interference (RNAi) is thus 
described as a biological process by which the expression of a gene can be altered by 
non-coding RNA molecules.  The pathway has been found in many single-cell and 
multicellular eukaryotes.  Not all eukaryotes contain the required enzymes or effector 
RNA for a functional RNAi mechanism.  For example, some protozoa such as 
Leishmania major, Trypanasoma cruzi and Saccharomyces cerevisiae lack the RNAi 
pathway, while other protozoa such as Trypanasoma brucei, Tetrahymena thermophile, 
and Saccharomyces castelli contain the canonical RNAi components (Kolev et al., 2011, 
Aravind et al., 2000).  The RNAi pathway is believed to be similar to an immune system 
in cells that can defend against viral infection and transposons for chromatin integrity and 
development (Matzke and Matzke, 2004).  It remains unclear for what purpose the 
presence or absence of a functional RNAi pathway is among these single-celled 
organisms.  It has been hypothesized that select organisms might lose the need for an 
RNAi mechanism thus the necessary genes for a functional pathway (Kolev et al., 2011). 
The RNAi mechanism is initiated by the presence of long dsRNA.  In the cytosol, 
dsRNA molecules are cleaved into smaller 20-25 nucleotide duplexes with a 2-nucleotide 
3’ overhang by a member of the RNAse III family called Dicer (Siomi and Siomi, 2009, 
Bernstein et al., 2001).  The RNA product is called either microRNA (miRNA) or small 
interfering RNA (siRNA, Figure 1.3.).  The RNA duplex is then transferred to an 
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Figure 1.3.  RNA interference pathway.  RNAi is initiated by the presence of long 
dsRNA that is cleaved by Dicer.  Within RISC, small RNAs are bound by an Argonaute 
protein and guided to their target mRNA through either a perfect match or mismatch 
complementarity (guide strand in red).  In the nucleus, the RITS complex controls 
transcription through histone modifications or small RNA interactions with DNA or 
RNA.  An enhanced silencing effect can be observed by amplification of effector RNA 
by an RdRp.  (Adapted from Matzke and Matzke, 2004) 
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Argonaute protein in the RNA-induced silencing complex (RISC).  Within RISC, the 
antisense strand of the RNA duplex guides the RISC complex to its target mRNA, which 
gives its name as the guide strand.  The sense strand, or passenger strand, is removed and 
degraded (Preall et al., 2006, Okamura et al., 2004).  Generally the outcome of gene 
regulation occurs based on the complementarity of the miRNA or siRNA to the mRNA 
target.  Perfect match interactions result in mRNA degradation, while mismatch 
interactions result in translational repression (Figure 1.3.).  MiRNAs generally function in 
translational repression, as they rarely contain perfect match complementarity to mRNA 
targets (Okamura et al., 2004).  MiRNA binding sites can be found throughout target 
mRNA structures (i.e. CDS, 5’ and 3’-UTR), but most often located within the 3’ UTR of 
the mRNA (Lim et al., 2004, Friedman et al., 2009).  The effects of these small non-
coding RNAs can be amplified through the synthesis of secondary siRNAs produced by 
an RNA-dependent RNA polymerase (RdRp).  The RNAi mechanism also allows for the 
maintenance and organization of the genome by transcriptional regulation via  the RNA 
induced transcriptional silencing (RITS) complex (Figure 1.3., Holmquist and Ashley, 
2006). 
Since its discovery, RNAi has quickly become the preferred methodology to 
precisely, efficiently, and stably down-regulate any gene of interest for functional studies 
(Saurabh et al., 2014).  DsRNA can be easily generated and introduced into a cell or 
organism.  Since synthetic RNAs can be recognized and utilized by the enzymes involved 
in the RNAi pathway, functional genomic applications such as mapping and annotation 
have been possible in organisms where traditional engineering methodologies are 
difficult (Saurabh et al., 2014, Kupferschmidt, 2013).  RNAi has also been used to 
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genetically engineer plants to produce lower levels of toxins, improve stress tolerance 
and act as an insecticide (Grimm et al., 2006, Kupferschmidt, 2013). 
1.6.2.  Argonaute protein 
Argonaute proteins are central to the RNAi mechanisms, where they direct small 
non-coding RNAs to induce gene silencing.  In eukaryotes, gene silencing can occur at 
the transcriptional, post-transcriptional and chromatin remodeling levels by (i) 
degradation of mRNA target, (ii) translational repression or (iii) by causing chromatin 
modifications.  Argonaute proteins were first discovered in plants and named after a 
phenotype of A. thaliana mutant that resembled the animal Argonauta argo (Bohmert et 
al., 1998).  Among eukaryotes, the total number of Ago proteins can vary among 
organisms.  Drosophila melongaster, Homo sapiens, and C. elegans, contain five, eight 
and 27 paralogs, respectively, while Schizosaccharomyces pombe and S. castellii contain 
only one (Jinek and Doudna, 2009).  When an organism contains more than one ortholog 
of Ago, each paralog may have a different function from one another despite their 
sequence similarity.  For example, one paralog of Ago could be found within the nucleus 
while another in the cytosol to facilitate transcriptional or post-transcriptional gene 
silencing, respectively. Organisms that contain a single ortholog of Ago, the protein can 
be found within the nucleus and cytosol and participate in both transcriptional and post-
transcriptional gene regulation. 
Based on sequence homology and phylogenetic analysis, Ago proteins are 
categorized in three subfamilies; (i) the Ago-like subfamily, whose members resemble A. 
thaliana Ago1.  Members of the Ago-like subfamily contain two conserved domains 
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called PAZ (Piwi-Argonaute-Zwille) and Piwi (P-element induced wimpy testis). They 
are typically ~100 kDa and interact with miRNAs and siRNAs. Their Piwi domain also 
contains the canonical catalytic triad, DDH/E. (ii) The Piwi-like subfamily, whose 
members resemble D. melanogaster Piwi protein.  Piwi-like subfamily members contain 
only the Piwi domain, are generally ~40 kDa and interact solely with PIWI-interacting 
RNAs (piRNAs).  (iii) The WAGO subfamily, whose members are only found in C. 
elegans.  For the purpose of this thesis I will be focusing on members of the Ago-like 
subfamily. 
1.6.2.1.  The function of Argonaute in the mechanism of gene silencing 
Ago proteins bind small non-coding RNAs and play important part in the 
mechanism of gene silencing.  Ago-bound small RNAs alone cannot catalyze the reaction 
without first forming a fully functional RISC.  The formation of RISC involves (i) 
loading and (ii) subsequent unwinding of the small RNA duplex by Ago.  Theoretically 
either strand of the small RNA duplex could act as the guide strand, but 
thermodynamically the termini of small RNA determine which strand is loaded or 
discarded in Ago proteins.  Generally, the less stably paired 5’-end of the RNA duplex is 
loaded to Ago, and is known as the guide strand (Khvorova et al., 2003, Schwarz et al., 
2003).  This reaction requires ATP hydrolysis to mediate a conformational change of Ago 
to accommodate the small RNA.  After the RNA duplex is bound, Ago reverts back to its 
closed state, which drives the removal and degradation of the passenger strand 
(Kawamata and Tomari, 2010).  The exact mechanism of unwinding and discarding of 
the passenger strand remains unclear.  The complex between Ago and the single-strand 
guide RNA, referred to as the miRISC, recognizes its target mRNA through 
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complimentary base pairing.  Although many software applications aimed to predict 
miRNA targets have been developed and refined, the success in the identification of 
mRNA targets is still limited. This, in part, is due to the lack of consensus rules 
describing the exact base pairing or structure of small RNA to be loaded onto miRISC.  
Single-molecule fluorescence resonance energy transfer (FRET) analysis showed that 
human HsAgo2 initially scans for its target by using 2-4 nucleotides of the guide strand 
sequence.  The stability of the interaction increases with base pairing of the seed 
sequence 2-8 nucleotides from the 5’ end of the guide strand.  Perfect-matched 
complementarity promotes mRNA cleavage, while mismatches in the central region lead 
to translational repression of the target mRNA (Chandradoss et al., 2015).   Translational 
repression could still lead to mRNA degradation due to deadenylation and decapping of 
the target mRNA (Nishihara et al., 2013, Arribas-Layton et al., 2013). 
Under stress conditions Ago proteins have been shown to localize to the nucleus 
to facilitate transcriptional regulation by associating with chromatin modifiers and 
splicing factors (Ameyar-Zazoua et al., 2012).  For example, the catalytically inactive 
HsAgo1 and catalytically active HsAgo2 have both been shown to promote methylation 
of the H3K9 histone to slow RNA polymerase II elongation rate (Wu et al., 2006). 
1.7.  Non-coding effector RNAs 
Regulatory non-coding RNAs (ncRNAs) are single stranded or double-stranded 
RNA molecules transcribed by either RNA polymerase II or III to produce a functional 
RNA molecule (Morey and Avner, 2004).  NcRNAs originate from intergenic regions as 
antisense RNA or from overlapping protein-coding genes.  NcRNAs are classified by 
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their function as a housekeeping or regulatory RNA.  Examples of housekeeping ncRNAs 
include transfer RNAs and ribosomal RNAs while examples of regulatory RNAs include 
microRNAs (miRNAs) and small interfering RNAs (Morey and Avner, 2004, Brosius, 
2005, Palazzo and Lee, 2015). 
1.7.1.  Long non-coding RNAs 
Long non-coding RNAs (lncRNAs) are grouped based on their length of 200-
2,000 nucleotides.  LncRNAs function to control gene expression by (i) sequence 
complementarity for gene silencing, (ii) secondary structure formation of scaffolds to 
assemble complexes, (iii) or act as a decoy for transcription factors (Yoon et al., 2013). 
1.7.1.1.  Antisense RNA 
Long antisense RNAs are single-stranded RNAs that can be transcribed by either 
RNA polymerase II or III or the product of spliced introns of pre-mRNA.  Antisense 
RNAs function by binding to the complementary nucleotides in mRNA gene targets.  The 
first studies of antisense RNA as an effector RNA is the hok/sok system of E. coli.  The 
R1 plasmid, which encodes for the hok gene (host killing), also encodes an antisense 
RNA, sok.  When the sok antisense is expressed, the translation of complementary hox 
mRNA is inhibited by base pair complementation, causing an obstruction to the 
translation machinery (Gerdes et al., 1985).  Transcription of long antisense RNA is often 
associated with the expression of its protein-coding gene (Engstrom et al., 2006, Korneev 
et al., 2015).  Xist and Tsix are perhaps the most well-known non-coding single-stranded 
RNAs, involved in random X inactivation in female mammalians.  Xist ncRNA is 
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expressed from one X chromosomes, and is regulated by the expression of an antisense 
ncRNA Tsix to induce transcriptional silencing (Stavropoulos et al., 2001). 
1.7.1.2.  Long double-stranded RNA 
In eukaryotes long dsRNA is formed by the transcription of complementary sense 
and antisense RNA molecules or by transposable elements (Wicker at al., 2007).  The 
presence of transposable elements can cause truncated coding and non-coding transcripts 
in both sense and antisense directions.  DsRNAs are shown to involve in chromatin 
remodeling, RNA editing, processing and nuclear localization (Meister and Tuschl, 
2004).  DsRNA can be acquired as a result of viral infection.  RNA viruses use RNA 
rather than DNA as its genetic material which can be present as long dsRNA that initiates 
the RNAi mechanism (Blevins et al., 2006). 
1.7.2.  Small double-stranded RNAs 
MiRNAs and siRNAs are the most pertinent small RNAs to be discussed here. 
They are derived from long dsRNAs which are (i) exogenous dsRNA such as viral RNA, 
(ii) endogenously transcribed as RNA-encoding genes, or (iii) spliced introns, called 
mirtrons (Rother and Meisster, 2011).  These small dsRNAs are central to the post-
transcriptional gene regulation mechanism which alters gene expression by causing 
mRNA destruction or translational repression.  Conversely, small dsRNAs can also bind 
mRNA targets to increase their activity via recruitment of transcriptional or translational 
initiation machinery (Rother and Meisster, 2011). 
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1.7.2.1.  MicroRNAs 
Lee and co-workers at Dartmouth College described the first single-stranded non-
protein-coding regulator RNA, lin-4 in C. elegans (Lee et al., 1993).  The lin-4 locus 
encodes for small RNA molecules with partial complimentary to several sequences 
located on the 3’ untranslated region of lin-14 mRNA, which is important for larval 
development.  lin-4 regulates the expression of lin-14 through an antisense RNA 
mechanism (Lee et al., 1993, Wightman et al., 1993).   let-7 is another excellent example 
of functional small RNA.  let-7 represses the expression of  lin-41 which is important in 
developmental transitions of C. elegans (Reinhart et al., 2000).  MiRNAs are well 
conserved in both plants and animals. However, miRNA biogenesis are different among 
organism kingdoms (Axtell et al., 2011). 
1.7.2.2.  Mammalian miRNAs 
Mammalian miRNAs are able to recognize and bind their target mRNA via 
Watson-Crick base pairing at positions 2 to 8 from the 5’ end of the miRNA, called the 
seed sequence (Bartel, 2004).  Thus, miRNA families are generally grouped based on 
their seed sequence.  By using transcriptome-wide mapping of miRNA binding sites 
(Ago HITS-CLIP), Soek et al (2016) showed that miRNA target binding occurred 
through non-canonical sites and interactions.  Canonical miRNA target interactions 
would be the 2-8 nt seed sequence of the guide RNA.  These non-canonical interactions 
may include a near perfect match (1 nt mismatch), a 1 nt bulge, or a wobble (G:U non-
Watson-Crick base-pairing).  Another contributing factor is the central nucleotides 
termed seed-like motifs.  The interaction with the seed-like motif negates the need for 
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perfect match binding within the seed region (Soek et al., 2016).  These above described 
interactions induce translational repression, which may eventually lead to mRNA 
degradation rather than direct cleavage of target mRNA.  Noteworthy, a miRNA family 
could have hundreds of different mRNA targets, and a target could be regulated by 
multiple miRNAs (Bartel, 2004). 
Mammalian miRNAs can be transcribed by either RNA polymerase II or III from 
intergenic regions or from spliced introns (Lee at al., 2004, Faller et al., 2008).  Multiple 
miRNAs can be produced as ploycistronic units by one long dsRNA primary miRNA 
(pri-miRNA).  A single pri-miRNA, ~80 nucleotides, may contain one up to six miRNAs.  
Pri-miRNAs produced by pol II result in a transcript that is capped at the 5’ end and 
polyadenylated.  The resulting pri-miRNA folds into a secondary double-stranded 
structure (Figure 1.4, Lee et al., 2004, Altuvia et al., 2005). RNA polymerase III can also 
transcribe pri-miRNAs, but these RNAs are not capped or polyadenylated (Faller at al., 
2008).  A member of the RNaseIII family cleaves the pri-miRNA to form a single hairpin 
structure, referred to as pre-miRNA (Figure 1.4., Murchison et al., 2004).  Pre-miRNAs 
produced from spliced introns are also called mirtrons. Pre-miRNAs are exported from 
the nucleus by the nucleocytoplasmic Exportin-5.  Once exported, Dicer, which is 
another RNAseIII family member, cleaves the pre-miRNA to produces a 20-25-
nucleotide miRNA duplex (Figure 1.4. B, Lund et al., 2006). 
19 
 
 
Figure 1.4. MicroRNA biogenesis.  Pri-miRNAs produced by pol II result in a transcript 
that is capped at the 5’ end and polyadenylated.  The resulting pri-miRNA folds into a 
secondary double-stranded structure. Drosha cleaves pri-miRNAs to form pre-miRNAs 
that are exported from the nucleus by Exportin-5.  Dicer cleaves the pre-miRNAs to 
produces a 20-25-nucleotide miRNA duplex with a 2-nucleotide overhang on the 3’ end.  
MiRNAs and their target mRNA interaction cause either mRNA degradation or 
translational repression (Adapted from Hoffmann, et al., 2012). 
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Dicer cleavage creates a 2-nucletoide overhang on the 3’ end of each miRNA strand 
(Lund et al., 2006, Murchison et al., 2004). 
1.7.2.3.  Plant miRNAs 
Unlike mammalian miRNAs, plant miRNAs usually have a near-perfect base 
pairing interaction with their target mRNAs.  Plant pri-miRNAs are generally transcribed 
by pol II from independent non-coding intergenic regions, by inverted duplication of 
protein-coding or non-protein-coding regions.  This accounts for the extensive target 
complementarity required by plant gene regulation mechanisms.  The majority of pri-
miRNAs encode a single mature miRNA. Therefore, pri-miRNAs derived from intron 
splicing are rare (Axtell et al., 2011).  Processing of pri-miRNAs to a mature miRNA 
duplex occurs in the nucleus by an RNaseIII Dicer homolog, Dicer-like 1 (DCL1).  The 
miRNA duplex is also methylated at the 3’ overhang by an RNA methyltransferase 
protein called Hua-Enhancer 1 (HEN1); which has not been observed in mammalian 
miRNAs.  The duplex is then transported from the nucleus by an Exportin-5 homolog 
called Hasty (HST, Axtell et al., 2011, Lelandais-Briere et al., 2010). 
1.7.2.4. Small interfering RNAs 
In 1999, Baulcombe and Hamiliton discovered small interfering RNAs (siRNAs) 
while studying viral infection in plants (Hamilton and Baulcombe, 1999).  However, 
siRNAs can also be endogenous (endo-siRNA) generated by three mechanisms; (i) a 
perfect match hairpin derived from inverted repeats, (ii) a cis-natural siRNAs (cis-nat 
siRNAs) transcribed from the same genomic locus as their target but from the opposite 
DNA strand or (iii) trans-natural siRNAs (trans- nat-siRNAs) transcribed at different loci 
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that encode for a gene and a pseudogene (Figure 1.5A, Elbashir et al., 2001).  Endo-
siRNAs are generated by a similar mechanism as miRNAs mentioned above (1.7.2.2.). 
However, exo-siRNA precursors originate from viral infection generated by an RNA-
dependent RNA polymerase and processed by a cytosolic RNAseIII member (Figure 1.5, 
D.).  On the other hand, endo-siRNAs are first transcribed and processed within the 
nucleus by an RNAseIII member then transported to the cytosol by an Exportin-5 
homolog, as observed in mammalian miRNA biogenesis (Figure 1.5.).  The resultant 
mature siRNAs duplexes contain a phosphorylated 5’ end and a hydroxylated 3’ end with 
a two-nucleotide overhang (Bernstein et al., 2001, Elbashir et al., 2001). 
1.8.   MiRNA and siRNA structure leads to function 
When Dicer processes long dsRNA RNA molecules, the PAZ domain binds to the 
3’ end of the RNA substrate to aid in stabilization of the dsRNA for cleaving.   Upon 
binding, dsRNA interacts with the intermolecular dimer of two RNAseIII domains of 
Dicer.  Each RNAseIII domain cleaves one of the two-dsRNA strands and creates the 
canonical 3’ 2 nucleotide overhang (Tomari and Zamore, 2005).  This interaction and 
subsequent enzymatic reaction yield products of 20-25 nucleotides long.  Argonaute 
proteins preferentially bind and keep the stand with the less stable paired 5’ end of the 
small dsRNA.  The passenger strand is degraded from the complex.  Thermodynamically, 
the unwinding of A:U bonds are preferred to G:C bonds because of the fewer hydrogen 
bonds necessary to disrupt, hence, A:U rich 5’ ends are preferred.  Binding of the small 
RNA to Argonaute requires ATP for conformational changes to accommodate the small 
RNA (Kim, 2005).  The “slicer” activity of Argonaute takes place within the Piwi domain 
where the phosphodiester linkage between nucleotides of the target mRNA are cleaved. 
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Figure 1.5.  Origins of small non-coding RNAs.  A. Endo-siRNAs originate from hairpin 
derived from inverted repeats, cis-natural siRNAs, or trans-natural.  B. MiRNAs 
biogenesis.  D. Exo-siRNA precursors originate from viral infection.  Dicer processes 
small RNAs in the cytosol to produce effector RNAs.  (Adapted from Rother and 
Meisster, 2011) 
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Once the cleaved mRNA is removed from the complex the guide strand can remain 
bound to Argonaute to engage another target mRNA (Tomari and Zamore, 2005). 
1.9.  Post-translation modifications by SUMOylation 
In 1997, Melchior discovered a mysterious protein mobility shift that was due to 
the addition of a novel protein modification that she would later name SUMO (small 
ubiquitin-related modifier).  This later lead to the discovery of the post-translational 
modification pathway called SUMOylation described as the reversible addition of a 
SUMO (small ubiquitin-like modifier) peptide (90-110 amino acids) to a protein substrate 
(Mahajan et al., 1997).  Unlike ubiquitination, where proteins are polyubiquitinylated and 
sent to lysosomes for degradation, the addition of a SUMO peptide aids in protein 
localization, stabilization and activity (Hay, 2005, Komander and Rape, 2012).  The 
addition of SUMO has been observed in proteins involved in DNA repair, transcription, 
RNA processing, nuclear-cytoplasmic transport, stress response and progression through 
the cell cycle (Hay, 2005, Liu and Shuai, 2008). 
The pathway is initiated through the cleavage of a SUMO precursor by a protease 
called Ulp1 (ubiquitin-like protease 1).  Ulp1 is a cysteine peptidase that is highly 
specific for the SUMO peptide as it recognizes the tertiary structure of SUMO rather than 
an amino acid sequence (Mossessova and Lima, 2000).  To form a mature SUMO, Ulp1 
cleaves amino acid residues from the C-terminal end of the SUMO precursor to reveal a 
di-glycine motif that is required for attachment to target proteins (Figure 1.6, A.).  Ulp1 
cleaves peptide bonds via hydrolysis that involves a thiol group of a cysteine residue as a 
nucleophile, a histidine and an aspartic acid, which forms the Ulp1 catalytic triad.  The 
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Figure 1.6.  The SUMOylation pathway.  The SUMOylation pathway is initiated by the 
presence of a SUMO precursor that is cleaved from the C-terminal end to reveal a di-
glycine motif by Ulp1 (A).  The mature SUMO is transferred to an E1 then E2 complex 
(B, C).  E3 ligates SUMO to a protein substrate (D), which recognizes the KxE 
consensus sequence (where  is a large hydrophobic residue and x is any residue).   Ulp1 
also removes SUMO from conjugated protein substrates (E).  (Adapted from Hay, 2013) 
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mature form of SUMO with its revealed di-glycine motif is transferred to the catalytic 
cysteine of an E1 activating enzyme by the formation of a thioester bond (Figure 1.6, B.).  
Next, SUMO is transferred to the catalytic cysteine residue in the E2 conjugating enzyme 
which directly binds to a protein substrate. SUMO is then conjugated to the protein 
substrate by an E3 ligase that recognizes a KxE consensus sequence (where  is a large 
hydrophobic residue and x is any residue) on the protein substrate (Figure 1.6. C and D.).  
The carboxyl group of the di-glycine motif is ligated to the –amino group of a lysine 
residue on the substrate.  Ulp1 is also responsible for the removal of SUMO from 
SUMOylated proteins (Mossessova and Lima, 2000, Watts 2013). 
1.10.  Research Objectives 
Toxoplasma contains all the canonical components of a post-transcriptional gene 
silencing mechanism including RNAi genes Argonaute and Dicer as well as effector 
RNAs.  Although an RNAi-like gene silencing can be observed in Toxoplasma with long 
dsRNA, the functions of the underlying mechanism are still unknown.  The following 
chapters describe my investigation towards the better understanding of RNA directed 
gene regulation in Toxoplasma. 
The first goal (Chapter 2) describes the development of a reporter system 
allowing for the study of gene silencing in Toxoplasma.  Using our dual luciferase 
reporter system we investigated the ability of endogenous Toxoplasma miRNAs to induce 
a gene silencing effect (Chapter 3).  The Renilla luciferase transcript was engineered to 
contain binding sites for the two most abundant miRNA families, miR-60 and miR-4.  
The silencing effect caused by endogenous miRNAs could be altered by the use of 
miRNA mimics and inhibitors.  As the most abundant miRNA family, miR-60 was 
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directed to down-regulate a gene of interest for functional studies.  This new 
methodology proved extremely useful for fast and efficient down-regulation of an 
essential and non-essential gene.  We compiled a comprehensive review on antisense 
RNA technologies and their current uses in Toxoplasma in Chapter 4.  This review 
outlines the applications, advantages and disadvantages of antisense RNA as a genetic 
modifier.  Although Toxoplasma miRNAs are functional, their underlying importance in 
gene regulation induced gene silencing remained unclear.  Chapter 5 describes my work 
on the identification and characterization of a model gene target of Toxoplasma miRNAs.  
This endeavor uncovered an interesting self-regulating gene (TgUlp1) by the miR60 
family whose expression and activity could greatly impact overall parasite cell biology.  
Disregulation of TgUlp1 expression created a cascade of events that can lead to parasite 
termination.  Chapter 6 describes my work on Toxoplasma Argonuate.  Even though the 
expression of TgAgo has been identified to a single locus, two forms of TgAgo are 
expressed.  Further investigation is still required in this area however these are the first 
studies to suggest that multiple forms of Argonaute could arise from alternative 
translational start sites. 
Overall, this dissertation reveals the importance of proper gene regulation directed 
by non-coding RNAs in Toxoplasma.  These studies have led to the development of a 
methodology that can be used as a genetic tool to quickly and efficiently down-regulate a 
gene for functional analysis and to study its importance to parasite cell biology.  Thereby, 
this tool could also lead to quicker and more effective drug development studies.  
Although the use of synthetic siRNAs in biomedical research to induced gene silencing 
as a drug therapy is promising (Schiffelers et al., 2004), and Tg-miRNA mimics and 
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inhibitors could be directed as an anti-Toxoplasma therapy, these studies were first aimed 
at understanding the post-transcriptional gene silencing mechanism by miRNAs. 
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CHAPTER 2 
Evaluation of the ability of short and long double-stranded RNAs to induce homologous 
gene silencing in the protozoan parasite, Toxoplasma gondii 
2.1.  Introduction 
Since its discovery (Elbashir et al., 2001 and Fire et al., 1998), RNA interference 
(RNAi) has become one of the most effective tools used in biological research for 
altering gene expression patterns for studying functional genetics. The RNAi 
methodology has expanded to serve many applications and purposes in both diagnostic 
and medical sciences (Grimm, 2009 and Kim and Rossi, 2008). Fundamentally, RNAi is 
a naturally occurring, evolutionary conserved, highly efficient and specific pathway by 
which short double-stranded RNAs (dsRNA) trigger the inhibition of gene expression 
(Carthew et al., 2009 and Meister et al., 2004). In metazoans, dsRNAs are expressed in 
the form of long primary transcripts, called pri-miRNAs. Pri-miRNAs are single, fold-
back molecules that form dsRNA structures by intramolecular interactions, which are 
then processed by one or more RNAseIII members (i.e. Drosha and Dicer) into short and 
functional silencing RNAs, called miRNAs (Carthew et al., 2009 and Grimm, 2009). One 
single strand of the miRNA, called the mature guide or antisense strand, is then loaded 
onto the RNA-induced silencing complex (RISC), which allows it to bind its mRNA 
target to induce gene silencing (Brodersen et al., 2009). In protozoans, such a mechanism 
has been elucidated in Trypanosoma brucei, a parasitic and pathogenic kinetoplast (Ngo 
et al., 1998), which has a more complex silencing mechanism than Tetrahymena, a 
ciliated paramecium (Schramke et al., 2004). 
The discovery of an RNAi mechanism in T. brucei (Ngo et al., 1998) has sparked 
considerable interest in exploiting the mechanism for the study of pathogenesis in a 
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variety of pathogenic protozoan parasites, including T. cruzi (Chagas disease), 
Leishmania spp. (leishmaniasis), Plasmodium spp. (malaria) and T. gondii 
(toxoplasmosis). Limited success has been reported (Kolev et al., 2011), and its possible 
causes could lay in their evolutionary divergence (Ullu et al., 2004). The genome 
sequence revealed the absence of RNAi genes in T. cruzi (El-Sayed et al., 2005) and old-
world L. major and L. donovani (Ivens et al., 2005), thus explaining their lack of response 
to dsRNA. Enigmatically, P. falciparum, whose genome lacks conserved RNAi-genes, 
was shown to exhibit homologous gene silencing, akin to RNAi, where dsRNA could 
trigger down-regulation of gene expression (McRobert et al., 2002). Based on their 
evolutionary divergence, only some species have conventional RNAi genes and 
functions; while others retain only some homologs and/or functions. More investigations 
are required to unravel the mechanism of homologous gene silencing and to render a 
fruitful genetic tool for these protozoan parasites. 
Among these evolutionarily distant protozoan organisms, T. gondii harbors an 
ortholog of Dicer, Argonaute and RNA-dependent RNA polymerase (Al Riyahi et al., 
2006, Braun et al., 2010 and Kolev et al., 2011). T. gondii, an obligate intracellular 
parasite of the phylum Apicomplexa, is one of the most successful parasitic pathogens 
that has infected an estimated one third of the population and is a major threat in 
immunocompromised individuals (Montoya and Liesenfeld, 2004). To gain a better 
understanding of the biology and pathogenesis of T. gondii, a homologous gene silencing 
via RNAi methodology offers an excellent genetic tool. Although the canonical RNAi 
mechanism has not yet been demonstrated in T. gondii, it was shown that miRNAs in T. 
gondii (Tg-miRNAs) are expressed in a high abundance in some lineage strains such as, 
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RH (type I), PRU (type II) and CTG (type III) (Braun et al., 2010). Some of these 
annotated Tg-miRNAs were shown to associate with translation machinery, suggesting 
their functions in the regulation of gene expression similar to other eukaryotes. Moreover 
the possible targets of Tg-miRNA were predicted to interact by perfect or partial base-
pair interaction similar to those of siRNA and miRNA of other eukaryotes (Braun et al., 
2010). 
Despite a lack of a mechanistic characterization, our group is one of few 
laboratories which successfully showed that homologous gene silencing, similar to RNAi, 
is functional and can be used in the study of T. gondii biology (Al-Anouti and 
Ananvoranich, 2002, Al-Anouti et al., 2003, Al-Anouti et al., 2004, Adams et al., 2005, 
Ananvoranich et al., 2006, Yu et al., 2008 and Yu et al., 2009, Holmes et al., 2010). 
However, these results have proved difficult to reproduce in other laboratories (Kolev et 
al., 2011). Here, in an attempt to standardize homologous gene silencing in T. gondii, a 
dual luciferase reporter system was employed so that the expression of Photinus (firefly, 
Ffluc) and Renilla (Rnluc) luciferases, served as an internal control and a test target, 
respectively. Such a reporter system would allow any interested laboratories to set up 
comparable experiments to ensure reproducibility of the RNAi activity. A similar reporter 
system was successfully used in the study of an RNAi mechanism in mammalian cell 
cultures, including Hela, Cos-7 and Huh-7 cells (Choe et al., 2010 and Elbashir et al., 
2001). The reporter system would thus allow for an unbiased analysis of the silencing 
capability and effectiveness found in T. gondii, in comparison to those of other 
organisms. In addition, we have demonstrated that both long and short dsRNA are 
capable of invoking homologous gene silencing in T. gondii with different silencing 
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abilities. Here we referred to the short dsRNA with perfect-matched central bases as 
“siRNA”, and that with mismatched central bases as “miRNA”. This study was the first 
to show the ability of miRNA to induce gene silencing in T. gondii. 
2.2.  Material and Methods 
 
2.2.1.  Cell and parasite cultures 
 
Human foreskin fibroblasts (HFF; ATCC, #1041) were maintained using 
Dulbecco’s Modified Eagle Media (D-MEM) with high D-glucose and L-glutamine 
(Invitrogen, #12100046) supplemented with 10% cosmic calf serum (ThermoFisher 
Scientific, Hyclone, #H3008704N) and diluted (0.5x) Antibiotic-Antimycotic 
(Invitrogen, #15240-062) at 37 °C in 5% CO2. RHΔHX, T. gondii type I strain (NIH 
AIDS Research and Reference Reagent Program, #2857) was cultured in confluent HFF 
using Minimum Essential Media (MEM, Invitrogen, #61100061) supplemented with 1% 
dialyzed fetal bovine serum (ThermoFisher Scientific, Hyclone, #SH3007903) and 
diluted (0.5x) Antibiotic-Antimycotic. 
 
2.2.2. Reporter plasmids 
 
Expression plasmids, pTubRn and pTubFf, were derived from pRL-3xBulge and 
pFL-Con (Pillai et al., 2005) and pTub_eGFP_mCherry_CAT which were gifts from W. 
Filipowicz (Friedrich Miescher Institute for Biomedical Research, Switzerland) and J. 
Murray (University of Pennsylvania, USA), respectively. In separate reactions, the DNA 
fragments containing the coding sequence of Rnluc and miRNA-testing target sites and 
the coding sequence of Ffluc were excised from the plasmids pRL-3xBulge and pFL-Con 
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following (i) Not I digestion, (ii) Klenow Fragment treatment, (iii) NheI digestion and 
(iv) gel extraction. The resulting DNA fragment containing either designed Rnluc-
silencing target or Ffluc was ligated to prepared pTub_eGFP_mCherry_CAT. In the 
preparation of pTub_eGFP_mCherry_CAT, the coding sequence of eGFP_mCherry 
fusion was removed following (i) Afl II digestion, (ii) Klenow Fragment treatment, (iii) 
Nhe I digestion and (iv) gel extraction to give the cloning vector carrying the T. gondii-
Tubulin (TgTub) promoter and the polyadenylation signal, contained within the 3’-UTR 
of T. gondii dihydrofolate reductase (TgDHFR), flanking the Rnluc or Ffluc coding 
sequence, and chloramphenicol acetyltransferase cassette. Resultant pTubRn and pTubFf 
plasmids were subjected to restriction endonuclease analyses and nucleotide sequencing 
reactions to confirm their identity and correct open reading frame. 
 
2.2.3.  In vitro transcription of long and short dsRNAs 
In vitro transcription reactions were carried out using either 2 μg DNA amplicons 
or 2 μM annealed primers as templates in the presence of T7 RNA polymerase (~5 units), 
80 mM HEPES-KOH (pH 7.5) 24 mM NaCl2, 2 mM spermidine, 40 mM DTT, 10 mM 
rNTPs, and ~1 unit pyrophosphatase in 50 μL reaction mixtures at 37° C for 16 hours, 
similar to previously described conditions (Al-Anouti and Ananvoranich, 2002). 
Resultant RNAs were extracted with one volume of phenol-chloroform mixture (1:1), 
subsequently precipitated and quantified using a spectrophotometer (Thermo Scientific 
NanoDrop2000). The DNA amplicons were prepared using oligonucleotide primers 
containing a gene specific sequence and the sequence of the T7 promoter, as listed in 
Table 2.1, under standard conditions for Taq DNA polymerase (New England Biolabs). 
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Table 2.1.  Oligonucleotide primers used in the study.  The sequence of T7 RNA 
polymerase promoter and its complementary bases are in bold and underlined, 
respectively. 
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For Rnluc-dsRNAs, pTubRnluc was used as templates for PCR amplification using two 
sets of oligonucleotide primers: FW_RnLuc_1 and RV_RnLuc_1 to yield Rnluc- 
dsRNA_1, or FW_RnLuc_2 and RV-RnLuc_2, to yield Rnluc-dsRNA_2. The amplicon 
used in the generation of control dsRNA was amplified from a plasmid containing T. 
gondii uracil phosphoribosyl transferase (TgUPRT) and a pair of oligonucleotide primers, 
called FW_UP and RV_UP. 
For short dsRNA in vitro transcription, annealed oligonucleotide primers were 
used as templates. The oligonucleotide primers were designed to contain a 
complementary sequence of the T7 RNA polymerase promoter and the target sequences 
to independently generate sense and antisense strands of the RNA. The templates for the 
sense RNA strand synthesis were formed by heating a mixture of 2 μM T7promoterGG 
and Sense_Tpl for 5 minutes at 70 °C and slowly cooling to room temperature. The 
mixture was then used in the in vitro transcription reaction. Similar procedures were 
carried out to create the templates for the antisense strands carrying a perfect or mismatch 
complementarity by using T7promoterGG to anneal with Antisense_match_Tpl or 
Antisense_mismatch_Tpl respectively. Following the in vitro transcription, resultant 
RNAs were quantified. Equal amounts of sense and antisense RNAs were mixed and 
annealed by heating the mixture to 70 °C for 5 minutes and cooled to room temperature 
to generate double-stranded silencing RNA with perfect-matched central bases (siRNA) 
or with mismatched central bases (miRNA) (Figure 2.1.). The sense and antisense strands 
of the control RNA were generated similarly using T7promoterGG to anneal with 
Sense_CTRL or Antisense_CTRL, respectively, to create templates for in vitro 
transcription reactions. 
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Figure 2.1.  Sequences of short dsRNAs. 
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2.2.4.  Dual luciferase assay following transfection by electroporation 
  Freshly lysed parasites were harvested and counted. Approximately 2x10
6
 
parasites were used for each transfection via electroporation using a BTX ECM 630 
(1500 volts, 25 Ω, and 25 μF). For each transfection, reporter plasmids with or without 
tested RNAs were mixed with harvested parasites in an electroporation mixture (400 μL) 
containing 120 mM KCl, 0.15 mM CaCl2, 10 mM K2HPO4/KH2PO4 (pH 7.6) 2 mM 
EDTA, 5 mM MgCl2, 2 mM ATP, 5 mM glutathione in a 4 mm-gap cuvette and 
electroporated (Roos et al., 1994). Following electroporation, the parasites were cultured 
in confluent HFF monolayers grown in T25 flasks using MEM media with L-glutamine 
without phenol red (Sigma Aldrich, #M3024) and supplemented with 1% dialyzed fetal 
bovine serum and diluted (0.5x) Antibiotic-Antimycotic at 37 °C in 5% CO2 for selected 
periods. 
 For dual luciferase assays, the infected monolayers were harvested and lysed with 
100 μL of 1x Passive Lysis Buffer (Promega, #E1531) and incubated for 10 minutes at 
room temperature. Lysates were cleared of debris by centrifugation (10,000 x g for 1 
minute), and the supernatant was kept on ice and used in the dual luciferase assay, which 
was carried out in a 2-step fashion. For a Ffluc assay, 20 μL of lysate was added to a 
freshly made reaction mixture (100 μL) containing 200 μM D-luciferin (Sigma Aldrich, 
#L9504), 20 mM Tricine, 10 mM MgSO4, 5 mM DTT, 250 μM ATP and 250 μM 
Coenzyme A. The mixture was incubated for 10 seconds at room temperature. For a 
Rnluc assay, 20 μL of lysate was added to a freshly made reaction mixture (100 μL) 
containing 0.1 μM Coelenterazine (Santa Cruz Biotechnology Inc, #sc-205908), 100 mM 
K2HPO4/KH2PO4 (pH 7.67.6) 500 mM NaCl, 1 mM EDTA, and 0.02% BSA. The 
mixture was incubated for 10 seconds at room temperature. The luminescence signals 
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from both reactions were measured with a 20/20n Luminometer (Turner Biosystems). 
Rnluc signals were normalized to Ffluc signals for a direct comparison across 
independent experiments. For each experiment, the reporter plasmid electroporation 
without tested RNA, called mock electroporation, was carried out to allow for the 
measurement of the dual luciferase expression under independently tested conditions. At 
least two independent experiments were performed. 
 
2.3.   Results and Discussion 
2.3.1.   Strategy and dual luciferase reporter system 
In the design of the dual luciferase reporter system for the gene silencing study, 
we aimed to have an equal transcript production of both transcription units. Therefore, 
the reporter system was engineered so that the expression of both Ffluc and Rnluc are 
under the control of a strong and constitutive T. gondii promoter, called TgTubulin, 
which also provides the necessary 5’-UTR for the protein’s expression. Furthermore, to 
ensure similar levels of transcript stability and protein synthesis from both constructs, the 
3’-UTR of TgDHFR (dihydrofolate reductase) were placed downstream from the coding 
sequence (Figure 2.2a.). The transcript derived from Rnluc was used as the target for the 
homologous gene silencing by three different RNA modulators, including long dsRNA, 
miRNA and siRNA, while the Ffluc transcript served as an internal control for 
transfection, expression, and detection. 
Due to the parasitic nature of T. gondii, in a gene expression and silencing 
analysis, the reporter system and silencing RNAs would be introduced into the parasite 
prior to infection of a host monolayer. We viewed that the success of the subsequent 
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analysis would rely greatly on the viability of the post-electroporated parasite and the 
efficiency of transfection. The viability of the post-electroporated parasite was evaluated  
using the ability of the viable parasite to exclude trypan blue and propidium idodide 
(Jones et al. 1985). From three independent experiments we detected that 75 ± 10% were 
viable and able to multiply when up to 60 μg of nucleic acids (RNA or DNA) were used 
in the electroporation conditions (see Material and Methods). The efficiency of 
transfection was evaluated by determining the amounts of remaining and internalized 
nucleic acids following electroporation. Nucleic acids (RNA or DNA) were randomly 
labeled with fluorescein during in vitro transcription or PCR amplification, and used in 
the electroporation. Approximately 52% of labeled nucleic acids were internalized (Al-
Anouti & Ananvoranich, unpublished data). We thus concluded that under similar 
controlled conditions, the electroporation of nucleic acids (60 μg, DNA plasmids and/or 
RNAs) would allow sufficient numbers of viable parasites for gene silencing assays. 
Next we assessed the expression of our newly engineered dual luciferase system 
to allow for a sensitive detection of a broad range of different silencing activities, while 
remaining within a linear range for a direct comparison. Based on a previous report 
(Behnke et al., 2008) using a similar reporter system in T. gondii, when a promoter of 
interest and a well-characterized promoter were placed to control the expression of Rnluc 
and Ffluc, respectively, the transfection was carried out using 60 μg of the Rnluc and 
Ffluc reporter plasmids (1:2 ratio). Keeping the total amount of DNA used at 60 μg, we 
varied the ratio of Rnluc:Ffluc at either 1:1, 1:2 or 2:1. All ratios tested yielded 
reproducible data (Figure 2.2b). Consequently, the plasmid ratio at 1:1 was kept for 
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Figure 2.2.  Dual luciferase reporter system. (A) Schematic representation of mRNA 
reporters used in this study. Numbers indicate the first nucleotide of the start codon and 
the last nucleotide of coding sequence. The transcript encoding Rnluc was used as target 
for the gene silencing study and from which silencing RNAs were designed (see Table 
2.1 and Materials and Methods). (B) Dual luciferase expression was assayed using three 
different ratios of Rnluc and Ffluc plasmids, while the total amount of plasmids were 
kept at 60 µg for the transfection. The graph is a representative of compiled experimental 
results. (C) Dose-response of dual luciferase expression was assessed when the ratio of 
Rnluc:Ffluc plasmids were kept at 1:1 ratio. The expression of the dual luciferase is 
shown as relative Rnluc/Fluc light forming units. The assays were carried out 24 hours 
post-electroporation. Values were obtained from at least two independent experiments. 
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simplicity. Other experimental parameters, including the total plasmid concentration, the 
number of extracellular parasites, and incubation time (post-transfection and conditions 
luciferase assays), were evaluated in different combinations to establish optimization for 
the study.  When varied numbers of harvested parasites were used in the transfection, 
~10
5
-10
6
 freshly released parasites were the most suitable for the study because the 
parasites remained intracellular at 24, 48 or 72 hours post-electroporation under the 
conditions tested (see Materials and Methods). These data indicated that both 
transcription units were efficiently expressed and maintained during the testing period (3 
days). Because lower amounts of the reporter system were used in other eukaryotic 
systems (Choe et al., 2010 and Elbashir et al., 2001), we thus progressively lowered the 
total amounts of plasmids from 40 to 0.2 μg (Ffluc:Rnluc = 1:1) so that the gene silencing 
data could be directly compared. It was detected that within the amounts of plasmids 
tested; both transcription units were still sufficiently expressed and allowed for detection 
within a linear range (Figure 2.2.). In all succeeding silencing analyses, 1 μg of each 
reporter plasmid (2 μg total) was used. 
 
2.3.2.   Homologous gene silencing by long double-stranded RNA 
Long dsRNAs (ca. 300-800 nts) have previously been shown to induce 
homologous gene silencing in T. gondii (Al-Anouti and Ananvoranich 2002, Al-Anouti et 
al., 2003, Al-Anouti et al., 2004, Ananvoranich et al., 2006, Holmes et al., 2010). To test 
our newly developed reporter system, two species of long dsRNAs were designed to have 
homologous sequences to the Rnluc mRNA. Rnluc-dsRNA_1 (596 nts) was homologous 
to nucleotides 12 to 607 of the Rnluc coding sequence, and Rnluc-dsRNA_2 (589 nts) 
was derived from the Rnluc coding sequence at nucleotides 458-933 and the proximal 
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region (113 nts) of its 3’-UTR (Table 2.2.). These long dsRNAs have an overlapping 
region (149 nts) spanning the nucleotides 458 to 607 of the Rnluc coding sequence. 
Using these dsRNAs, we aimed to evaluate whether dsRNAs derived from these regions 
exhibited similar silencing inducing ability. This in turn would reflect inter-molecular 
interactions formed between the mRNA target and different dsRNAs, given potential 
structural preferences. 
To determine the extent of dsRNA ability to induce gene silencing, varied 
amounts of tested dsRNAs (0.25 to 4 μg) were co-transfected along with 2 μg reporter 
plasmids (1:1) by electroporation. When 0.25 μg dsRNA was used, a negligible reduction 
(<10%) of the relative Rnluc/Ffluc level was detected at 24 hours post-electroporation 
(Figure 2.3, A). A clear silencing effect (~30-40%) was observed when 0.5 μg of Rnluc-
dsRNA_1 and 2 were used and able to reduce the relative Rnluc/Ffluc level to 73 ± 4 % 
and 61 ± 1%, in comparison with a mock silencing control (without dsRNA). The 
silencing effects were slightly increased when higher amounts of both dsRNAs were 
used. The maximal silencing ability was observed when 2-4 μg dsRNA caused the 
relative Rnluc/Ffluc reduction to 52 ± 10% and 62 ± 1% for Rnluc-dsRNA_1 and 
dsRNA_2, respectively at 24 hours post-electroporation (Figure 2.2a). Similar levels of 
silencing were observed when the electroporated parasites were allowed to incubate 
longer, and the dual luciferase assays were carried out at 48 hours post-electroporation   
(Supplementary Figure 2.1.). The findings suggested that the transfection of long 
dsRNAs at 2 μg or ~5.1 pmoles, despite their targeted regions, have saturated the 
silencing machinery and reached their maximal ability to cause a silencing effect under 
conditions tested. 
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Table 2.2.  List of silencing RNAs used in the study. Numbers of the nucleotides are 
corresponding to the Rnluc transcript depicted in Figure 2.2a. 
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Figure 2.3.  Gene silencing effect caused by (A) long dsRNA was detected at 24 hours 
post-electroporation (B) and siRNA and miRNA at 24 hours and 48 hours post- plasmids 
(1 µg of each Rnluc and Ffluc plasmid) in the absence of tested silencing RNAs. 
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Figure Supplementary 2.1.  Gene silencing effect caused by Rnluc-dsRNA_1 was 
detected at 24 and 48 hours post-electroporation. 
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To evaluate the specificity of the homologous gene silencing, an unrelated dsRNA 
whose nucleotide sequence is different from the intended target (the Rnluc transgene) was 
tested under similar conditions. TgUPRT dsRNA (629 nts) did not cause any silencing 
effect on Rnluc expression (Figure 2.3a, the lightest shaded bars), indicating that the 
silencing effect is sequence specific. The presence of unrelated dsRNA (as high as 4 μg 
or 10.3 pmoles) did not affect the activity of Rnluc or Ffluc. It thus indicated that in a 
unicellular organism, such as T. gondii, the presence of long dsRNA in a large quantity (4 
μg) did not cause a general cellular response affecting the transcription processes and/or 
the degradation of gene products over the tested conditions. 
In summary, we have confirmed that a homologous long dsRNA has the ability to 
induce gene silencing in T. gondii. DsRNA exhibited the ability to induce Rnluc silencing 
and to drop the relative Rnluc/Ffluc to 60% in comparison to a mock electroporation. 
This silencing effect (~40% reduction of gene expression) was considered a mild effect in 
comparison to when miRNA was used in silencing (~80% reduction) the expression of 
Rnluc in mammalian cell cultures (Choe et al., 2010 and Elbashir et al., 2001). However, 
such a mild silencing ability could be useful, when it is sufficient to produce a detectable 
phenotype (i.e. the change in an enzymatic activity). However, when TgUPRT or 
Toxoplasma lactate dehydrogenases (TgLDHs) were silencing targets, their homologous 
dsRNAs were able to reduce their expression by ~90%. In those experiments, Al-Anouti 
et al., (2003) detected the silencing outcomes by radioactive uracil uptake assays for 
TgUPRT study and by in vitro and in vivo growth and differentiation assays for TgLDH1 
and TgLDH2 experiments (Al-Anouti et al., 2004). It is highly likely that the level or 
extent of silencing effect is gene-dependent, since here the silencing effect towards Rnluc 
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was observed at ~40%, similar to that of Toxoplasma enolase experiments (Holmes et al., 
2010). 
Despite its mild silencing ability, a homologous dsRNA-induced gene silencing 
procedure offers a very easy-to-use method. One would require little information about 
the gene target, such as the sequence of the transcripts or the exons, prior to initiating a 
silencing protocol. Moreover, long dsRNAs can quickly be synthesized in a very cost-
effective way via in vitro transcription. One drawback of the system would be due to its 
inherited long target region(s). When more than one species of transcripts are produced 
from the same exon(s), the long homologous dsRNA would not be able to discern one 
transcript over another. Considering its pros and cons, this homologous dsRNA-induced 
gene silencing methodology is a valuable method-of-choice. Keeping in mind, with its 
potentially mild silencing ability, the lack of a desirable phenotype might not indicate the 
failure of the silencing procedure, but could be an indication of the critical level of gene 
expression required for maintaining a phenotype. 
2.3.3.  Homologous gene silencing by short double-stranded RNAs 
Due to their availability and reliability to induce gene silencing, gene-specific siRNAs 
and miRNAs have become powerful reagents used in biological research. Recent 
genomic and biochemical research has pointed that the T. gondii genome harbors both the 
RNAi genes and miRNAs (Al Riyahi et al., 2006, Braun et al., 2010, Kolev et al., 2011). 
It was thus crucial to investigate whether difference in complementarity could induce 
gene silencing of designated gene target. Based on predicted secondary structures and 
known constraints of short dsRNAs (Kim et al., 2005), we used the mfold nucleic acid 
folding and hybridization prediction software (Zuker 2003) and SciTool RNAi design 
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software (Integrated DNA Technologies, Inc., Iowa) to predict the most probable target 
sites and to design short dsRNAs specific to the Rnluc transcripts. Twenty possible 
targets and siRNA candidates were predicted and ranked from the most to the least 
probable location for the interactions. We chose the three most probable sites located 
between the Rnluc stop codon and the proximal region (103 nts) of its 3’-UTR (Table 
2.2). Two silencing RNAs were designed and synthesized for the study. One contains 
nucleotides perfectly complementary to its target, representing a siRNA interaction; 
while the other, with five-central nucleotide mismatch, represents a miRNA interaction 
(Figure 2.1). These silencing RNAs have three possible recognition sites located within 
the 3’ UTR between the nucleotides 943 and 1022 of the Rnluc transcript (Table 2.2). 
Varied amounts of siRNA and miRNA (0.25 to 4 μg, or 15 to 246 pmoles) were 
independently tested for their ability to induce gene silencing using conditions similar to 
those tested for the long dsRNA-induced gene silencing. At 0.25 or 0.5 μg, siRNA was 
better than long dsRNA or miRNA (at the same amounts) to lower the Rnluc expression 
(Figure 2.3b upper panel) at 24 hours post-electroporation. Both siRNA and miRNA at 1 
to 4 μg exhibited similar ability to silence the expression of Rnluc (~60% reduction). 
Interestingly, when the silencing assays were carried out at 48 hours post-electroporation, 
the effect was more pronounced for all amounts of siRNA and miRNA tested (Figure 
2.3b, lower panel). Both siRNA and miRNA (at 0.25 μg) exhibited similar silencing 
ability (54 ± 2% reduction), which was higher than those at 24 hours. At higher amounts 
used, miRNA seems to show slightly better ability than siRNA to induce gene silencing. 
This silencing effect was not detected with an unrelated small RNA at either 24 or 48 
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hours (Figure 2.3, B, lightly shade bars), confirming the homologous nucleotide 
specificity. 
An enhanced silencing effect found at a longer incubation was not observed in 
dsRNA-induced gene silencing (Figure S2.1.). It is possible that siRNA- or miRNA-
engaged machinery could be more stable than, or different from, that of a dsRNA-system. 
Considering the nature of transient expression of the reporter plasmids, the more stable 
the silencing machinery is, the more robust the machinery is to compete against the 
expression of reporters. Another possibility could be due to the presence of an RNA-
dependent RNA polymerase, to which T. gondii carries a homologue, which would allow 
for the amplification of short dsRNAs using the transcripts as templates. Thus, their 
silencing ability would remain longer and could be enhanced as long as the transcript is 
present. 
In summary, our findings clearly indicated that small silencing RNAs (siRNA and 
miRNA) are able to specifically induce gene silencing in T. gondii. This study is the first 
to demonstrate the activity of miRNA in gene silencing in the Apicomplexan protozoan 
parasites. More importantly, we showed that the silencing effect was within the range 
(~80% reduction siRNA and miRNA tested (Figure 2.3b, lower panel). Both siRNA and 
miRNA (at 0.25 μg) exhibited similar silencing ability (54 ± 2% reduction), which was 
higher than those at 24 hours. At higher amounts used, miRNA seems to show slightly 
better ability than siRNA to induce gene silencing. This silencing effect was not detected 
with an unrelated small RNA at either 24 or 48 hours (Figure 2.3b, lightly shade bars), 
confirming the homologous nucleotide sequence was required. 
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2.3.4.  Which silencing RNA (long dsRNA, siRNA and miRNA) is the best to induce 
homologous gene silencing? 
Using the dual luciferase reporter system, we demonstrated that silencing RNAs, 
including long dsRNA, siRNA (perfect-match bases) and miRNA (central-mismatch 
bases), were capable of inducing gene-specific silencing. Long dsRNA exhibited the least 
silencing effect (~40% reduction of gene expression). The mild silencing effect was 
maintained for 48 hours, which could be due to (i) additional processing steps required to 
process the long dsRNA into small silencing RNAs, or (ii) a different silencing 
mechanism being engaged. As stated earlier, long dsRNA-induced gene silencing could 
be a useful tool when a quick assessment is required for evaluating a putatively essential 
gene. In a shorter tested period (24 hours), siRNA and miRNA were equally effective 
where the silencing effect was ~50%. When a prolonged and high silencing effect is 
required, miRNA offers the best tool among these tested silencing RNAs. Tested miRNA 
affected the Rnluc expression the most (80% reduction), which is equivalent to those 
tested in different mammalian cell cultures (Choe et al., 2010 and Elbashir et al., 2001). 
Therefore, we concluded that miRNA, with central-mismatch bases, is the best silencing 
RNA to use when a homologous gene silencing is required for the study of a gene of 
interest. 
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CHAPTER 3 
 
Utilization of inherent miRNAs in functional analysis of Toxoplasma gondii genes 
 
3.1.   Introduction 
 
Toxoplasma gondii, a member of the phylum Apicomplexa, is one of the most 
successful intracellular parasitic pathogens. It was reported that up to one third of the 
world’s population has been infected, and could develop a disease called toxoplasmosis 
(Montoya and Liesenfeld, 2004). In general T. gondii infection does not cause clinical 
illness because the parasite in its rapidly growing tachyzoite form could easily be cleared 
by the host’s immune system during the initial course of infection. If not cleared, residual 
tachyzoites could differentiate into slowly growing bradyzoites, which could be very 
resistant to an immune response and persist throughout the lifetime of the infected human 
host. When the dormant bradyzoites reconvert to tachyzoites, they could cause a relapse 
leading to fatality in individuals with weaken immunity (Cenci-Goga et al., 2011). 
Throughout the life cycle of T. gondii, a tight regulation of gene expression is 
required to ensure and sustain its viability (i) within its human and other non-definitive 
hosts during its asexual cycle including tachyzoite –bradyzoite interconversion, and (ii) 
within the gut of feline definitive host during its sexual reproduction to yield zygote-
containing cysts or oocysts (Montoya and Liesenfeld, 2004). To date, various molecular 
and genetic tools have been generated and employed to modulate the expression of the 
gene of interest at various stages of parasite development and aimed at gaining a better 
understanding of its function(s) in the host-parasite interaction and pathogenesis (Roos et 
al., 1994 and Boothroyd et al., 1997). An effective molecular manipulation of the 
parasites could easily be achieved following a transfection via electroporation of the 
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freshly released tachyzoites (Soldati and Boothroyd, 1993, Roos et al., 
1994 and Boothroyd et al., 1997). In 2007, Meissner and co-workers reviewed and 
cataloged molecular tools available for T. gondii to include reliable non-homologous and 
homologous recombination, as well as an elusive RNAi-targeting technology. T. gondii 
tool box has continuingly been expanded to include a tetracycline-inducible gene 
expression system (Meissner et al., 2001, van Poppel et al., 2006 and Jammallo et al., 
2011), a site-specific cre/loxP-based recombination system (Heaslip et al., 2010), and a 
ligand-induced protein stability system (Herm-Götz et al., 2007). Moreover, homologous 
recombination events could be enhanced with the use of a permissive parasite strain 
(Huynh and Carruthers, 2009) and well-designed plasmid systems (Upadhya et al., 2011). 
The Miessner group later reviewed and cataloged advantages and disadvantages of 
currently available controllable gene expression systems acting at either transcriptional 
and/or post-transcriptional levels (Jiménez-Ruiz et al., 2014). In June 2014, two reports 
showed that CRISPR (clustered regularly interspaced short palindromic repeats) 
technology can successfully be applied to engineer the genome of T. gondii and to allow 
for deletion, replacement, site-directed mutagenesis and epitope tagging (Shen et al., 
2014 and Sidik et al., 2014). Collectively these methodologies have enabled a selective 
and specific down-regulation of a gene of interest and proven to be very valuable. 
Although many sophisticated and varieties of genetic tools have become 
available, RNA-based silencing techniques have not yet been explored and improved to 
provide consistent outcomes. One contributing factor could stem from the lack of 
understanding of how endogenous RNA effectors (miRNAs and/or siRNAs) and their 
engaged machineries operate at molecular levels in T. gondii. The presence of hallmark 
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RNAi genes have been repeatedly confirmed in T. gondii to include Argonaute (TgAgo), 
Dicer, and an RNA-dependent RNA polymerase (Ullu et al., 2004, Al Riyahi et al., 
2006, Braun et al., 2010 and Kolev et al., 2011). Tg-miRNAs have been detected via 
deep-sequencing methodologies (Braun et al., 2010, Wang et al., 2012 and Xu et al., 
2013). It was also shown that T. gondii harbors a chimeric RNAi mechanism containing 
plant- and fungal-like effector RNAs, and metazoan-like RNAi genes (Braun et al., 
2010). Musiyenko et al. (2012) further demonstrated that TgAgo displays a weak target 
RNA cleavage activity linked to its lack of canonical DDE/H catalytic triad. A greater 
target RNA cleavage activity was observed upon the subsequent association of a Tudor 
staphylococcal nuclease (TSN) and a protein Arg methyl transferase, PRMT1. The study 
strongly suggested that the RNA-induced silencing complex of T. gondii utilizes the 
slicer activity of TSN as for partially mismatched miRNA target pairs, and that of Ago 
for a perfectly matched miRNA target pairs. With its unique silencing machinery and/or 
mechanism, the RNA-directed gene silencing can effectively be achieved in T. gondii. 
Taken together these findings, a consistent RNA silencing methodology for T. gondii 
should be within reach. 
The study here was aimed to gain a better understanding of how T. gondii utilizes 
its miRNAs in the RNA silencing mechanism to give rise to eventual outcomes of down 
regulation of gene expression. To do so, we used a dual luciferase reporter system to 
evaluate (i) the extent of their silencing effect with the two most abundant Tg-miRNAs, 
namely Tg-miR-60a and Tg-miR-4a, (ii) the nature of their interactions with target 
transcripts, and (iii) the effect of Tg-miR-60a miRNA mimics and inhibitors on their 
silencing effect. Furthermore, we explored the utility and versatility of Tg-miR-60a as a 
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genetic tool in modulating the expression of a gene of interest. As a proof of concept, the 
highly expressed Tg-miR-60 family was directed to control the expression of (i) DEAD-
box RNA helicase (TgHoDI), and (ii) a metabolically important lactate dehydrogenase 
isoform 1 (TgLDH1). We showed that when the binding sites of Tg-miR-60a were 
introduced into the parasite’s transcripts via homologous recombination at either locus, 
the expression levels of the chosen genes can significantly be altered. It was thus proven 
that Tg-miRNAs could be directed and controlled to assist in loss-of-function analyses. 
 
3.2.   Materials and Methods 
 
3.2.1.  Mammalian cell and parasite cultures 
 
Human foreskin fibroblasts (HFF, ATCC-1041) were grown using Dulbecco’s 
Modified Eagle Medium (DMEM) with high D-glucose and L-glutamine (Invitrogen, 
#12100046) supplemented with 10% v/v cosmic calf serum (ThermoFisher Scientific, 
Hyclone, # H3008704N) and diluted (0.5x) Antibiotic-Antimycotic (Invitrogen, # 15240-
062) and maintained at 37 °C in 5% CO2. RHΔHX, T. gondii type 1 strain, was obtained 
from NIH AIDS Research and Reference Reagent Program (#2857); ∆Ku80 strain which 
is a RHΔHX-derived strain, was obtained from Dr. Vern B. Carruthers (University of 
Michigan). Unless stated otherwise, both strains were maintained in HFF using Minimum 
Essential Medium (MEM, Invitrogen, #61100061) supplemented with 1% v/v dialyzed 
fetal bovine serum (ThermoFisher Scientific, Hyclone, # SH3007903) and diluted (0.5x) 
Antibiotic-Antimycotic. 
3.2.2.  Plasmid construction 
 
The nucleotide sequences of primers used in the study are shown in Table 3.1. 
The dual luciferase plasmid system, which was previously described in Crater et al. 
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(2011), was adopted for the study. The system consists of two plasmids referred to as 
pTubFf and pTubRnLet7a3x. The former was unmodified and served as an internal 
control for transfection efficiency and expression assays. The latter was used as the 
parental plasmid of all construction in the study to create multiple Rnluc expression 
plasmids carrying one or three binding sites for any Tg-miRNAs. To replace the three 
consecutive Hs-let-7a binding sites in the parental plasmid, Phusion High-Fidelity DNA 
polymerase reaction (New England Biolabs, #F-530) was used according to the 
manufacturer’s protocol with specific primer sets to reconstitute the desired binding 
site(s). In addition, each primer of the set was designed to carry a partial sequence of one 
chosen restriction endonuclease to allow for future restriction analyses of resultant 
plasmids when they were reconstituted following construction. Once PCR reactions were 
completed, the amplicons were purified, treated with T4 polynucleotide kinase 
(Fermentas, #EK0031) and re-circularized using T4 DNA ligase (Fermentas, #EK0016). 
pTubRn construct, which lacks the binding site for Tg-miRNAs, was generated using 
FwRn and RvRn primers. For the construction of pTubRnMIR-60a3x plasmid to express 
Rnluc transcripts carrying three binding sites of Tg-miR-60a, the primers named miR-
60aFw and miR-60aRv were used, and the newly generated EcoRI site was introduced 
for its endonuclease analysis. Similarly, three primer pairs, including miR-4aAFw/miR-
4aARv, miR-4aBFw/miR-4aBFw, and miR-4aCFw/miR-4aCRv, were used in the 
construction of plasmids to express Rnluc transcripts carrying three binding sites of Tg-
miR-4a with different complementary interactions, respectively. When the plasmids were 
engineered to carry only one binding site, FwRn or RvRn primer was paired with another 
primer with sequence encoding one or two binding site for Tg-miR-60a or Tg-miR-4a. 
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Table 3.1.  Oligonucleotide primers used in the study.  The nucleotide sequence coding 
for Tg-miRNA binding sites are in bold.  Nucleotides corresponding to restriction 
endonuclease recognition sites are in italics.  
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For example, FwRn was paired with miR-60aRv to generate a plasmid encoding for one 
binding site of Tg-miR-60a. Following successful confirmation by restriction analyses, a 
large scale plasmid preparation of reporter plasmids were prepared for a transfection by 
electroporation, which the reporter plasmids (1 μg of Ffluc and 1 μg of Rnluc) were 
introduced into approximately 2 x 10
6
 freshly lysed parasites via electroporation using a 
BTX ECM 630 (1500 volts, 25 Ω, and 25 μF) in a mixture (400 μL) containing 120 mM 
KCl, 0.15 mM CaCl2, 10 mM K2HPO4/KH2PO4. pH 7.6, 2 mM EDTA, 5 mM MgCl2, 
2 mM ATP, 5 mM glutathione in a 4 mm-gap cuvette. 
 
3.2.3.  In vitro transcription of miRNA mimics and inhibitors 
 
Using partial DNA duplexes as templates, in vitro transcription reactions were 
carried out in 50 μL-reaction mixtures in the presence of T7 RNA polymerase (~ 5 units), 
80 mM Hepes-KOH, pH 7.5, 24 mM NaCl2, 2 mM spermidine, 40 mM DTT, 10 mM 
rNTPs, and ~ 1 unit pyrophosphatase at 37 °C for 16 hours. Reactions were subsequently 
extracted with one volume of phenol-chloroform mixture (1:1), and resultant RNAs were 
precipitated and quantified (Thermo Scientific NanoDraop2000). As shown in Table 3.1, 
oligonucleotide templates were designed to carry two parts of complementary sequence 
(i) to encode for desirable resultant transcripts of the upper or lower strand of Tg-miR-
60a or Hs-let-7a, and (ii) to T7 RNA polymerase promoter (underlined, Table 3.1.). The 
individual oligonucleotide template (2 μM) was annealed with an equimolar of 
T7promoterGG following mixing and heating the mixture for 5 minutes at 70 °C and 
slowly cooled to room temperature to yield partial DNA duplexes. One fifth of the 
annealing reaction (or 400 nM of the partial DNA duplex) was used as templates for the 
RNA synthesis. Resultant single-stranded RNA products, which were generated using the 
67 
 
oligonucleotide template named miR-60a_upper or hs-let7a_upper, were referred to as 
Tg-miR-60a inhibitor and Hs-let-7a inhibitor, respectively. When an equal amount of Tg-
miR-60a inhibitor was mixed and annealed with the single-stranded RNA products 
obtained from the reaction using miR-60a_lower oligonucleotide template, the double-
stranded RNA products was referred to as Tg-miR-60a mimic. Hs-let-7a mimic was 
similarly generated from RNA products obtained from hs-let7a_upper and hs-let7a_lower 
oligonucleotide templates. Quality of RNA products were verified by gel electrophoresis 
to confirm their expected sizes prior to electroporation into freshly released parasites. 
 
3.2.4.  RNA isolation and RT-qPCR 
 
Forty-eight hours following electroporation, total RNA was isolated from freshly 
lysed parasites (approximately 3 × 10
6 
parasites) using TRI reagent (Molecular Research 
Center, Inc., #TR 118) according to the manufacturer’s protocol, and treated with RQ1 
Rnase-Free Dnase (Promega, #M6101) for 60 minutes at 37 °C. RNA samples were 
electrophoresed on a 1% agarose gel to verify for the presence of distinct rRNAs and 
mRNA smear bands, and the absence of DNA templates. Samples were kept for future 
use at −20 °C. Isolated total RNA (~500 ng) was annealed with 250 ng of an oligo-(dT) 
following heating at 65 °C for 5 minutes and quickly cooled on ice. The reactions were 
then divided in half. A half of each annealed reaction was used in a SuperScript III 
reverse transcriptase (RT) reaction (Invitrogen #18080-093), while the other aliquot was 
used in a control reaction in the absence of SuperScript III RT. The reaction mixtures 
were diluted 1/10, and diluted samples were subjected to real-time qPCR using Kapa 
Sybr Fast qPCR Kit Master Mix (2x) ABI Prism (Kapa Biosystems #KR0390) and 
OneStepPlus thermocycler (Applied Biosystems). All test samples were analyzed to give 
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technical triplicates. The expression level derived from the dual reporter system was 
measured and calculated, so that the Rnluc expression from tested expression plasmid 
was normalized by Ffluc expression using ΔΔCt protocol carried out by the StepOne 
Software v 2.1 (Applied Biosystem). To generate a data set which allowed for 
comparison across all technical and biological triplicates, the relative expression obtained 
from the dual reporter system where Rnluc transcripts lack miRNA binding sites was 
measured for each independent experiment set, and used for normalizing the effect of Tg-
miRNAs on the dual reporter expression. 
3.2.5.  Western blot analyses 
Cell-free lysates were prepared by addition of an appropriate amount of RIPA 
buffer to collected parasites, followed by sonication for 5 seconds. Protein concentration 
was measured using the RC DC Protein Assay according to manufacturer’s instructions 
(Bio-Rad Laboratories, #500- 0119). Approximately 10 μg was used for the analysis, of 
which the lysates were denatured using 6x SDS protein loading dye and resolved on a 
10% SDS-PAGE. The primary antibodies used were α-Flag mouse antisera (1:5,000, 
Applied Biological Materials Inc., Richmond, B.C, Canada, #G191), α-tub mouse 
antisera (12G10, 1: 1000, Developmental Studies Hybridoma Bank, University of Iowa, 
USA), and α-TgLDH1 rabbit antisera (1:2,000, Yang and Parmley, 1997). The signals 
were revealed using secondary antibodies: horseradish peroxidase (HRP) conjugated goat 
anti-mouse antisera (Rockland Immunochemicals Inc., #610-1319) or HRP conjugated 
goat anti-rabbit antisera (Rockland Immunochemicals Inc., #611-1322) at a 1:10,000 
dilution, and a Chemiluminescent HRP Substrate Kit (Millipore, #WBKLS0500). 
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3.2.6.  Immunocytochemistry 
 
HFF monolayers were cultured on coverslips until confluent, infected with ~1 x 
10
6
 freshly lysed parasites and incubated at 37 °C and 5% CO2. Infected monolayers on 
the cover slips were rinsed three times with 1x phosphate buffer saline (PBS), fixed with 
3% paraformaldehyde for 5 minutes and permeabilized with 0.25% Triton X-100 in PBS 
for 10 minutes. Coverslips were then washed in 1x PBS and subsequently incubated in a 
blocking solution (5% bovine serum albumin, BSA in PBS) with gentle agitation for 1 
hour at room temperature. Coverslips were then incubated for 1 hour in a humidity 
chamber with a specific primary antibody diluted in 2% BSA. The primary antibodies 
used were α-FLAG mouse antisera at 1:500 dilutions and α-TgLDH1 rabbit antisera at 1: 
5,000 dilutions. Coverslips were washed in 1× PBS (5 minutes, twice) and incubated for 
1 hour with secondary antibody diluted in 2% BSA. Corresponding secondary antibodies 
were used at 1:1000 dilutions. Cells were then incubated with Hoechst staining solution 
(10 μM) at room temperature for 5 minutes, washed twice with 1x PBS and mounted on 
glass slides. For the study carried out using extracellular parasites, the parasites were 
collected and filtered through a 3-μm filtering set. Approximately 1 × 106 parasites were 
transferred onto coverslips and further incubated for an hour to allow for adhering onto 
the surface of coverslips. The coverslips were rinsed in 1x PBS, fixed with 3% 
paraformaldehyde for 5 minutes and permeabilized with 0.25% Triton X-100 for 10 
minutes. Subsequent blocking and antibody interaction steps were as same as those of 
intracellular parasites. Image acquisition was carried out using a Leica DMI 6000B 
inverted fluorescent microscope using HCX PL Apo 100×/1.40–0.70 objective and a 
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Leica DFC 360FX camera with Leica Advanced Fluorescence Application Software 
V.2.3.0. Post-acquisition image processing was performed with Adobe Photoshop 7.0. 
 
3.2.7. Utilization of Tg-miR-60a family for loss-of-function analysis 
 
3.2.7.1.   Rationale 
 
Despite their possible redundancy, most genes are tightly regulated to allow for 
their necessary functions to display in a spatial- and temporal-specific manner. In order to 
accurately assess the functionality of a gene, the pattern of spatial and temporal 
requirements should be taken into consideration. Particularly when the specific gene 
silencing was implemented, a natural expression profile of the gene product should be 
used as a point of reference. 
3.2.7.2.   Experimental design 
 
To standardize the silencing effects with a gene’s natural expression profile, the 
binding site for the Tg-miR-60a family was introduced into the genomic locus at the 
position immediate after the protein coding sequence of the gene of interest via 
homologous recombination (Figure 3.5a). Transforming plasmids were constructed using 
pSF-TAP-LIC-HX plasmid (obtained from Dr. Vern B. Carruthers, University of 
Michigan). First the parental plasmid was modified by site directed mutagenesis to 
integrate three binding sites of Tg-miR-60a using miR-60aFWSF and miR-60aRVSF 
primers (Table 3.1), and the resultant plasmid was named pSF-TAP MIR603x_LIC-HX. 
Both pSF-TAP-LICHX and pSF-TAP MIR603x_LIC-HX were linearized by PacI 
digestion prior to the treatment with T4 DNA polymerase to create compatible ends in the 
presence of dGTP for a ligation-independent cloning procedure as described by Huynh 
and Carruthers (2009). Amplicons corresponding to either of TgLDH1 (1073 bps) or 
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TgHoDI (2767 bps) were prepared using gene specific primer pair of 
LDH1_Fw/LDH1_Rv and HoDI_Fw/HoDI-RV respectively (Table 3.1), and purified 
prior to the treatment with T4 DNA polymerase to create compatible ends in the presence 
of dCTP. Equimolar concentrations of the prepared plasmid and insert were allowed to 
anneal and subsequently used in bacterial transformations. The resultant plasmids were 
analyzed to confirm their sequences via restriction endonuclease digestions. The plasmids 
were then used in the transformation of T. gondii. Transgenic parasites were selected and 
grown in culturing media containing mycophenolic acid (25 μg/mL) and xanthine (50 
μg/mL). 
 
3.2.8. Loss-of-functional analysis 
 
Functional analyses were carried out using parasites generated from test or control 
plasmids which were cultured and treated under similar conditions. Assessment of growth 
profile was performed after the parasites were allowed to infect HFF monolayers for 24 
hours. The numbers of parasites per vacuole were counted and calculated to obtain 
population distribution. Analyses were performed in triplicate (n = 3), and at least 100 
vacuoles were counted for each test. 
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3.3.   Results and discussion 
 
3.3.1.   Evaluating the silencing effect of Toxoplasma gondii miRNAs 
 
A large collection of Tg-miRNAs were identified via a deep sequencing 
methodology, from which 14 families were grouped according to their seed sequences (6 
nucleotides) and their expression levels (Braun et al., 2010). Two of the highest 
expressed Tg-miRNA families, named Tg-miR-60a and Tg-miR-4a, were selected for the 
study. The guide strands (26–27 nucleotides) and seed sequences of Tg-miR-60a and Tg-
miR-4a are shown Table 3.2.  A dual reporter system was designed and engineered so 
that Renilla luciferase (Rnluc) transcripts carry the complementary nucleotide sequence 
to the guide strand, referred to here as a Tg-miRNA binding site(s). Also as part of the 
reporter system, the transcripts of Firefly luciferase (Ffluc) were used as an internal 
control for transfection efficiency among various experiments (Figure 3.1a). Both 
transcripts have the same controlling elements of Tg-Tubulin-5′ UTR and Tg-DHFR-3′ 
UTR, and expressed under the control of a TgTubulin promoter to ensure equal 
expression and stability of transcripts (Crater et al., 2011). The engineered reporter 
system was utilized in the first part of the study, which was aimed for gauging the extent 
of the silencing effect of Tg-miR-60a and Tg-miR-4a toward reporter transcripts, in 
corresponding to (i) their expression levels and (ii) the nature of their complementarity to 
their target transcripts. 
 
3.3.2.   Extent of Tg-miRNAs to induce a silencing effect 
 
Between the two selected Tg-miRNA families, Tg-miR-60a was found to be about 
2.4 times more abundant than Tg-miR-4a (Braun et al., 2010). The Rnluc transcript was 
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Table 3.2.  Chosen Tg-miRNAs and their predicted gene targets and interactions. The 
sequences of TgmiRNAs are in lower case, while their predicted targets are in capital 
letters. Underline indicates their seed sequence.  
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designed for the assessment of the extent of Tg-miRNA silencing ability in respect to two 
factors: (i) the abundance of Tg-miRNA species, and (ii) the number of binding sites 
found on target transcripts. The resultant Rnluc transcripts carried either one or three 
binding sites for Tg-miR-60a or Tg-miR-4a. Forty-eight hours following transfection of 
the reporter system (1 μg of each construct) into freshly released T. gondii (106 parasites), 
the parasites were collected, and their cell-free extracts prepared and used for the 
measurement of relative expression of Rnluc and Ffluc luciferases. At least three 
independent experiments were performed for each construct, and the data were 
normalized using the reporter system without any binding sites for Tg-miRNAs, for each 
independent test and to allow for cross referencing among various sets of experiments. 
The presence of one binding site for individual Tg-miR-60a and Tg-miR-4a in the Rnluc 
transcripts caused the relative expression to reduce to 20 ± 2.7% and 60 ± 5.3%, 
reflecting 80% and 40% silencing effect, respectively (Figure 3.1b). The presence of 
three binding sites for individual Tg-miR-60a and Tg-miR-4a in the Rnluc transcripts 
decreased the relative expression to 17 ± 2.4% and 39 ± 2.3%, reflecting 83% and 61% 
silencing effect, respectively. Notably, the higher abundance of Tg-miR-60a conferred 
the higher silencing effect, as detected in the constructs carrying one binding site of Tg-
miR- 60a. An increasing in the number of binding sites for Tg-miR-60a did not result in a 
drastic increase in the silencing effect, suggesting a saturation of the silencing machinery 
employing Tg-miR-60a as its effector. On the other hand, when the saturation of the 
silencing machinery was not reached by an excess amount of Tg-miRNA, such as those 
utilizing a lower abundant Tg-miR-4a, an increase in the number of binding sites, from 
one to three, could augment the silencing effect. When the Rnluc transcript carrying three 
75 
 
 
  
76 
 
Figure 3.1.  Gene silencing effect induced by endogenous Tg-miRNAs. A. Graphical 
representation of transcripts generated from the dual luciferase reporter system used in 
the study. Renilla luciferase (Rnluc) transcripts carry either one (1×) or three (3×) 
binding sites for Tg-miRNAs, whose location is indicated by asterisk (*). Firefly 
luciferase (Ffluc) transcripts were generated under the control of same promoter and 
controlling elements as those of Rnluc transcripts, and were used as an internal control 
for the transfection and expression analyses. B. The expression levels of the dual 
luciferase reporter system whose Rnluc transcripts carrying either one (1x) or three (3x) 
binding site(s) for Tg-miR60a, Tg-miR4a or Hs-let-7a were calculated to obtain relative 
expression levels when compared to those without a Tg-miRNA binding site (no sites). 
The extent of Tg-miRNAs to induce gene silencing, which was derived from the 
reduction of relative gene expression, was plotted to show relative silencing effect (%). 
Data was obtained from three independent trials, and plotted as means ± standard 
deviations. 
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binding sites for Hs-let-7a miRNA was used, and no changes in the relative expression 
level and silencing effect were observed. It strongly suggested that T. gondii does not 
express any miRNAs closely related to Hs-let-7a miRNA, and/or that the level of Hs-let-
7a-related Tg-miRNA is much lower than those of Tg-miR-60 and Tg-miR-4 families. 
Moreover the findings indicated that the silencing effect occurs only (i) when the 
transcripts have the binding site and (ii) when the miRNA is present. 
3.3.3.  The effect of nucleotide sequence complementarity on Tg-miRNA-induced gene 
silencing 
 
It has been demonstrated that miRNAs bind their target transcripts using perfect 
or imperfect complementary base-pair interactions (Pillai et al., 2005, Wakiyama et al., 
2007). While no predicted targets for Tg-miR-60a was reported, three potential gene 
targets of Tg-miR- 4a were predicted to include three independent loci in the genome of 
T. gondii (Braun et al., 2010). These loci, namely (A) TGGT1_203470, (B) 
TGGT1_246940, and (C) TGGT1_268390, encode for three hypothetical proteins (Gajria 
et al., 2008). The transcripts from these loci were predicted to interact with Tg-miR-4a in 
three different complementarity formats; via a perfect match (A), one bulge with two 
mismatch bases (B), and two bulges with one mismatch base (C), respectively (Table 
3.2). Three binding sites corresponding to these individual interactions were placed into 
the Rnluc transcripts. In addition, a similar design with a perfect match was made for Tg-
miR-60a to allow for an equivalent comparison between the effect of Tg-miR-60a and 
Tg-miR-4a. As shown in Figure 3.2a, with a perfect complementarity, we observed a 
20% higher silencing effect when Rnluc transcripts carry Tg-miR-60a than those of Tg-
miR-4a (format A). The levels of silencing effect caused by Tg-miR-4a were not 
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Figure 3.2.   Effect of nucleotide complementarity. Rnluc transcripts of the dual 
luciferase reporter system were engineered to have three binding sites for Tg-miR60a 
with a perfect match, and for Tg-miR-4a mimicking the different base-pair interactions of 
its three predicted target genes. Their sequences and interactions are shown in Table 3.2. 
A. Relative silencing effect was calculated as compared to those without a binding site. 
B. Relative Rnluc mRNA levels were determined for each construct using the (ΔΔCt) 
method, where the obtained mRNA levels were normalized and compared to the 
construct containing no binding sites. Data was obtained from at least three independent 
experiments for each constructed tested, and plotted as means ± standard deviations. 
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significantly different with perfect or imperfect complementarity at ~60% silencing 
effect.  Using RT-qPCR analysis to assess the levels of Rnluc and Ffluc mRNAs in the 
evaluation of the different formats of target pairing interactions, it was detected that 
perfect and imperfect matches of Tg-miR-4a target pairs gave no significant difference in 
the levels of Rnluc mRNA in comparison to those of Ffluc mRNA (Figure 3.2b). The 
data indicated that the silencing effect resulted from translational repression following 
Tg-miR-4a and target interactions. According to Musiyenko et al. (2012), the imperfect 
matched pair of miRNA and target would engage a stronger silencing activity of TSN 
than that of levels the perfect match of miRNA to engage Ago slicer activity, both 
leading to a directed mRNA degradation. Moreover, we detected a drastic difference in 
the relative Rnluc mRNA between the perfect matched pairing by Tg-miR-60a and Tg-
miR-4a (Figure 3.2b). The reduction of Rnluc target mRNA by Tg-miR-60a strongly 
suggested that transcript degradation was a mode of Tg-miR-60a action, while the 
unchanged level of Rnluc target mRNA of Tg-miR-4a was indicative of translational 
suppression. The findings suggested that T. gondii RISC could be directed by Tg-
miRNAs and resulted in mRNA degradation as well as translational suppression. The 
finding was not surprising because TgAgo, via pull-down and MS analysis, was shown to 
associate with various initiation and elongation factors of translational machinery (Braun 
et al., 2010). However, further investigation is needed to address how the Tg-miR-4a-
induced silencing machinery could silence its target genes without discriminating among 
various forms of base-pair interactions. Most importantly the silencing effect was not a 
result of the degradation of the transcripts. Until we could identify authentic targets of 
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Tg-miR-60a, here it was assumed that the perfect match of Tg-miR-60a caused transcript 
degradation. 
3.3.4.   The effect of exogenous small RNAs on Tg-miRNA-induced gene silencing 
Despite the significance of the underlying mechanism of Tg-miRNA-induced 
gene silencing, no indication from genome analysis could currently suggest how different 
species of Tg-miRNAs could engage different silencing machineries. Here we focused 
our effort in making use of the abundant Tg-miRNA species to direct functional analyses 
of T. gondii genes. Therefore it was of importance to examine whether the extent of Tg-
miR-60a-induced gene silencing effect could be altered by exogenous small RNAs. We 
generated two species of small RNAs carrying a sequence pertinent to Tg-miR-60a, 
including (i) one with exact sequence and structure as Tg-miR-60a, referred to as miR-
60a mimic, and (ii) the other with only the one strand of Tg-miR-60a, referred to as miR-
60a inhibitor. Using the Rnluc construct carrying three Tg-miR-60a binding sites, we 
monitored the silencing effect following the transfection of various amounts of small 
RNAs along with the reporter constructs where the ratio of Rnluc to Ffluc (2 μg Rnluc, 1 
μg Ffluc) was altered to ensure the detection of silencing alteration. In the absence of 
small RNAs, the reporter expression was reduced by the abundant Tg-miR-60a with the 
silencing effect detected at 65 ± 2.2% (Figure 3.3a), confirming (i) a higher amount of 
transcripts was generated, and (ii) a larger portion of the transcripts escaped the Tg-miR-
60a-induced silencing machinery to produce final gene products than when 1 μg of Rnluc 
was used (Figure 3.2a, 83 ± 2.5%). Subsequent experiments were carried out with the 
increased amount of Rnluc (2 μg) construct to allow for the comparison of Tg-miR-60a 
mimic and inhibitor under similar testing conditions. Exogenous supplies of Tg-miR-60a 
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Figure 3.3.  Effect of miRNA mimics and inhibitors. The engineered dual reporter 
system, whose resultant Rnluc transcripts carry three Tg-miR60a binding sites, was 
electroporated into the parasites along with various amounts of small RNAs (μg): A. 
Double-stranded Tg-miR60a mimic or B. Single-stranded Tg-miR60a inhibitor. Hs-let-7a 
mimic and inhibitor were used as control. Three independent experiments were 
performed for each test, and the data were plotted as means ± standard deviations. 
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mimic gave rise to an increase in the silencing effects from 65 ± 2.2% in the absence of 
small RNAs, to 83 ± 2.5% in the presence of 10 or 20 μg of Tg-miR-60a mimic (Figure 
3.3a). The presence of 20 μg Hs-let-7a mimic did not cause any silencing effect. The 
results suggested that miRNA mimics could be engaged in the same silencing machinery 
as endogenous miRNAs. The saturation of Tg-miR-60a-induced silencing machinery 
gave rise to a maximum of ~80% silencing effect, under conditions used with the 
engineered reporter system. When an increase amount of Tg-miR-60a inhibitor was 
supplied, the silencing effect was diminished in a dose-dependent manner (Figure 3.3b). 
The presence of Tg-miR-60a inhibitor as little as 1 μg could perturb the silencing effect 
caused by Tg-miR-60a-induced silencing machinery. A maximal disturbance was 
observed with 10 - 20 μg of Tg-miR-60a inhibitor, where the silencing effect was 
abolished to ~6.2%. When miRNA inhibitors with an unrelated nucleotide sequence, 
namely Hs-let-7a-inhibitor (20 μg) was supplied, the relative expression and silencing 
effect was unaffected. These findings suggested that small RNAs with nucleotide 
sequences identical to one or both strands of miRNA could be exploited as genetic tools 
for the moderation of miRNA-directed gene regulation in T. gondii, to gain a better 
understanding of the function of gene of interest following a negative regulation at the 
post-transcription level. 
3.3.5.  Effective gene silencing caused by directed Tg-miR-60a 
 
As a proof of principle that the highly expressed Tg-miR-60 family can be 
directed to control the expression of any genes of interest, we chose two unrelated target 
genes to evaluate (i) the effect of directed gene silencing and (ii) the practicality and 
usefulness of this genetic tool in functional analysis. The first chosen target is a less 
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studied gene, named DEAD-box RNA helicase (TgHoDI, TGGT1_089230; Cherry and 
Ananvoranich, 2014), whose ortholog is dispensable for growth in yeast (Tseng-Rogenski 
et al. 2003). The second is a metabolically crucial gene, lactate dehydrogenase (TgLDH1, 
TGGT1_232350). Due to (i) the relatively high abundance of Tg-miRNAs and (ii) the 
lack of information on authentic targets of Tg-miRNAs, it was possible that any given 
transcript species might already be under the control of a Tg-miRNA species. To ensure 
that the effect observed here was the result of our Tg-miR-60a-directed silencing 
machinery and not from other Tg-miRNA effects, the entire nucleotide sequences of 
TgHoDI and TgLDH1 transcripts (pre-mRNA and mature mRNA) were searched for a 
possible Tg-miR-60a binding site to partially (at least 50%) or fully interact with the seed 
or entire sequence of Tg-miR-60a (Table 3.2, underlined sequence). No potential binding 
sites of Tg-miR-60a were found on either transcript. 
3.3.5.1.  Silencing of DEAD-box RNA helicase (TgHoDI) expression by Tg-miR60a 
caused a subtle change, but sufficiently demonstrated its physiological importance during 
the re-invasion 
 
TgHoDI is a member of DEAD-box RNA helicase superfamily, which contains 
highly conserved proteins and implicated in almost all aspects of RNA metabolism in 
organisms ranging from yeast to complex eukaryotes (Hooper and Hilliker, 2013; Carroll 
et al., 2011). TgHoDI was reported to be involved in the formation of mRNA-
ribonucleoprotein (mRNP) complexes and granules during stress response (Cherry and 
Ananvoranich, 2014). Tseng-Rogenski et al. (2003) showed that a null mutant of DEAD-
box RNA helicase (DHH1) in yeast is not lethal but exhibits a temperature sensitive 
phenotype. Using this Δdhh1 strain, Cherry and Ananvoranich (2014) showed that the 
expression of TgHoDI cDNA in the yeast strain under DHH1 promoter could 
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complement and partially restore its phenotype. In an attempt to study the physiological 
significance of TgHoDI in T. gondii, a ligand-controlled destabilization domain 
(ddFKBP) version of TgHoDI was generated. Although stable parasite lines expressing 
TgHoDI-ddFKBP fusion protein were obtained, the ligand-induced protein degradation 
was not achieved (unpublished data). Indirectly this suggested (i) that the C-terminus of 
TgHoDI was not solvent-exposed, and (ii) that TgHoDI could be involved in the rapid 
formation of mRNPs similar to other DEAD-box RNA helicase members (Hooper and 
Hilliker, 2013). Due to its possibly tight regulation and physiological importance, 
TgHoDI was chosen as a target for Tg- miR60a-directed gene silencing. 
Stable parasite lines expressing either TgHoDI-SF (control) or TgHoDI-SF-miR (test) 
were generated and maintained for the study. Under normal growth conditions the test 
strain expressing TgHoDI-SF-miR expressed approximately 50% and 30% less TgHoDI 
protein and mRNA, respectively, in comparison to the control strain (−, Figure 3.4, A and 
B). The introduction of Tg-miR- 60a mimic (+, Figure 3.4, A and B) enhanced the extent 
of Tg-miR60adirected silencing and decreased the levels of TgHoDI protein and mRNA 
to approximately 25% and 10%, but did not affect the expression of TgHoDI in the 
control strain. TgHoDI was previously shown as a protein marker of mRNP granules 
called stress granules (Cherry and Ananvoranich, 2014). The accumulation of 
cytoplasmic mRNA granules, including those of stress granules, in extracellular 
tachyzoites was showed to be important to the ability of extracellular parasites to survive 
and re-establish their infectivity. The higher numbers and larger sizes of the stress 
granules formed during the stressful conditions translated to a higher success in 
reestablishment of infection (Lirussi and Matrajt, 2011). Using these stable parasite lines, 
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Figure 3.4.   TgHoDI expressions under the control of Tg-miR60a-induced gene 
silencing. Freshly released transgenic parasites, namely TgHoDI-SF and TgHoDI-SF-
miR were electroporated with Tg-miR60a mimic (20 μg, +; 0 μg, −). A. Thirty-six hours 
following electroporation, the parasites were released and harvested for the cell-free 
lysates which were analyzed for the levels of TgHoDI-SF fusion protein using α-Flag 
antisera. The levels of tubulin detected using α-tubulin antisera were used as a loading 
control. Relative signals of TgHoDI-SF fusion protein was normalized by those of 
tubulin. The data were obtained from three independent tests. B. At a similar time point, 
total RNAs were isolated and subjected to RT-qPCR analyses. Daggers (†) represent p-
value ≤ 0.05, while double daggers (‡) represent p-value ≤ 0.01. C. Representative 
images of extracellular parasites following incubation in either culturing medium or 
Hepes-KOH solution (60-minute treatment), the accumulation of TgHoDI were assessed 
using α-Flag antisera in conjunction with α-mouse FITC conjugated antisera. Micrometer 
bar represents 5 μm. D. A parallel analyses of those shown in C. An aliquot of treated 
parasites were transferred onto HFF monolayers to allow for a reinvasion. Their ability to 
reinvade and recover from the treatment was assessed 24 hours later. The number of 
parasites per vacuole was counted. Data was collected and calculated from at least three 
independent trials, where clear bars represent those from TgHoDI-SF, and hatched bars, 
TgHoDI-SF-miR. 
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we aimed to validate the function of TgHoDI in re-establishing their infectivity. To 
establish a stress condition where the accumulation of TgHoDI and mRNP granules could 
clearly be monitored, the extracellular parasites of TgHoDI-SF control strain were 
released from infected monolayers and subjected to stressful conditions. We utilized a 
Hepes-KOH solution treatment. Use of a buffering solution containing 27 times higher 
KCl, and 22 times less NaCl than those of the culturing media was previously shown to 
induce a stress response in T. gondii (Lirussi and Matrajt, 2011). The Hepes-KOH 
solution (25 mM Hepes-KOH pH 7.2, 142 mM KCl, 5 mM NaCl, 2 mM EGTA, 5 mM 
MgCl2, and 1 mg/mL BSA) mimicked the composition of the host cell cytosol ionic 
conditions, which the parasites come in contact with during egress. It was observed that 
the incubation of extracellular parasites in this Hepes-KOH solution for 60 minutes at 37 
°C caused maximal formation of mRNP granules, as observed by the accumulation of 
TgHoDI aggregates throughout the cytosol (Figure 3.4c, upper right panel). Subsequently 
we silenced the TgHoDI expression to the lowest level possible by introducing Tg-miR-
60a mimic into freshly released TgHoDI-SF-miR parasites via electroporation. The 
parasites were allowed to infect and to grow in HFF monolayers for 48 hours to ensure 
that the level of TgHoDI protein was approximately 75% lower than those of the control 
untreated parasites (as shown in Figure 3.4a). Extracellular parasites were then released 
and subjected to the solution treatment for 60 minutes at 37 °C. It was observed that the 
numbers and sizes of TgHoDI aggregates were diminished as compared those of the 
control conditions (Figure 3.4c, lower right panel). In parallel, these treated parasites 
were allowed to re-invade HFF monolayers after the stressful conditions and were 
monitored for their reinvasion ability by microscopic examination 24 hours following an 
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infection of HFF monolayers. When the extracellular parasites were kept in their 
culturing media for 60 minutes at 37 °C (without the solution treatment), both parasite 
strains were able to retain a similar infectivity, namely reinvasion and multiplication 
(Figure 3.4d left histogram, clear bars for TgHoDI-SF, control; hatched bars for TgHoDI-
SF-miR, test). The majority (50%) of the intracellular vacuoles contained 8 parasites per 
vacuole at 24 hours post-infection. Both stable parasite lines exhibited a similar growth 
profile with ~ 6-8 hours doubling time, indicating that the changes in the level of TgHoDI 
gene products did not significantly affect the parasite ability to multiply under non-stress 
conditions. On the other hand, following the solution treatment, the extracellular parasites 
of the test strain with electroporated Tg-miR-60a mimic were slower in progressing 
through reinvasion and multiplicity. The majority of the formed vacuoles of the test strain 
contained 4 parasites per vacuoles (hatched bars), in comparison to 8 parasites per 
vacuoles in those of control strain (clear bars) when subjected to a similar treatment. The 
decrease of TgHoDI protein (four times less than the control) was concomitantly detected 
along with the slowing down of parasite multiplicity (Figure 3.4d, right histogram). The 
changes in growth profiles were not observed in mock or Hs-let-7a- mimic 
electroporation, nor were the detectable changes in TgHoDI accumulation and growth 
observed in other electroporation reactions in either strain (data not shown). The findings 
thus confirmed that the accumulation of stress granules in extracellular tachyzoites is 
important to the ability of extracellular parasites to re-establish their infectivity. 
3.3.5.2.  Expression of lactate dehydrogenase isoform 1 is critical to the parasite cell 
biology 
Being an obligate intracellular parasite, T. gondii obtains its nutrients from the 
host cells. Under anaerobic conditions, the parasite relies on TgLDH which is the last 
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committed enzyme of the glycolytic pathway to interconvert pyruvate and lactate, as well 
as NAD+ and NADH. Because of the necessity of the NAD+-NADH conversion under 
anaerobic conditions, TgLDH is thus considered one of potential drug targets. Two active 
TgLDH isoforms, namely TgLDH1 and TgLDH2, are produced in a stage specific 
manner. TgLDH1 is detected in tachyzoites, while TgLDH2 in bradyzoites (Yang and 
Parmley, 1997). To date, the mechanism underlining the requirement of each specific 
isoform is still under investigation. The presence of stage specific TgLDH1 protein is 
commonly used as a marker in displaying the tachyzoite development stage Yang and 
Parmley, 1997). While no documentation on a TgLDH1 null mutant, one successful 
TgLDH1 knockdown was reported using long double-stranded RNA expression 
generated from a head-to-head promoter construct (Al-Anouti et al., 2004). The TgLDH1 
knockdown strain was documented to grow slower and to convert into bradyzoites in a 
lesser degree than the parental strain, indicating its physiological importance. As part of 
the proof of principle, the metabolic important TgLDH1 gene was chosen as a second 
target to further gauge the level of Tg-miR-60a-induced silencing system toward a critical 
and essential gene. Similar to the TgHoDI study, two stably transgenic lines, TgLDH1-SF 
and TgLDH1-SF-miR were desirable for the study. While TgLDH1-SF parasite strain 
was easily obtained and maintained, we were unable to obtain or maintain the TgLDH1-
SF-miR strain, despite a number of control conditions tested. It thus indirectly indicated 
that the level of TgLDH1 expression was effectively silenced below a threshold level to 
allow the parasite to maintain a metabolic requirement for its viability. To further 
investigate the cause(s) of our difficulties in the generation and/or maintenance of 
TgLDH1-SF-miR line, the transfection reactions were performed to include those with 
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pTgLDH1-SF, or pTgLDH1-SF-miR (Figure 3.5a). The electroporated parasites were 
allowed to infect HFF monolayers for 36 hours using selective media. Due to the nature 
of transfection reactions, the bulk of parasites contained both transformed and non-
transformed parasites. The level of TgLDH1-SF fusion protein was thus quantified in 
comparison to the total level of TgLDH1 and tubulin background from three independent 
experiments by using immunoblot-densitometric analyses (Figure 3.5b). The level of 
TgLDH1 protein was drastically decreased in the Tg-miR- 60-induced silencing strain 
(T1), whose expression could be restored by the introduction of Tg-miR60a inhibitor 
(T2). The silencing effect was also detected by immunocytochemistry (Figure 3.5c). 
Using α-Flag antisera, the epitope tagged TgLDH1 protein was detected in CTL, and T2, 
respectively. However, no α-Flag signals were detected in T1. Altogether, it indicated 
that transgenic TgLDH1-SF-miR parasites can be generated, but the stable clonal line 
cannot be maintained for further study. The findings thus reiterated the importance of 
TgLDH1 functionality in parasite viability. In addition, the findings also confirmed that 
the abundant Tg-miR60a can be directed to silence a target gene, and that Tg-miR60a 
inhibitor can be used to restore the parasites from detrimental effect of gene silencing. 
3.3.5.3. Versatility and possible limitation of the methodology 
 
The miRNA-directed gene silencing methodology reported here offers an 
alternative approach to currently available functional genetic procedures. Due to the 
abundance and variety of Tg-miRNAs, necessary reagents could be tailored to the 
appropriate gene of interest. The plasmids could easily be modified to introduce the 
binding site of another species of Tg-miRNAs, when Tg-miR-60a is not appropriate for 
the gene of interest. For example, when the gene of interest is already under the control of 
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Figure 3.5.  TgLDH1 loss-of-function analyses. Freshly released Δku80 tachyzoites were 
electroporated with indicated plasmid construct (20 μg), which was engineered to allow 
for a homologous recombination at the TgLDH1 locus. A. Representation of plasmid 
constructs aimed for a homologous recombination to incorporate the nucleotide sequence 
coding epitope tags of Strep and Flag (SF) to be fused to the coding sequence of the gene 
(pTgLDH1-SF, CTL), and for the similar construct with the presence of three binding 
sites for Tg-miR60a immediate after the stop codon (as indicated by asterisk (*), 
pTgLDH1-SF-miR; test). B. Thirty-six hours following electroporation, the parasites 
were released and harvested for the cell-free lysate preparation. The lysates were 
prepared from electroporation reactions containing CTL, test construct (T1) and test 
construct in the presence of Tg-miR60a inhibitor (20 μg, T2). The levels of TgLDH1 and 
TgLDH1-SF fusion proteins were detected using α-TgLDH1 and α-Flag antisera. Α-
Tubulin antiserum was used as a loading control. Notably, immunoblots probed with α- 
Flag antisera were over-exposed to allow for the visualization of Flag tagged signals from 
T2 samples. Densitometric data were obtained from three independent immunoblot 
analyses of the samples, and plotted as means ± standard deviations. The light bars 
represent those of TgLDH1-SF and the dark bars of TgLDH1. Both were normalized the 
signals obtained from TgTubulin. Daggers (†) represent p-value ≤ 0.05, while double 
daggers (‡) represent p-value ≤ 0.01. C. The expression of TgLDH1 and TgLDH1-SF 
proteins was monitored by immunocytochemistry analyses thirty-six hours following the 
electroporation. Micrometer bar represents 5 μm. 
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Tg-miR-60a, the introduction of more Tg-miR-60a binding sites will not yield any 
significant down regulation effect for the analysis. This possible limitation, however, 
could easily be remedied by utilizing or directing other Tg-miRNAs, such as Tg-miR-4a 
to the target gene products. It is also possible that the expression profile of Tg-miR-60a is 
not suitable for that of the gene of interest or the parasite archetype strain. When such 
conditions occur, the reagents could be modified so that the expression profile and strain 
are suitable and compatible. 
3.4.  Conclusion 
 
We showed that Tg-miRNAs, at least the two most abundant Tg-miRNAs, namely 
Tg-miR-60a and Tg-miR-4a, are functional effectors to alter the expression of a reporter 
gene, Rnluc of the dual luciferase reporter system. The extent of their silencing effect was 
influenced by (i) the number of binding sites and (ii) the abundance of Tg-miRNA 
species. A higher silencing effect was observed (i) when the transcripts carry multiple 
binding sites, and (ii) when the levels of Tg-miRNA effector are present in a higher 
concentration. The nature of the interactions between target transcripts and the Tg-
miRNA species directed the mode of gene silencing, either mRNA degradation or 
translational suppression. It remains to be investigated how the complementarity and 
specific Tg-miRNA species dictate the mode of reactions, as unexpectedly we observed 
that perfect matches of Tg-miR-60a and Tg-miR-4a had a different mode of silencing 
despite their similar end point. Moreover, we could take advantage of Tg-miR-60a 
miRNA mimics and inhibitors to modulate the silencing effect. As a proof of principle, 
we successfully demonstrated that the endogenously abundant miRNAs can be directed 
to down regulate the expression of two model targets, TgHoDI and TgLDH1. The extent 
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of gene silencing can be further enhanced by miRNA mimics or diminished by miRNA 
inhibitors, as needed. In conjunction with recent and powerful CRISPR technology, the 
binding site(s) of Tg-miRNAs can easily be introduced into any ectopic sites to cause 
specific gene silencing, when a knockdown, but not knockout, of the target gene is 
needed. Nonetheless, the most important consideration should be placed on developing of 
an effective readout of the gene silencing. Naturally to maintain cellular activities, 
various regulatory systems work in concert. Gene and functional redundancy would allow 
the expression of genes to be temporarily compromised. While TgHoDI knockdown was 
effective, it required an effective measurement to detect the subtle changes. In the case of 
an essential gene, such as TgLDH1, a gene knockout would be lethal and difficult for 
gaining further information. By having a gene knockdown protocol, the information 
could be extracted and deduced. 
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CHAPTER 4 
 
Antisense technologies in the studying of Toxoplasma gondii 
 
4.1.  Toxoplasma gondii, a model organism 
 
T. gondii is one of the most successful intracellular parasites which is reported to 
infect any warm-blooded animals, and an estimated one third of the world’s population 
(Kim and Weiss, 2008). As a member of the phylum Apicomplexa, Toxoplasma has a 
unique non-photosynthetic apicoplast organelle, similar to that found in other important 
and pathogenic microorganism members, including Plasmodium which is the cause of 
malaria, Cryptosporidium a waterborne parasite, as well as Eimeria, Neospora, and 
Theleria all can cause disease in animals. These pathogenic microorganisms share a 
remarkable evolutionarily relationship. Using Toxoplasma as a study model, we review 
various types of non-coding RNAs which have emerged and could be effectors in the 
regulation of gene expression (Radke et al., 2005; Hassan et al., 2012; Ramaprasad et al., 
2015). Recent research shows that Toxoplasma contains a “mix-and-match” of plant- and 
animal-like machinery used to direct RNA for gene regulation (Braun et al., 2010; 
Musiyenko et al., 2012). Toxoplasma can be easily cultured using any nucleated cell 
cultures and has proven previously to be a very useful model to develop a number of 
molecular and genetic tools (Roos et al., 1994; Kim and Weiss, 2004). Taken together, 
Toxoplasma is an important model organism, and a fascinating system for exploring the 
progress in antisense technologies. 
4.2.  History of antisense RNAs and other regulatory RNAs 
The term “antisense RNA” was coined in the early 1970s, and first used in 
describing “RNA repressors” in prokaryotes. Spiegelman et al. (1972) showed that 
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antisense RNA molecules can hybridize with complementary sense RNA to render it 
inactive. This experiment was among the first to define the function of regulatory RNA 
as a highly specific repressor or inhibitor of gene expression. Coleman et al. (1985) 
showed that antisense RNA could be used to target foreign genes in an experiment, in 
which resistance to bacteriophage SP infection could be conferred to Escherichia coli. 
They achieved this by creating plasmids coding for RNA sequences which targeted genes 
coding for bacteriophage coat protein and/or replicase. By the time that Green et al. 
(1986) published a review on antisense RNA technologies, it was widely accepted that 
antisense RNA can perform a repressor function, and that the 5′ end of the messenger 
RNA (mRNA) was the key target sequence. Antisense RNA which did not include 
sequences complementarity to the 5′ end of the target mRNA required much higher 
concentrations to achieve an effective repression. Additionally, some genes remained 
resistant to repression by antisense RNA. It was suggested that mRNA with a high degree 
of secondary structure was resistant to hybridization with antisense RNA. Pioneer work 
on antisense RNAs in prokaryotes has provided us with fundamental knowledge on 
various aspects of RNA directed gene regulation, both inhibition and activation of 
replication, transcription and translation. 
The applications of antisense technology in eukaryotic systems began as early as 
1978. Zamecnik and Stephenson (1978) were able to temporarily inhibit the production 
of Rous sarcoma virus (RSV) in chick embryo fibroblast tissue cultures. This study 
targeted the intermediate provirus DNA, and as such used antisense DNA rather than 
RNA. As with antisense RNA, hybridization between the provirus DNA and the injected 
antisense DNA was believed to prevent the normal function of the oligonucleotide, in this 
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case the necessary circularization and/or incorporation of the viral genome. By 1984 
artificial antisense RNA was successfully used to regulate the expression of a eukaryotic 
gene, named thymidine kinase in murine cells (Izant and Weintraub, 1984). Bunch and 
Goldstein (1989) developed a system for generating antisense RNA in vivo with cultured 
Drosophila melanogaster cells. The methodology used by Bunch and Goldstein (1989) 
offered an alternative to the commonly used microinjection as a method by which 
artificial antisense RNA was introduced into the eukaryotic cells. The study also 
suggested that hybridization activity between sense and antisense RNA in eukaryotes 
occurred primarily in the nucleus with un-spliced mRNA. However, it was later shown 
by Vanhee-Brossollet and Vaquero (1998) that antisense RNA molecules have regulatory 
function both in the nucleus and cytoplasm, and at any step of gene expression. It has 
more recently been found that this multi-level expression control is possible due to 
several different types of antisense RNA. 
 
4.3.   Application of antisense technologies and their progress in Toxoplasma 
 
After decades of the discovery of antisense RNAs and other regulatory RNAs, 
underlining mechanisms and functions are still being investigated and appear to vary 
greatly among organisms and various types of regulatory RNAs. These RNAs are non-
protein-coding transcripts and referred to as non-coding RNAs (ncRNAs). Due to the 
varied structures and mechanisms, regulatory RNAs or ncRNAs are generally categorized 
based on their sizes: (i) small ncRNAs, whose lengths range from ~20 nucleotides to 
~200 nucleotides, include siRNA, miRNA, and piwiRNA. (ii) Long ncRNAs are varied 
from over 200 nucleotides to a few thousands nucleotides and include natural antisense 
transcripts (NAT), intra- and inter-genic ncRNAs, and intronic RNAs. Both small and 
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large regulatory ncRNAs could inhibit gene expression and be exploited as target specific 
genetic tools (Wahlestedt, 2013; Krishnan and Mishra, 2014; Miller, 2014). It is clear that 
the modes of inhibition are different depending on the type of ncRNAs. First, siRNAs 
and miRNAs affect mRNA stability mostly through the involvement of the RNA-induced 
silencing complex (RISC) in the cytoplasm and cause mRNA degradation and/or 
translational repression, while long ncRNAs primarily affect chromatin regulators, which 
suppress transcription, and thus act in the nucleus. Their spatial requirement could be a 
limiting factor, if we aim to perturb the natural function(s) of these regulatory RNAs. 
Second, small ncRNAs, miRNAs in particular, can affect the stability of multiple mRNA 
targets, while long ncRNAs, particularly cis-acting NAT, are locus specific. When target 
specificity is critical, the use of miRNAs and their derivatives require proper controls to 
discern between targeted-inhibition and an off-target effect. Thirdly, the abundance of 
small ncRNAs is likely to be higher than that of large ncRNAs. This could be an 
important factor in considering for their dose-to-efficacy property. In the following 
sections, we summarize genetic silencing tools and technologies used in Toxoplasma 
according to their capability related to naturally found regulatory RNAs. Table 4.1 shows 
the representative structures, relative sizes, and targets of antisense technologies 
summarized here. 
4.3.1.   Small non-coding RNAs 
The Toxoplasma transcriptome contains a large repertoire of small ncRNAs, 
including the most prominent group of miRNAs (Braun et al., 2010; Wang et al., 2012; 
Xu et al., 2013). Two of the most abundant miRNAs families, namely miR60a and miR4a 
of parasite strain GT1 (Braun et al., 2010), were tested using engineered dual luciferase 
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Table 4.1.  Representative structures and relative sizes of regulatory ncRNAs used in 
Toxoplasma gondii. The dash lines represent the antisense strands which will pair with 
their targets.  
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reporter system (Crater et al., 2015). The expression of engineered transcripts harboring 
binding sites of either miR60a or miR4a was repressed in a sequence specific manner, 
clearly indicating that Toxoplasma harbors miRNA-inducing silencing machinery (Crater 
et al., 2015). Also the silencing effect detected using the reporter system indicated that 
the extent of silencing effect is dependent on the abundance of miRNA present and the 
number of miRNA binding sites on a target transcript. It was noted in the same study that 
the nature of silencing effect could depend on the miRNA species. While miR60 was 
detected to induce mRNA degradation, miR4a was found to induce translational 
repression. The findings indicated that Toxoplasma silencing machinery could differ from 
those of other organisms. Musiyenko et al. (2012) showed that Toxoplasma-Argonaute 
(Ago) displays a weak RNA cleavage activity and requires an association with a Tudor 
staphylococcal nuclease (TSN) and Arginine methyl transferase for its activity. The study 
also strongly suggested that the RNA- induced silencing complex of Toxoplasma utilizes 
the slicer activity of TSN for partially mismatched miRNA target pairs, and that of Ago 
for perfect match targets. 
4.3.1.1.  siRNA and miRNA 
 
It has been demonstrated that exogenous supplies of miRNAs or siRNA could 
enhance or induce an inhibition of gene expression. We here referred to the short dsRNA 
(20–25 nt) with perfect-matched central bases as “siRNA”, and that with mismatched 
central bases as “miRNA” (Table 4.1). Yu et al. (2008) successfully showed that 
commercially designed and synthesized Stealth™ RNAi duplexes (25-mer dsRNA, 
Invitrogen) against Toxoplasma adenosine kinase can inhibit the gene expression. When 
individual siRNAs of the Stealth™ RNAi duplexes were introduced into the parasite by 
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transfection, it was detected that each siRNA exhibited varied efficacy depending on the 
target locations, and the dosage used. The findings are in accordance with other RNA-
targeted gene silencing methodologies in that not all target regions of an mRNA are 
equally accessible. Wahlestedt (2013) stated that only 10–15% of designed antisense 
oligonucleotides will reduce the expression of the target. To enhance the inhibition effect, 
a common practice is to make a cocktail of siRNA, as suggested and used with the 
commercial Stealth™ RNAi duplexes (Invitrogen). 
The capability of siRNA and miRNA to inhibit gene expression was systemically 
compared using engineered dual luciferase reporter system (Crater et al., 2012). By in 
vitro transcription, but not by chemical synthesized as those of Stealth™ RNAi system, 
siRNAs and miRNAs were made, and three binding sites for either siRNA or miRNA 
were placed onto the 3′-UTR of Renilla luciferase transcripts. Both siRNA and miRNA 
were shown to exhibit a similar silencing ability, and their effect appeared to be enhanced 
with longer incubation time (24 h vs. 48 h). In the same study, the effect of these small 
regulatory RNAs was compared to that of long double-stranded RNAs (~600 bp) which 
are specifically targeted Renilla luciferase transcripts. The silencing effect of long 
dsRNAs is lower than those of siRNA and miRNA. It is suggested that an additional 
processing step for the long dsRNA might be necessary, although we cannot exclude the 
possibility that it might be due to the different site of action of long and short RNA 
regulators. 
The above mentioned studies clearly indicate that small regulatory RNA, in the 
form of siRNA and miRNA can be designed and effectively used as a target-specific 
silencing tool. With the aid of reliable software’s algorithms, effective siRNA and/or 
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miRNA cocktails can be chemically or enzymatically synthesized. Most companies that 
commercialize the production of siRNA or miRNA provide designing services. Although 
we cannot advocate for a particular company or software to be superior to others, the best 
practice is to use multiple sites to confirm and re-confirm the design of siRNA and 
miRNA whenever possible. 
 
4.3.1.2.   miRNA inhibitors 
 
miRNA inhibitors are short single stranded RNA (~20–30 nucleotides) with 
sequence complementary to intercept the interaction of miRNA and its target mRNA or 
gene. While it is a challenge to identify the target gene of a miRNA species in an 
organism, due to the nature of perfect or impartial base-pairing of these small regulatory 
RNAs to their targets, Braun et al. (2010) identified a number of potential targets by 
allowing up to 3 mismatches between their identified miRNA and their targets. It was 
stated that more than 80 putative target transcripts were identified for miR-60a alone, and 
that an average of 25 cellular targets could be retrieved for each of the other identified 
Toxoplasma miRNAs. The effect of miR-60a inhibitor was investigated using an 
engineered dual luciferase reporter system (Crater et al., 2015). It was reported that the 
silencing effect of miR60a on the reporter system was diminished in a dose–response 
manner, when an increasing amount (1–20 μg) of miR-60a inhibitor was used. To 
evaluate the global effect of miR60a inhibitor on Toxoplasma infectivity, miR-60a 
inhibitor (20 μg) was introduced into freshly released extracellular parasites. The 
parasites electroporated with miR-60a inhibitor exhibited 80% less ability to form 
plaques than those electroporated with unrelated single stranded RNA of a similar length 
(Figure 4.1, A and B). The data indicates that the early process of Toxoplasma infection 
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Figure 4.1. Effects of miR60a inhibitor. Freshly lysed parasites (~1 × 10
6
) were 
resuspended in electroporation buffer (400 μl of 120 mM KCl, 0.15 mM CaCl2, 10 mM 
K2HPO4/KH2PO4. pH 7.6, 2 mM EDTA, 5 mM MgCl2, 2 mM ATP, 5 mM glutathione in 
a 4 mm-gap cuvette (Roos et al., 1994). Twenty micrograms of single-stranded RNAs, 
either miR60a inhibitor or an unrelated RNA with similar size and structure (CTL), were 
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in vitro synthesized, purified and added to the parasite suspension as described in Crater 
et al. (2015). The mixtures were then pulsed with 1500 V, 25 Ω, and 25 μF in a BTX 
ECM 630 (Roos et al., 1994). To allow for the antisense effect to take place, the 
transfected parasites were grown on confluent monolayers of human fibroblasts (60 × 15 
mm) for 48 h. Transfected parasites were released, and approximately 1000 parasites 
were used to re-infect a new plate (35 × 10 mm) and incubated for 72 h. Plates were then 
fixed with cold methanol and stained with 0.5% crystal violet blue and examined for the 
formation of plaques, as an indicator of successful invasion and infection. (A) 
Representative images of CTL and miR60a inhibitor plaque assays. Images were 
acquired using a Leica DMIRB with C PLAN 10×/0.22 LMC objective, and Northern 
Eclipse software. Micrometer bar represents 40 μm. (B) The number of plaques formed 
were counted from 50 random fields of view, and calculated from three independent 
experiments. This data indicates that miR60a inhibitor interfered with the infection 
process. In addition, 200 released parasites were transferred onto confluent monolayers 
grown on coverslips (22 × 22 mm) and incubated for 24 h. The coverslips were then fixed 
by 3% paraformaldehyde and stained with Hoechst (10 μM). (C) From three independent 
experiments, the numbers of parasites in 100 random vacuoles were counted to monitor 
multiplicity. Hatched bars represent those electroporated with miR60a inhibitor, and 
dotted bars are for control experiments. This indicates that miR60a inhibitor can also 
affect the parasites ability to multiply once entering. 
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was impaired. This impairment could be due to direct or indirect disturbance effect of 
miR-60a inhibitor on attachment and/or invasion. When the electroporated parasites were 
allowed to multiply for a limited period (24 h) without reaching their lytic phase, it was 
detected that the parasite multiplied at a slower rate than those of the control 
electroporation. Majority (60%) of vacuoles of parasites electroporated with miR-60a 
inhibitor contained 2 parasites/vacuole (hatched bars, Figure 4.1c), where those of control 
(40%) carried 8 parasites/vacuole (dotted bars, Figure 4.1c). Considering an average 
doubling time of the parasite is 6 h (CTL), the presence of miR-60a inhibitor clearly 
increased the doubling time. This finding confirms the global effect of miR60a inhibitor, 
which could be direct effects on the predicted 80 target genes (Braun et al., 2010) and/or 
indirect effects of these genes partaking in various steps of parasite pathogenesis. 
4.3.1.3.   Antagomir 
 
The term ‘antagomirs’ is used for a specific group of antisense single-stranded 
RNAs that have a phosphothioate backbone with 3′- cholesterol-conjugation and 
nucleobases complementary to miRNAs. Antagomirs first appeared and were 
successfully used by Krützfeldt et al. (2005) to inhibit the effect of miR-122-directed 
gene regulation in mice. With the success and relatively high stability of antagomirs, 
these antisense molecules have been extensively exploited for therapeutic uses in various 
diseases whose pathogenesis and/or prognosis involve miRNAs, such as cancers and 
cardiovascular diseases (Kaboli et al., 2015; Romaine et al., 2015). Although at the time 
of this manuscript preparation we did not find any reports on antagomirs in Toxoplasma, 
we present and include it here because antagomirs and miRNA inhibitors are closely 
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related both structurally and functionally. In addition we anticipate greater use of 
antagomirs in molecular microbiological and parasitological studies. 
 
4.3.1.4.   Morpholino oligomer 
 
Morpholino oligomer is a common name for phosphorodiamidate morpholino 
oligomer (PMO) which is used in an antisense silencing of a gene expression at 
translation step. Although the name “PMO” is telling more about its structure, which is 
composed of nucleobases bound to morpholine rings (instead of deoxyribose rings) 
linked through phosphorodiamidate groups (instead of phosphodiester linkage), 
morpholino oligomers is a more widely used name. Because of their chemical 
constituents, morpholino oligomers are less negatively charged than natural 
oligonucleotides, while still having high hydrophilicity and ability to form canonical 
base-pairing with target mRNA. Generally, morpholino oligomers are ~25 nt in length, 
which is similar to that of other small regulatory RNAs described above, but their binding 
location on the mRNA is preferably near the translational start site spanning the 5′-UTR. 
Most morpholino oligomers are used as research tools for reverse genetics by knocking 
down gene function. It was noted that the ability of this antisense technology to cross 
multiple cellular membranes is drastically increased when the 3′-terminus of morpholino 
oligomers is conjugated to transductive peptides (Lai et al., 2012). In the same study, the 
transductive peptide conjugated morpholino oligomers were shown to successfully block 
the translation of three genes encoding for Toxoplasma’s dihydrofolate reductase, enoyl-
ACP reductase and apetela 2 domain transcription factor XI-3. Witola et al. (2014) used a 
similar design of peptide-conjugated morpholino oligomer, but with nucleobases specific 
to interact with Toxoplasma mRNA encoding a major secretory protein, named GRA10 
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and showed that this antisense technology caused a reduction in growth and development 
of intracellular Toxoplasma. 
4.3.1.5.  Ribozymes 
Ribozymes are catalytically active RNA molecules. Thus far, naturally discovered 
ribozymes catalyze either the transfer of peptidyl or phosphoryl bond for nucleotide 
cleaving (Zhang et al., 2010). Those with catalytic ability to perform sequence-specific 
destruction of phosphoryl bonds of mRNA have been the most exploited for their 
potential as disease-specific therapeutics tools, and stretched further into our possible 
personalized medicine. Similarly, in the development of genetic tools and technologies 
various natural types of ribozymes (i.e. hammerhead, delta ribozymes), and artificial 
types (i.e. RNA ligase, RNA kinase) have been tested for gene sequence specific activity. 
Based on their mechanistic reactions, most ribozymes employ a step-wise reaction, 
whose initial step involves a nucleotide base-pairing or an “antisense” interaction to 
recognize their substrate whose final step yields destruction of their targets, for the 
purpose of knock-down or silencing of gene expression. The antisense pairing or 
substrate recognition often requires a short span of nucleobases ranging from 7 to ~20 
nucleotides (Table 4.1.). On this basis, we summarize the application of ribozymes in 
Toxoplasma under antisense technology related to small ncRNAs. Sheng et al. (2004) 
successfully used engineered delta ribozymes (antisense or substrate recognition 
sequence of 7 nt in length) to simultaneously down regulate the expression of uracil 
phosphoribosyltransferase (UPRT) and hypoxanthine guanine phosphoribosyltransferase 
(HXGPRT). These trans-acting ribozymes were engineered to express independently 
from the target gene, and multiple targets can be silenced simultaneously. More 
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elegantly, a self-cleaving hammerhead ribozyme, called Sm1, was engineered to perform 
specific nucleolytic activity in an inducible manner (Agop-Nersesian et al., 2008). In the 
study, toyocamycin-responsible hammerhead ribozymes were shown to control the 
expression of adenosine kinase, when the sequence of the ribozymes was placed onto the 
upstream sequence within the transcriptional units, called “cis-acting”. The self-cleaving 
or cis-acting riboyzmes, such as those of toyocamycin-responsive hammerhead 
ribozymes, have a possible drawback in that the sequence encoding the ribozyme has to 
be integrated into transcription unit of the gene of interest. As a consequence, it requires 
effective knock-in genetic manipulation. However, it also offers the advantage of 
maintaining the level of natural expression as the transcriptional unit is expressed by its 
own or endogenous promoter. 
It is important to note that although the genome of Toxoplasma contains no 
sequence encoding hammerhead-like or delta-like ribozymes, both ribozymes can 
effectively execute their desirable action of nucleolytic activity in a sequence specific 
manner. Thus it is of importance to point out that Toxoplasma actually has a naturally 
found ribozyme, called RnaseP (Mack et al., 1994). RnaseP has been used in other 
system and organisms to perform effective nucleolytic activity (Kim and Liu, 2007). The 
presence of natural RnaseP activity in Toxoplasma should be explored for the 
development of genetic technology. 
 
4.3.1.6.  Small guide RNAs 
In recent years, one of the most talked about regulatory RNA-derived 
technologies is that of the guide RNA of the CRISPR (clustered regulatory interspaced 
short palindromic repeats) system, originally identified as an adaptive immune system 
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found in bacteria. Since numerous reviews and commercial sites discuss the use of the 
CRISPR system, it is thus more appropriate here to limit our scope to those used in 
Toxoplasma to serve our aims in comparing various antisense technologies. A simplified 
version of the system involves an engineered plasmid expressing (i) a nuclease-directing 
guide RNA, and (ii) Cas9 nuclease (Sidik et al., 2014). The nuclease-directing guide 
RNA contains nuclease bases (i) acting as an antisense recognition sequence to pair with 
genomic DNA target, and (ii) directing the Cas9 nuclease to the desired location, which 
subsequently causes double stranded DNA breaks. Sidik et al. (2014) showed that the 
CRISPR/Cas9 system can be used to induce homologous recombination in the parasite to, 
for example, introduce point mutations without the need for antibiotic selection. The 
study also indicated that a non-homologous end-joining (NHEJ) pathway is required for 
the prevention of chromosomal instability and to achieve the best efficiency of 
CRISPR/Cas9 genetic modulation system. The system was shown to cause 100-fold 
increase in gene disruption, in comparison to traditional methods used via homologous 
recombination (Sidik et al., 2014). A similar study performed by Shen et al. (2014), 
showed that CRISPR/Cas9 not only disrupts genes by insertion but is also capable of 
deleting full genomic regions using homologous recombination. Shen et al. (2014) noted 
that the CRISPR/Cas9 system can be used to insert selectable markers without the need 
for homology arms. These reports show that gene disruption is most effective in wild-
type strains of Toxoplasma because of the functional NHEJ; however, genome editing in 
processes such as epitope tagging has superior success in ΔKU80 strains that lack NHEJ 
capability and therefore rely on homologous recombination (Sidik et al., 2014). The 
CRISPR/Cas9 system has many promising applications in Toxoplasma as well as a wide 
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variety of other organisms (Shen et al., 2014); however, there is still room for 
improvement in efficiency and off targeting (Sander and Joung, 2014) which will likely 
be addressed as it continues to come to the forefront of genome editing research. 
 
4.3.2.  Long non-coding RNAs 
 
Not only because of their sizes, are lncRNAs constituted as an interesting class of 
regulatory RNAs. lncRNAs, not mainly depending on sequence or structure, can function 
both by sequence complementarity to bind other nucleic acids and/or by structure to form 
molecular scaffolds for assembly of macromolecular complexes to result in either 
repression or activation of gene expression (Yoon et al., 2013; Krishnan and Mishra, 
2014). When the genome of Toxoplasma was surveyed using SAGE methodologies, more 
than 50% of the Toxoplasma genome was shown to transcribe during various stages of 
parasite development (Radke et al., 2005). Among polyadenylated transcripts analyzed 
by SAGE tags, 21.5% of total SAGE tags observed were annotated as antisense 
polyadenylated transcripts. Based on the average density of SAGE tags detected 
throughout 14 chromosomes of Toxoplasma, an average antisense polyadenylated 
transcripts is ~4000 nucleotides and derived from the opposite strands of the transcripts. 
It is interesting to note that the expression of antisense transcripts are inversely 
proportional to those of the sense transcripts and there are a number of intergenic regions 
(~ 2000 base-pairs in length) to be explored (Radke et al., 2005). Hassan et al. (2012) 
using high throughput RNA-sequencing data analysis showed that the Toxoplasma 
genome has a number of ncRNAs.  Ramaprasad et al. (2015) used a manual evaluation of 
strand-specific RNA sequencing and shotgun proteomics to identify cis-natural antisense 
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transcripts and long intergenic ncRNAs. Also, in this study a set of long antisense 
polyadenylated transcripts and sense coding transcript were reported, and the reverse 
correlation between the levels of the antisense noncoding transcripts and coding (sense) 
RNAs reported by Radke et al. (2005) was confirmed. However the length of long 
antisense polyadenylated transcripts is reported to be ~1300 nucleotides (Ramaprasad et 
al., 2015), instead of ~2000. The presence of cis-natural antisense RNA and other forms 
of long ncRNAs are indicative of the existence of a possible mode of gene regulation via 
long ncRNAs in Toxoplasma. 
 
4.3.2.1.  Long antisense RNAs 
 
The first report on utilizing long antisense RNA to regulate gene expression in 
Toxoplasma was by Nakaar et al. (1999). In the study, antisense RNA (~2 kb) 
corresponding to the coding sequence of nucleoside triphosphate hydrolase (NTPase) was 
expressed under the control of its own promoter to yield antisense transcript, whose 3′-
UTR was tailored by a cis-acting hammerhead ribozyme to ensure its nuclear retention. 
Resulting antisense NTPase transcripts subsequently pair with the mRNA with perfect 
matches to cause mRNA degradation in the nucleus. The silencing of NTPase was 
detected by immunoblotting to show the diminished level of target gene product. The 
same strategy was used to down regulate selectable markers, called HXGRPT and CAT 
(Nakaar et al., 2000). Both studies not only showed the silencing effect of nuclear 
antisense RNA, but also showed that catalytically active hammerhead ribozymes are able 
to silence the target without relying on endogenous machinery. Without a compartment-
directed expression, the over-expression of antisense RNA transcripts against the gene 
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encoding uracil phosphoribosyltransferase (UPRT) was shown to effectively silence the 
gene expression (Al-Anouti and Ananvoranich, 2002). Although these studies did not 
offer an insight into the silencing mechanism, the reported silencing effect strongly 
suggested that the basic mechanism of antisense-directed gene silencing must be 
conserved between Toxoplasma and other eukaryotic organisms. 
 
4.3.2.2.   Long double-stranded RNA 
 
Since the discovery of RNA interference mechanism, it is very well accepted that 
siRNA and long double-stranded RNA can be used in silencing gene expression. 
LaCount et al. (2000) showed that the overexpression of a transcript with promoters 
arranged in a head-to-head fashion causes a gene-specific knockdown of gene expression 
in Trypanosoma brucei. Al-Anouti and Ananvoranich (2002) adopted a similar strategy 
for Toxoplasma. Despite the lack of mechanistic evidence to show the presence of 
functional RNA interference in Toxoplasma, a similar expression system was used to 
down regulate a number of genes, including marker, metabolic and growth-related 
essential genes (Al-Anouti and Ananvoranich, 2002; Al-Anouti et al., 2003, 2004; Adams 
et al., 2005; Al Riyahi et al., 2006; Ananvoranich et al., 2006; Yu et al., 2009 and Holmes 
et al., 2010). It was noted that the silencing effect of double-stranded RNAs is better than 
that of antisense RNAs (Al-Anouti and Ananvoranich, 2002). The superior effect of 
double-stranded RNA could be due to (i) a higher stability of double stranded RNA 
and/or (ii) fewer processes involved in the double stranded RNA induced gene silencing. 
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4.4.   Future of antisense technologies 
 
This review summarizes a limited set of our ever-expanding toolbox for 
Toxoplasma, based on regulatory ncRNAs. With that in mind, using conventional genetic 
tools and the various mix-and-match technologies, antisense technologies could yield an 
array of valuable information. Two examples should be mentioned to encourage future 
development of genetic tools via mix-and-match of known methods. By taking advantage 
of homologous recombination system offered by ΔKU80 strains that lack NHEJ 
capability, the binding sites of miR60a can be placed onto the 3’UTR of the gene of 
interest in Toxoplasma (Crater et al., 2015). The resultant system was used to direct the 
endogenous miR-60a-directed machinery to silence Toxoplasma genes encoding for 
DEAD-box RNA helicase, and lactate dehydrogenase. In a more complex system, 
endogenous tagging with DiCre-mediated DNA recombination system can be used to 
insert U1 recognition sites at the last exon of the gene of interest to induce pre-mRNA 
degradation (Pieperhoff et al., 2015). As a concluding remark, it is definitely an exciting 
time to witness the expansion of genetic tools and technologies. More effective 
technologies will be developed and realized using a combination of approaches and 
methodologies. 
 
 
4.5.  Acknowledgments 
 
This work was supported by the Natural Sciences and Engineering Research 
Council of Canada (NSERC) .  
 
 
 
 
118 
 
4.6.   References 
 
Adams, B., Musiyenko, A., Kumar, R., Barik, S., 2005. A novel class of dual-family 
immunophilins. J. Biol. Chem. 280 (26), 24308–24314. 
 
Agop-Nersesian, C., Pfahler, J., Lanzer, M., Meissner, M., 2008. Functional expression 
of ribozymes in Apicomplexa: towards exogenous control of gene expression by 
inducible RNA-cleavage. Int. J. Parasitol. 38 (6), 673–681. 
 
Al Riyahi, A., Al-Anouti, F., Al-Rayes, M., Ananvoranich, S., 2006. Single argonaute 
protein from Toxoplasma gondii is involved in the double-stranded RNA induced gene 
silencing. Int. J. Parasitol. 36 (9), 1003–1014. 
 
Al-Anouti, F., Ananvoranich, S., 2002. Comparative analysis of antisense RNA, 
doublestranded RNA, and delta ribozyme-mediated gene regulation in Toxoplasma 
gondii. Antisense Nucleic Acid Drug Dev. 12 (4), 275–281. 
 
Al-Anouti, F., Quach, T., Ananvoranich, S., 2003. Double-stranded RNA can mediate the 
suppression of uracil phosphoribosyltransferase expression in Toxoplasma gondii. 
Biochem. Biophys. Res. Commun. 302 (2), 316–323. 
 
Al-Anouti, F., Tomavo, S., Parmley, S., Ananvoranich, S., 2004. The expression of 
lactate dehydrogenase is important for the cell cycle of Toxoplasma gondii. J. Biol. 
Chem. 279 (50), 52300–52311. 
 
Ananvoranich, S., Al Rayes, M., Al Riyahi, A., Wang, X., 2006. RNA silencing of 
glycolysis pathway in Toxoplasma gondii. J. Eukaryot. Microbiol. 53 (Suppl. 1), S162–
S163. 
 
Braun, L., Cannella, D., Ortet, P., Barakat, M., Sautel, C.F., Kieffer, S., Garin, J., 
Bastien, O., Voinnet, O., Hakimi, M.A., 2010. A complex small RNA repertoire is 
generated by a plant/fungal-like machinery and effected by a metazoan-like Argonaute in 
the single-cell human parasite Toxoplasma gondii. PloS Pathog. 6 (5), e1000920. 
 
Bunch, T.A., Goldstein, L.S.B., 1989. The conditional inhibition of gene expression in 
cultured Drosophila cells by antisense RNA. Nucleic Acids Res. 17, 9761–9782. 
 
Coleman, J., Hirashima, A., Inokuchi, Y., Green, P.J., Inouy, M., 1985. A novel immune 
system against bacteriophage infection using complementary RNA (micRNA). Nature 
315, 601–603. 
 
Crater, A.K., Cherry, A., Holmes, M., Kadri, D., Ananvoranich, S., 2012. Evaluation of 
the ability of short and long double-stranded RNAs to induce homologous gene silencing 
in the protozoan parasite, Toxoplasma gondii. Am. J. Biomed. Sci. 4, 1–13. 
 
119 
 
Crater, A.K., Manni, E., Ananvoranich, S., 2015. Utilization of inherent miRNAs in 
functional analyses of Toxoplasma gondii genes. J. Microbiol. Methods 108, 92–102. 
 
Green, P.J., Pines, O., Inouye, M., 1986. The role of antisense RNA in gene regulation. 
Annu. Rev. Biochem. 55, 569–597. 
 
Hassan, M.A., Melo, M.B., Haas, B., Jensen, K.D., Saeij, J.P., 2012. De novo 
reconstruction of the Toxoplasma gondii transcriptome improves on the current genome 
annotation and reveals alternatively spliced transcripts and putative long non-coding 
RNAs. BMC Genomics 13, 696. 
 
Holmes, M., Liwak, U., Pricop, I., Wang, X., Tomavo, S., Ananvoranich, S., 2010. 
Silencing of tachyzoite enolase 2 alters nuclear targeting of bradyzoite enolase 1 in 
Toxoplasma gondii. Microbes Infect. 12 (1), 19–27. 
 
Izant, J.G., Weintraub, H., 1984. Inhibition of thymidine kinase gene expression by anti-
sense RNA: a molecular approach to genetic analysis. Cell 36, 1007–1015. 
 
Kaboli, P.J., Rahmat, A., Ismail, P., Ling, K.H., 2015. MicroRNA-based therapy and 
breast cancer: a comprehensive review of novel therapeutic strategies from diagnosis to 
treatment. Pharmacol. Res. 97, 104–121. 
 
Kim, K., Liu, F., 2007. Inhibition of gene expression in human cells using RnaseP-
derived ribozymes and external guide sequences. Biochim. Biophys. Acta 1769 (11–12), 
603–612. 
 
Kim, K., Weiss, L.M., 2004. Toxoplasma gondii: the model apicomplexan. Int. J. 
Parasitol. 34 (3), 423–432. 
 
Kim, K., Weiss, L.M., 2008. Toxoplasma: the next 100 years. Microbes Infect. 10 (9), 
978–984. Krishnan, J., Mishra, R.K., 2014. Emerging trends of long non-coding RNAs in 
gene activation. FEBS J. 281 (1), 34–45. 
 
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K.G., Tuschl, T., Manoharan, M., 
Stoffel, M., 2005. Silencing of microRNAs in vivo with ‘antagomirs’. Nature 438 (7068), 
685–689. 
 
LaCount, D.J., Bruse, S., Hill, K.L., Donelson, J.E., 2000. Double-stranded RNA 
interference in Trypanosoma brucei using head-to-head promoters. Mol. Biochem. 
Parasitol. 111 (1), 67–76. 
 
Lai, B.S., Witola, W.H., El Bissati, K., Zhou, Y., Mui, E., Fomovska, A., McLeod, R., 
2012. Molecular target validation, antimicrobial delivery, and potential treatment of 
Toxoplasma gondii infections. Proc. Natl. Acad. Sci. U. S. A. 109 (35), 14182–14187. 
 
120 
 
Mack, D., McLeod, R., Stark, B., 1994. Characterization of ribonuclease P from 
Toxoplasma gondii. J. Eukaryot. Microbiol. 41 (5), 13S. Miller, A.D., 2014. Delivering 
the promise of small ncRNA therapeutics. Ther. Deliv. 5 (5), 569–589. 
Musiyenko, A., Majumdar, T., Andrews, J., Adams, B., Barik, S., 2012. PRMT1 
methylates the single Argonaute of Toxoplasma gondii and is important for the 
recruitment of Tudor nuclease for target RNA cleavage by antisense guide RNA. Cell. 
Microbiol. 14 (6), 882–901. 
Nakaar, V., Samuel, B.U., Ngo, E.O., Joiner, K.A., 1999. Targeted reduction of 
nucleoside triphosphate hydrolase by antisense RNA inhibits Toxoplasma gondii 
proliferation. J. Biol. Chem. 274 (8), 5083–5087. 
Nakaar, V., Ngo, E.O., Joiner, K.A., 2000. Selection based on the expression of antisense 
hypoxanthine–xanthine–guanine-phosphoribosyltransferase RNA in Toxoplasma gondii. 
Mol. Biochem. Parasitol. 110 (1), 43–51. 
Pieperhoff, M.S., Pall, G.S., Jiménez-Ruiz, E., Das, S., Melatti, C., Gow, M., Wong, 
E.H., Heng, J., Müller, S., Blackman, M.J., Meissner, M., 2015. Conditional U1 gene 
silencing in Toxoplasma gondii. PloS One 10 (6), e0130356. 
Radke, J.R., Behnke, M.S., Mackey, A.J., Radke, J.B., Roos, D.S., White, M.W., 2005. 
The transcriptome of Toxoplasma gondii. BMC Biol. 3, 26. 
Ramaprasad, A., Mourier, T., Naeem, R., Malas, T.B., Moussa, E., Panigrahi, A., 
Vermont, S.J., Otto, T.D., Wastling, J., Pain, A., 2015. Comprehensive evaluation of 
Toxoplasma gondii VEG and Neospora caninum LIV genomes with tachyzoite stage 
transcriptome and proteome defines novel transcript features. PloS One 10 (4), e0124473. 
Romaine, S.P., Tomaszewski, M., Condorelli, G., Samani, N.J., 2015. MicroRNAs in 
cardiovascular disease: an introduction for clinicians. Heart 101 (12), 921–928. 
Roos, D.S., Donald, R.G., Morrissette, N.S., Moulton, A.L., 1994. Molecular tools for 
genetic dissection of the protozoan parasite Toxoplasma gondii. Methods Cell Biol. 45, 
27–63. 
Sander, J., Joung, J., 2014. CRISPR-Cas systems for editing, regulating and targeting 
genomes. Nat. Biotechnol. 32 (4), 347–355. 
Shen, B., Brown, K.M., Lee, T.D., Sibley, L.D., 2014. Efficient gene disruption in 
diverse strains of Toxoplasma gondii using CRISPR/CAS9. Mbio 5 (3), e01114. 
Sheng, J., Al-Anouti, F., Ananvoranich, S., 2004. Engineered delta ribozymes can 
simultaneously knock down the expression of the genes encoding uracil 
121 
 
phosphoribosyltransferase and hypoxanthine–xanthine–guanine 
phosphoribosyltransferase in Toxoplasma gondii. Int. J. Parasitol. 34 (3), 253–263. 
Sidik, S.M., Hackett, C.G., Tran, F., Westwood, N.J., Lourido, S., 2014. Efficient 
genome engineering of Toxoplasma gondii using CRISPR/Cas9. PloS One 9 (6), 
e100450. 
Spiegelman, W.G., Reichardt, L.F., Yaniv, M., Heinemann, S.F., Kaiser, A.D., Eisen, H., 
1972. Bidirectional transcription and the regulation of phage λ repressor synthesis. Proc. 
Natl. Acad. Sci. U. S. A. 69, 3156–3160. 
Vanhee-Brossollet, C., Vaquero, C., 1998. Do natural antisense transcripts make sense in 
eukaryotes? Gene 211, 1–9. 
Wahlestedt, C., 2013. Targeting long non-coding RNA to therapeutically upregulate gene 
expression. Nat. Rev. Drug Discov. 12 (6), 433–446. 
Wang, J., Liu, X., Jia, B., Lu, H., Peng, S., Piao, X., Hou, N., Cai, P., Yin, J., Jiang, N., 
Chen, Q., 2012. A comparative study of small RNAs in Toxoplasma gondii of distinct 
genotypes. Parasites Vectors 5, 186. 
Witola, W.H., Bauman, B., McHugh, M., Matthews, K., 2014. Silencing of GRA10 
protein expression inhibits Toxoplasma gondii intracellular growth and development. 
Parasitol. Int. 63 (5), 651–658. 
Xu, M.J., Zhou, D.H., Huang, S.Y., Zhao, F.R., Nisbet, A.J., Lin, R.Q., Song, H.Q., Zhu, 
X.Q., 2013. Comparative characterization of microRNA profiles of different genotypes of 
Toxoplasma gondii. Parasitology 140 (9), 1111–1118. 
Yoon, J.H., Abdelmohsen, K., Gorospe, M., 2013. Post-transcriptional gene regulation by 
long noncoding RNA. J. Mol. Biol. 425 (19), 3723–3730. 
Yu, L., Gao, Y.F., Qiao, Z.P., Li, C.L., Li, X., Shen, J.L., 2008. Toxoplasma gondii: 
siRNA can mediate the suppression of adenosine kinase expression. Exp. Parasitol. 118 
(1), 96–102. 
Yu, L., Gao, Y.F., Li, X., Qiao, Z.P., Shen, J.L., 2009. Double-stranded RNA specific to 
adenosine kinase and hypoxanthine–xanthine–guanine-phosphoribosyltransferase retards 
growth of Toxoplasma gondii. Parasitol. Res. 104 (2), 377–383. 
Zamecnik, P.C., Stephenson, M.L., 1978. Inhibition of Rous sarcoma virus replication 
and cell transformation by a specific oligodeoxynucleotide. Proc. Natl. Acad. Sci. U. S. 
A. 75 (1), 280–284. 
122 
 
Zhang, J., Lau, M.W., Ferré-D’Amaré, A.R., 2010. Ribozymes and riboswitches: 
modulation of RNA function by small molecules. Biochemistry 49 (43), 9123–9131. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
123 
 
CHAPTER 5 
 
Ubiquitin-like protease 1 (Ulp1) as a model for the study of miRNA-induced gene 
regulation in Toxoplasma gondii 
5.1.  Introduction 
Toxoplasma gondii is an intracellular parasitic protozoan and a member of the 
phylum Apicomplexa whose members also include important pathogens such as 
Plasmodium, the cause of malaria; Cryptosporidium, a water borne parasite; and 
Neospora and Eimeria, important zoological parasites (Kim and Weiss, 2004).  T. gondii 
is able to infect any warm-blooded mammal, and has been reported to infect up to one 
third of the world’s population.  The life cycle of Toxoplasma consists of two stages; a 
sexual reproduction stage that occurs only in the gut of its feline definitive hosts, and an 
asexual reproduction stage in other warm-blooded hosts.  The asexual stage contains two 
distinct forms: a rapidly growing form called tachyzoite, and a latent cyst encapsulated 
form called bradyzoite.  Although the tachyzoite form is easily removed by the host’s 
immune system, the parasites are able to convert to the bradyzoite form and evade the 
host’s immune response.  When the host’s immune system becomes weakened, the 
bradyzoites are able to reconvert to their rapidly growing tachyzoite form. 
One of our research focus is to study a mechanism of post-transcriptional gene 
regulation directed in Toxoplasma by small interfering RNAs, including siRNAs and 
miRNAs.  We showed that the abundance of Tg-miRNAs and the number of binding sites 
within a transcript can influence the levels of silencing effects (Crater et al., 2015).  The 
presence of miRNA mimics and inhibitors altered the silencing effects.  To gain a better 
understanding of miRNA roles in the regulation of gene expression and parasite cellular 
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biology, we endeavored to establish a model gene to facilitate the study.  It was shown 
previously that Toxoplasma small interfering RNAs were generated by plant/fungal-like 
machinery (Braun et al, 2010).  In Toxoplasma type I strain, the most abundant miRNAs 
are members of Tg-miR-60 family, and predicted to have approximately 80 putative 
target genes. Using this information as our starting point, we used the seed sequence 
(CACAGT, 6 nts) of the Tg-miR-60a guide strand 
(ACACAGTCGGTACGAAATCCATACT, 25 nts) as a query in a blast search.  
Seventy-five genes were identified to have at least one location with six consecutive 
nucleotides to base-pair with the seed sequence. To ensure strong interactions between 
Tg-miR-60a and the transcripts, we filtered out any genes with less than 18 nucleotides 
complementarity, including those to the seed sequence.  The transcripts of eight genes 
were found to have at least one location with at least 18 nucleotides complementary to 
Tg-miR-60a guide strand.  Among these genes, three genes were annotated to have a 
putative function in the Toxoplasma database (Gajria et al, 2008).  Sorting based on the 
number of probable Tg-miR-60a binding sites, we selected the locus containing a gene 
with the highest number of probable Tg-miR-60a binding sites. Seven probable sites were 
identified in a locus encoding ubiquitin-like protease 1 (TgUlp1, TGGT1_214470); four 
sites locate on the non-coding strand, and three sites on the coding strand of the gene 
encoding TgUlp1 (Figure 2a, Table 5.1.). This identification prompted us to investigate 
and explore whether TgUlp1 could offer a model for the study of miRNA-induced gene 
silencing in Toxoplasma. 
Prototypic Ulp1, was first identified in baker’s yeast by Li and Hochstrasser 
(1999) where it was found to have an essential role in the G2/M phase progression of the 
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Table 5.1.  Predicted miR-60a binding sites on TgUlp1-pre-mRNA based on plant 
miRNA binding.  Predicted base pairing is indicated by *.  Seed sequence is highlighted 
in orange and target sequence is red. 
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cell cycle (Li and Hochstrasser, 1999).  Ulp1 is an essential gene in eukaryotes, which 
encodes an enzyme involved in a post-translational modification pathway called 
SUMOylation.  The pathway of SUMOylation is involved in the reversible addition of a 
small ubiquitin-like modifier (SUMO) peptide (90-110 amino acids) to a protein 
substrate.  Unlike ubiquitination, where target proteins are polyubiquitinylated and sent to 
lysosomes for degradation, SUMOylation of target proteins aids in the protein’s 
localization, stabilization and activity (Hay, 2005; Komander and Rape, 2012).  
SUMOylation plays an important role in DNA repair, transcription, RNA processing, 
nuclear-cytoplasmic transport, stress response and progression through the cell cycle 
(Hay, 2005).  The pathway is initiated by Ulp1 in the activation of a SUMO precursor.  
Ulp1 is a cysteine peptidase that is highly specific for the SUMO peptide, as it recognizes 
the tertiary structure of SUMO rather than an amino acid sequence (Mossessova and 
Lima, 2000).  Ulp1 cleaves amino acid residues from the C-terminal end of the SUMO 
precursor to reveal a di-glycine motif that is required for attachment to target proteins.  
The hydrolysis of a peptide bond by Ulp1 involves the thiol group of a cysteine residue as 
a nucleophile, a histidine, and an aspartic acid to assist the reaction.  The mature form of 
SUMO with its revealed di-glycine is subsequently transferred by E1 and E2 enzymes 
and ligated to its protein substrate by an E3 enzyme which recognizes the KxE 
consensus sequence on the substrate (where  is a large hydrophobic residue and x is any 
residue).  The catalytic activity of Ulp1 is also responsible for the removal of SUMO 
peptide from SUMOylated proteins (Watts 2013). 
In Toxoplasma, a study was undertaken to explore the biological significance of 
SUMOylation (Braun et al., 2009).  The cDNA coding for the SUMO peptide was 
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identified (TGME49_266460).  Since a knockout or over-expression of TgSUMO was 
found to be lethal, a N-terminal HA-Flag tagged version was generated under the control 
of its endogenous promoter. Affinity purification of HA-Flag-TgSUMO expressed in 
tachyzoites coupled to mass spectrometry identified 120 putative SUMOylated proteins.  
The majority of identified SUMOylated proteins (~27 %) were found to be involved in 
protein translation and folding.  Other identified proteins were involved in (i) metabolism 
and post-translational modification and (ii) degradation, which makes up 19 and 11 % of 
the total identified proteins, respectively (Braun et al., 2009).  Using an anti-HA antisera, 
HA-Flag-TgSUMO was found to localize to the nucleus of transgenic parasites.  They 
next developed a polyclonal antibody raised against a recombinant TgSUMO protein 
expressed from bacteria.  To confirm the specificity of the new antibody for TgSUMO, 
the HA antisera signal was compared to the TgSUMO antisera signal for localization and 
western blot analysis.  Since the anti-TgSUMO antisera could recognizes free SUMO and 
SUMOylated proteins, localization during the parasite lytic cycle was analyzed.  Upon 
contact with a host cell during invasion, TgSUMO was found on the parasite membrane 
at the point of contact.  As the parasite entered the host cell, TgSUMO staining migrated 
down the length of the parasite at the moving junction.  Once the parasite successfully 
invaded, the TgSUMO signal was found within the parasite’s nucleus.  Under bradyzoite 
conditions a TgSUMO signal was found on the parasitophorous vacuole membrane 
(PVM). These studies suggest SUMOylation in T. gondii is a dynamic processes required 
for parasite invasion and bradyzoite conversion.   SUMOylation orthologs, Ulp1, E1, E2 
and E3 have been identified yet their functions remain unknown (Braun et al., 2009). 
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5.2.   Materials and Methods 
5.2.1.  Cell cultures 
5.2.1.1.  Mammalian cell cultures 
Human foreskin fibroblasts (HFF; ATCC, #1041) were grown in Dulbecco’s 
Modified Eagle Media with high D-glucose and L-glutamine (DMEM; Invitrogen, 
#12100046) supplemented with 10% v/v Cosmic Calf Serum (Hyclone, #H3008704N) 
and 0.5x Antibiotic–Antimycotic (Invitrogen, #15240-062).  Cultures were maintained at 
37 C in 5% CO2. 
5.2.1.2.   Toxoplasma gondii culture 
RHHX, T. gondii type I strain, was obtained from NIH AIDS Research and 
Reference Reagent Program (#2857); Δku80 strain, which is an RHΔHX-derived strain, 
was obtained from Dr. Vern B. Carruthers (University of Michigan). Unless stated 
otherwise, both strains were maintained in HFF using Minimum Essential Medium 
(MEM, Invitrogen, #61100061) supplemented with 1% v/v dialyzed fetal bovine serum 
(ThermoFisher Scientific, Hyclone, #SH3007903) and diluted (0.5x) Antibiotic-
Antimycotic and maintained at 37 C in 5% CO2.  Selection of transgenic parasites was 
grown in culture media containing either, mycophenolic acid (25 μg/mL) and xanthine 
(50 μg/mL) or pyrimethamine (1M), for hypoxanthine-xanthine-guanine 
phosphoribosyltransferase (HXGPRT) or dihydrofolate reductase (DHFR) resistance, 
respectively. 
5.2.1.3.   Saccharomyces cerevisiae 
Wild type strain, MHY500 (MATa his3-200 leu2-3, 112 ura3-52, lys2-80, 1trp1-
1, gal2) and the ulp1 shuffle strain, YOK 40 (ulp1::HIS3, ULP1/URA3) gifts from Dr. 
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Oliver Kerscher, (The College of William and Mary, Williamsburg, Virginia) were 
grown under their nutrient requirements on YEPD plates. 
5.2.2.   Plasmid construction 
TgUlp1-SF transforming plasmid was constructed using pSF-TAP-LIC-HX 
(obtained from Dr. Vern B. Carruthers, University of Michigan). The plasmid was 
linearized by PacI digestion prior to the treatment with T4 DNA polymerase to create 
compatible ends in the presence of dGTP for a ligation-independent cloning procedure as 
described by Huynh and Carruthers (2009).  TgUlp1 (1298 bp) amplicon was prepared 
using gene specific primer pair of TgUlp1LICFw/TgUlp1LICRv (Table 5.2.), and 
purified prior to the treatment with T4 DNA polymerase to create compatible ends in the 
presence of dCTP. Equimolar concentrations of the prepared plasmid and insert were 
allowed to anneal and subsequently used in bacterial transformations. The resultant 
plasmid, pUlp1-SF-TAP-LIC-Hx was analyzed to confirm its sequence via restriction 
endonuclease digestions. The plasmid was then used in the transformation of T. gondii 
(ΔKu80). Transgenic parasites were selected and grown in culturing media containing 
mycophenolic acid (25 μg/mL) and xanthine (50 μg/mL). 
CRISPR/Cas9 constructs for TgUlp1 knock out were generated by PCR reaction 
using the pU6-universal parental plasmid (obtained from S. Lourido, Whitehead Institute 
for Biomedical Research, Cambridge, MA) as a template.  Opposing primers, 
gRNAUlp1NsiI and U3upstrem and gRNAUlp1XhoI and U3upstrem were used to 
generate gRNAUlp1_1 and gRNAUlp1_2 plasmids (Table 5.1).  PCR products were gel 
purified using QiaexII Gel Extraction kit (Qiagen #20021) according to the manufacturer 
protocol.  Purified PCR products were then phosphorylated using T4 PNK  (New 
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Table 5.2.   Oligo nucleotide primers used in the study. 
Primer name Sequence 
Plasmid Construction and verification 
TgSUMO-GFP 
XbaIRBS5Sumo AATCTAGAAGGAGATATACCATGTCGGACGACAAGAAG 
EcoRI3Sumo AAGAATTCTGCGCCCCCCGTCTGTT 
EcoRISer5eGFP AAGAATTCTCCATGGTGAGCAAGGGCGAG 
HindIII3eGFP AAAAGCTTCGAACTCCAGCAGGACCA 
LIC constructs 
TgUlp1LICFw (b) TACTTCCAATCCAATTTAATgcacgaacaaaacctggttc 
TgUlp1LICRv  (b’) 
TCCTCCACTTCCAATTTTAGCgtcgagttcgccgccgacga 
FlagRv (e) TGCGGATGAGACCAAGAACC 
GST-TgUlp1 
GST_Ulp1_FwCf GATCTGGTTCCGCGTggatccATGATGTATGTTGACCTC 
Ulp1EcoR1_RvCf CTCGAGTCGACCCGGgaattcTCAGGGGTCGAGTTCGCCGC 
Ulp1RvRT TCAGGGGTCGAGTTCGCCGC 
TgUlp1 yeast construction 
ScUlp1Fw GGTACCGGGCCCCCCCTCGAGACACATATATTACACAAGTA 
ScUlp1Rv GTCAACATACATCATATGCATTATTATGATATCCAAAGGTC 
TgUlp1Rv TCCTTTGCTAGCCATGCGGCCGCGGTCGAGTTCGCCGCCGA 
TgUlp1Fw TTGGATATCATAATAATGCATATGATGTATGTTGACCTCCC 
CRISPR 
gRNAUlp1NsiI ggacagctcgagtgtctgtaGTTTTAGAGCTAGAAATAGCAAG 
gRNAUlp1XhoI ggacagctcgagtgtctgtaGTTTTAGAGCTAGAAATAGCAAG 
TgUlp1DHFRFw 
gcgggacagctcgagtgtctGCTTCGCCAGGCTGTAAATC 
TgUlp1DHFRRv 
aaaatcaaagcttcgtccgtCAGGAATTCATCCTGCAAGTG 
U3upstrem aacttgacatccccatttacc 
RT-PCR 
qGAPDH_Fw GGTGTTCCGTGCTGCGAT 
qGAPDH_Rv GCCTTTCCGCCGACAAT 
qUlp1_Fw (a) ACGCGCTCTGGGACAAAA 
qUlp1_Rv (a’) GAACAGAGGCGAAGTCGTAGGT 
Exon6Fw ( c ) 
AGCTCGAGTGTCTGTACGGCT 
UPRTFw GGTCACTGCTGCTGTTGACATC 
UPRTRv 
TTTTCCAGTCCGCGATTC 
In vitro transcription 
T7promoterGG TAATACGACTCATATAGG 
antiMIR60a_tpl ACACAGTCGGTACGAAATCCATACTccTATATGAGTCGTATTA 
antiMIR4a_tpl ATGTTTGCTTGGAAGCTGTAGTCATTccTATATGAGTCGTATTA 
Ulp1intron7FwT7 TAATACGACTCACTATAGGacgcgctctgggacaaaa 
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England BioLabs #B0201S) according to the manufacturer protocol.  Subsequent 
reactions were then ligated by a T4 DNA ligase (Fermentas #02076201) and analyzed by 
NsiI and XhoI restriction endonuclease reactions, respectively.  A DHFR (dihydrofolate 
reductase) selection cassette was prepared by a PCR reaction with primers 
TgUlp1DHFRFw and TgUlp1DHFRRv that contained 20-nucleotide homology to 
TgUlp1 genomic sequence where Cas9 cleavage would occur.  The resultant PCR 
product was extracted with 1 volume of phonol:chloroform then ethanol precipitated.  
Parasites were transformed with 50 μg of each CRISPR/Cas9 plasmid, gRNAUlp1_1 and 
gRNAUlp1_2, and 20 μg of purified DHFR selection insert.  Parasites were cultured in 
Ed1 media containing 1 μM pyrimethamine. 
For expression of GST-Ulp1 in bacteria, the pGEX-4T-1 plasmid was prepared by 
restriction endonuclease reaction with BamHI and EcoR1 restriction endonucleases.  For 
generation of the 2355 bp TgUlp1 amplicon, cDNA which was generated by 
SuperScriptIII reverse transcriptase (Invitrogen #18080-093) with 250 ng of total RNA 
and 2 pmol gene specific primer Ulp1RvRT, was used as a template.  Amplicons were 
produced with primers, GST_Ulp1_FwCf and Ulp1EcoR1_RvCF in a PCR reaction.  
Each primer carries an 18-nucleotide homology to the linearized plasmid.  Purified vector 
and insert were subjected to a Cold Fusion cloning reaction (System Biosciences 
#MC010A-1) according the manufacture’s protocol at a 1:1 ratio.  Resultant plasmid was 
confirmed by EcoRI restriction endonuclease. 
Expression of the TgSUMO-eGFP recombinant protein substrate was generated 
by linearization of pET28b plasmid by a XbaI and HindIII restriction endonuclease 
reaction.  To generate a TgSUMO (TGGT1_266460) insert, a PCR reaction with primers 
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XbaIRBS5Sumo and EcoRI3Sumo with cDNA was used.  The resultant PCR product 
was digestion with XbaI and EcoR1 restriction endonuclease reaction and gel purified.   
For generation of the eGFP insert, a PCR reaction with primers EcoR1ser5eGFP and 
HindIII3eGFP were used with a ptub-mcherryFP-EGFP plasmid (from Dr. Vern B. 
Carruthers, University of Michigan) as a template.  Resultant amplicon was digested with 
EcoRI and HindIII and gel purified.  Purified linear plasmid and TgSUMO and eGFP 
inserts were ligated at a 2:1:1 ratio using T4 DNA ligase.  Resultant plasmid was 
confirmed by restriction endonuclease reactions. 
For yeast complementation assays, the parental plasmid pScUlp1-GFP/LEU2 (gift 
from Dr. Oliver Kerscher, The College of William and Mary, Williamsburg, Virginia) 
was prepared by digested with XhoI and NotI endonucleases to remove the ScUlp1 
promoter and coding region.  Primers ScUlp1Fw and ScUlp1Rv were used with the 
parental plasmid as a template to generate the ScUlp1 promoter insert.  The resultant 
product was subjected to XhoI endonuclease reaction to create a complimentary end 
between the 5’ end of the promoter insert and the linearized plasmid used for ligation.  
TgUlp1 coding region was generated in a PCR reaction with primers TgUlp1Fw and 
TgUlp1R with the pGEX-TgUlp1 plasmid as a template for TgUlp1.  The PCR product 
was then digested with NotI endonuclease to create complimentary 3’ end used for 
ligation.  Purified components were ligated with T4 DNA ligase at a 2:1:1 ratio.  
Resultant plasmid was confirmed by XhoI restriction endonuclease reaction. 
5.2.3.  Yeast complementation assay 
Standard lithium acetate transformation protocol for yeast cultures was used 
(Gietz and Schiestl, 2007). YOK 40 strain (referred to as Δulp1 shuffle strain) was grown 
133 
 
overnight at 30 °C and prepared for transformation. While a parental pAA3 plasmid was 
used as a negative control (empty vector), a plasmid expressing Ulp1 from its 
endogenous promoter (pUlp1-GFP/LEU2, obtained from Dr. Oliver Kerscher, The 
College of William and Mary, Williamsburg, Virginia) served as a positive control 
(Elmore et al., 2011). The construct of TgUlp1 cDNA under the endogenous yeast Ulp1 
promoter was used in the transformation to monitor the level of functional 
complementation. All yeast strains and their transformed cultures were grown to a mid-
log phase of growth and then subsequently diluted to ~0.5 (OD600).  Serial dilutions were 
performed using sterile 1x TE.   Each dilution was spotted (3 μL) onto YEPD plates 
containing a final concentration of 1 mg/mL of 5-Fluoroorotic acid (5-FOA, Bio Basic 
#703-95-7) and 20 g/mL of uracil (Bio Basic #UD0564) at pH 4.5 for induction of Ulp1 
knockout.  Plates were incubated at 30 °C for 72 hours. Growth analyses were performed 
using densitometry (ImageJ 1.44p) for three independent experiments. 
5.2.4.  RNA isolation and qRT-PCR 
Total RNA was isolated from freshly lysed parasites (approximately 10
6
 parasites) 
using TRI reagent (Molecular Research Center, Inc., #TR 118) according to the 
manufacturer’s protocol, and treated with RQ1 Rnase-Free Dnase (Promega, #M6101) 
for 30 minutes at 37 °C.  Samples were kept at −20 °C until use.  Isolated total RNA 
(~500 ng) was annealed with 250 ng of an oligo-(dT) following heating at 65 °C for 5 
minutes and slowly cooled.  The reactions were then divided in half. A half of each 
annealed reaction was used in SuperScript III reverse transcriptase (RT) reaction 
(Invitrogen #18080-093), while the other aliquot was used as a negative control reaction 
in the absence of SuperScript III RT.  For real-time qPCR, the reaction mixtures were 
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diluted 1/10, and analyzed by using Kapa Sybr Fast qPCR Kit Master Mix (2x) ABI 
Prism (Kapa Biosystems #KR0390) and OneStepPlus thermocycler (Applied 
Biosystems).  Samples were analyzed in technical triplicates among at least biological 
tests.  Relative TgUlp1 expression levels in comparison to TgGAPDH expression levels 
were measured and calculated using ΔΔCt protocol carried out by the StepOne Software 
v 2.1 (Applied Biosystem).  To generate a data set, relative TgUlp1 expression from no 
addition of RNA was used for normalization of Tg-miR-60a and Tg-miR-4a (control) 
inhibitor TgUlp1 mRNA levels.  PCR was performed using Hot Start Taq DNA 
Polymerase (New England Biolabs, Inc., #M0495S) according to the manufacturer’s 
protocol. 
5.2.5.   In vitro transcription of effector RNAs 
Using partial DNA duplexes as templates, in vitro transcription reactions were 
carried out in 50 μL-reaction mixtures in the presence of T7 RNA polymerase (~5 units), 
80 mM Hepes-KOH, pH 7.5, 24 mM NaCl, 2 mM spermidine, 40 mM DTT, 10 mM 
rNTPs, and ~1 unit pyrophosphatase at 37 °C for 16 hours. Reactions were subsequently 
extracted with one volume of phenol-chloroform mixture (1:1), and resultant RNAs were 
precipitated and quantified (Thermo Scientific NanoDraop2000).  The oligonucleotide 
template (2 μM) was annealed with an equimolar of T7promoterGG following mixing 
and heating the mixture for 5 minutes at 70 °C and slowly cooled to room temperature to 
yield partial DNA duplexes. One fifth of the annealing reaction (or 400 nM of the partial 
DNA duplex) was used as templates for the RNA synthesis. Resultant single-stranded 
RNA products, which were produced using the oligonucleotides named antimiR-60a_tpl 
and antimiR4a_tpl were referred to as miR-60a inhibitor and miR-4a inhibitor, 
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respectively.  For the production of pri-miR-60, DNA amplicons were prepared using an 
oligonucleotide primers containing a gene specific sequence and the sequence of the T7 
promoter only on the forward primer, as listed in Table 5.1, under standard conditions for 
Hot Start Taq DNA polymerase (New England Biolabs).  Isolated genomic DNA from 
type I parasites was used as a template with primers: TgUlp1intron7T7 and qUlp1Rv to 
produce a 710 bp product and primers:  TgUlp1intron7T7 and Ulp1LICRv to produce a 
2308 bp product.  In vitro transcription reactions were carried out in similar conditions as 
described above using 1 g of DNA amplicon.  Quality of RNA products were verified 
by gel electrophoresis to confirm their expected sizes prior to electroporation into freshly 
released parasites. 
5.2.6.  Dual luciferase assay 
For dual luciferase assays, 48 hours post-transfection, freshly lysed parasites were 
harvested and lysed with 100 μL of 1x Passive Lysis Buffer (Promega, #E1531) and 
incubated for 10 minutes at room temperature. Lysates were cleared of debris by 
centrifugation (10,000 xg for 1 minute), and the supernatant was kept on ice and used in 
the dual luciferase assay, which was carried out in a 2-step fashion as previously 
described by Crater et al. (2015). Luminescence signals were measured with a 20/20n 
Luminometer (Turner Biosystems).  Rnluc signals were normalized to Ffluc signals for a 
direct comparison among different independent experiments. For each experiment, the 
reporter plasmid electroporation without tested in vitro synthesized RNA, was carried out 
to allow for the measurement of the dual luciferase expression under at least three 
independently tested conditions. 
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5.2.7.   Western blot analysis 
Cell-free lysates were prepared by the addition of RIPA buffer to collected 
parasites and sonicated for 30 seconds (x3).  Protein concentration was measured using 
the RC DC Protein Assay according to manufacturer’s instructions (Bio-Rad 
Laboratories, #500-0119). Approximately 20-25 μg was used for the analysis, of which 
the lysates were denatured using 6x SDS protein loading buffer and resolved on a 10% 
SDS-PAGE. The primary antibodies used were α-Flag mouse antisera (1:5,000, Applied 
Biological Materials Inc., Richmond, B.C, Canada, #G191), α-tub mouse antisera 
(12G10, 1:1,000, Developmental Studies Hybridoma Bank, University of Iowa, USA), 
and α-GFP goat antisera (1:2,500, Rockland Immunochemicals Inc., #600-101-215).  The 
signals were revealed using secondary antibodies: horseradish peroxidase (HRP) 
conjugated goat anti-mouse antisera (Rockland Immunochemicals Inc., #610-1319) or 
rabbit anti-goat antisera (Rockland Immunochemicals Inc., #605-4302) at a 1:10,000 
dilution, and a Chemiluminescent HRP Substrate Kit (Millipore, #WBKLS0500). 
5.2.8.   Recombinant protein purification 
Both GST-TgUlp1 and TgSUMO-GFP fusion proteins were expressed in E. coli, 
BL21-codonPlus (DE3)-RIL cells (Agilent #230245), by the addition of 1 mM IPTG and 
grown overnight at room temperature.  GST-TgUlp1 was purified on glutathione-agarose 
beads (Novagen #7044-3) and eluted with 10 mM glutathione and 50mM Tris-HCL, pH 
8.0.  Freshly purified protein was then used for cleavage assays.  TgSUMO-GFP was 
purified on Ni-NTA agarose beads (Invitrogen #537735A) and eluted with 250 mM 
imidazole,  then dialyzed with 50 mM Tris-HCL, pH 8.0, 150 mM NaCl, and 0.2 % 
Tween 20 and stored at -80 C for future use. 
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5.2.9.  TgUlp1 cleavage assays 
5.2.9.1.  TgUlp1 activity within parasite lysates 
For TgUlp1 activity within type I parasites, 48 hours post-transfection with the 
indicated concentration of miR-60a inhibitor, parasites were lysed in reaction buffer 
containing 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.2 % Tween 20 and 1 mM 
dithiothreitol, and no protease inhibitors, and sonicated for 30 seconds.   Total protein 
was quantified and 25 g of parasite lysates were combined with 4 M of substrate and 
incubated at 37 C for two hours.  Aliquots were removed every 30 minutes and reactions 
were stopped by the addition of SDS loading buffer and boiled for 10 minutes.  Samples 
were then resolved by 10 % SDS-PAGE and subjected to western blot analysis.  
TgSUMO-GFP amounts were quantified by densitometry for at least three experimental 
trials. 
5.2.9.2.  In vitro TgUlp1 activity 
Equal amounts of GST-TgUlp1 and TgSUMO-GFP (4 M) were combined in 
reaction buffer containing 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.2 % Tween 20 and 
1 mM dithiothreitol, and no protease inhibitors, and incubated at 37 C for 30 minutes.  
Reactions were terminated by the addition of SDS loading buffer and boiled for 10 
minutes.  Samples were then resolved by SDS-PAGE and visualized via coomassie 
staining.  TgSUMO-GFP amounts were quantified by densitometry for at least three 
experimental trials. 
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5.2.10.  Bioinformatics 
Multiple sequence alignments were performed with the Clustal Omega tool 
(Sievers et al., 2011) while sequence similarities were performed by GGSEARCH for 
global and by SSEARCH for local protein analysis (Pearson 1988). 
5.2.11.  Statistical analysis 
Statistical analysis was completed by the paired-wise student t-test methodology 
assuming a null hypothesis.  All values were calculated from at least three independent 
tests. 
5.3.  Results 
5.3.1.   TgUlp1 is the most probable target of Tg-miR-60a 
To verify if TgUlp1 expression is controlled by miR-60a, we used a miRNA 
inhibitor to alter its expression.  The mRNA levels of TgUlp1 were determined by qRT-
PCR.  To confirm the effects of the miR-60a inhibitor on protein levels, we used our 
engineered dual luciferase reporter system where our Renilla luciferase transcript (Rnluc) 
contains three perfect match sites to miR-60a in the 3’ UTR as previously described 
(Crater et al. 2015).  Upon the introduction of increasing concentrations of miR-60a 
inhibitor (5, 10 and 20 g), relative TgUlp1 mRNA levels increased to 2.4  0.23, 5.15  
0.35 and 10.15  0.60, respectively (Figure 5.1a).  When an unrelated miRNA inhibitor 
for Tg-miR-4a was used, relative TgUlp1 mRNA levels were 1.28  0.22.  To confirm 
the sequence specific effects of the miR-60a inhibitor, two unrelated genes (TgGAPDH 
and TgUPRT) showed no change in relative mRNA levels (Figure 5.1b).  The effects of 
the miR-60a inhibitor (5, 10, and 20 g) on relative Rnluc activity increased to 46.6  
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Figure 5.1.  TgUlp1 expression is affect by a miR-60a inhibitor.  A.  qRT-PCR indicates 
that the presence of a miR-60a inhibitor can increased relative TgUlp1 mRNA levels in a 
sequence specific manor.  B.  RT-PCR indicates an overall low expression of TgUlp1 
when compared to housekeeping genes.  TgUlp1 mRNA levels increase in the presence 
of a miR-60a inhibitor while transcripts with no miR-60a binding sites remain 
unchanged.  C.  Rnluc activity was also compared in subsequent parasite lysates. (P-
values from at least three independent trials are, ‡ p≤ 0.001, * p≤0.005 and ● p≥ 0.01) 
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3.2, 83.8  2.7 and 90  2.2 %, respectively, when compared to no inhibitor at 17  1.6 
(Figure 5.1c).  The unrelated miR-4a inhibitor caused no change in relative Rnluc 
activity, 25.0  4.0 %.  As a control, the maximal amount of miR-60a inhibitor (20 g) 
was also tested with the Rnluc construct with no miR-60a binding sites.  Relative Rnluc 
activity remained unchanged indicating the sequence specificity of the miR-60a inhibitor 
(Figure 5.1c). 
5.3.2.  TgUlp1 genomic arrangement and miR-60a binding sites 
Since miR-60a has a near perfect complementarity to intron 7 of TgUlp1 pre- 
mRNA we sought to examine the genomic arrangement of this region in relationship to 
the predicted miR-60a binding sites.  We hypothesized that if miR-60a is able to bind 
intron 7, it may cause intron retention.  Total RNA was isolated and reverse transcribed 
using a poly(T) oligonucleotide (polyA RT).   For polyA generated cDNA, the PCR 
reaction using primer set a-a’, which spans exons 7-8, produced two transcript products at 
110 and 710 bps.  The 110 bp product corresponds to joined exons 7 and 8 of TgUlp1 
mRNA, and the 710 bp product would include exon 7, intron 7, and exon 8.  The lack of 
a product in the no RT reaction suggests the 710 bp amplicon is not the result of genomic 
DNA contamination and could be the effect of intron 7 retention (Figure 5.2b).  PCR 
reactions for primer sets b-b’, a-b’ and c-a’ produced one transcript size each that 
corresponds to TgUlp1 mRNA at 281, 538 and 198 bp respectively (Figure 5.2b).  As a 
control, we also generated cDNA by a gene specific primer for TgUlp1 (primer b’ RT).  
Unexpectedly, primer set a-a’ only produced a PCR product at 110 bp.  Subsequent 
reactions (c-a’and a-b’) produced products of 198 and 281 bp, respectively, which 
correspond to TgUlp1 mRNA. 
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Figure 5.2.  TgUlp1 genomic arrangement.  A. Predicted miR-60a binding sites on 
TgUlp1 locus are indicated by * and ● on the coding and non-coding strand, respectively.  
B.    Primer set a-a’ spans intron 7 where a near perfect match binding to miR-60a is 
located.  Polyadenylated generated cDNA produced two PCR bands at ~110 and ~710 bp.  
The 710 bp product is not present in gene specific generated cDNA (by primer b’), only 
the 110 bp from mRNA.  C.  The 710 bp product is only detected in antisense generated 
cDNA by primer a. 
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Complementary DNA for the antisense RNA was also generated and tested 
(primer a RT).  To our surprise, primer set a-a’ produced a product at 710 bp.  The lack of 
amplicons in the subsequent reactions with antisense cDNA (a-b’, b-b’, and No RT) 
could indicate the location for the promoter of the antisense RNA (Figure 5.2c).  These 
data suggests the 710 bp product is not the effect of intron retention but of a 
polyadenylated antisense RNA. 
The antisense RNA contains a sequence that resembles the sequence of miR-60a 
guide strand.  To investigate the ability of the identified 710 nt antisense RNA to confer a 
gene silencing effect, we used our dual luciferase reporter assay.  The 710 nt nucleotide 
sequence of antisense RNA was in vitro transcribed and tested.  In the presence of in 
vitro synthesized 710 RNA, Rnluc activity decreased when compared to no in vitro 
synthesized RNA (Figure 5.3.).  When the 710 in vitro synthesized RNA was RNaseIII 
treated prior to transfection, Rnluc activity decreased further to 24.8  2.3 % (Figure 
5.3.). A longer antisense RNA molecule (2803 nt) from the same locus was used as a 
control.   In the presence of the 2803 nt RNA and RNAseIII treated RNA Rnluc activity 
was 43.6  0.36 and 36.9  1.1 %, respectively, when compared to no RNA added at 47.2 
 3.7 % (Figure 5.3.).  These data suggest that the expressed antisense RNA could confer 
gene silencing and a possible locus is pri-miR-60a. 
Taken altogether, our findings suggest that TgUlp1 could be identified as the first 
self-regulating gene in T. gondii by miRNAs.  A self-regulating gene could be an 
indication of an essential gene.  Therefore we sought to determine the function and 
importance of TgUlp1 to parasite cell biology and the effects of miRNA-induced gene 
regulation of TgUlp1 in the SUMOylation pathway. 
143 
 
 
 
 
Figure 5.3.  Antisense RNA acts as effector RNA.  In vitro transcribed antisense RNA 
(710) is able to decrease Rnluc activity when the transcript contains miR-60a binding 
sites.  RNAseIII treatment of antisense RNA (710R) can decrease Rnluc activity further.  
To confirm the silencing effect, a 2803 nt RNA corresponding to the antisense region to 
the 3’ coding region of TgUlp1 was tested (2803).  No alteration in Rnluc activity was 
observed even when the RNA was RNAseIII pre-treated (2803R).  (P-values compared to 
Rnluc activity in the presence of miR-60a binding sites, but no additional RNA from at 
least three independent trials are ‡ p≤ 0.001) 
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5.3.3. TgUlp1 function by yeast complementation 
Due to the conserved catalytic triad and high sequence similarity of the functional 
domain of TgUlp1 (TGGT1_214470) with yeast Ulp1 (GenBank:KZV07496.1), we 
anticipated TgUlp1 to display similar activities as observed with yeast Ulp1.  To 
determine if TgUlp1 could function similarly to ScUlp1, we used a conventional yeast 
complementation analysis.  A Ulp1 shuffle strain (ulp1::HIS3, Ulp1/URA3), referred to 
as Ulp1, which is a conditional knock-out in the presence of 5-fluoroorotic acid (5-
FOA), was used (Li et al., 2003, Elmore et al., 2011).  To determine a background level 
of growth, the Ulp1 strain was grown on plates containing 5-FOA and uracil at 30 C 
for 72 hours and growth was determined via densitometry.  Growth of the Ulp1 strain 
was 20.6  2.6 % when compared to the wild-type (WT) (Figure 5.4.).  Transfection of 
Ulp1 with the pAA3 (LEU2) empty vector displayed a similar growth phenotype to 19.6 
 2.5 % as compared to WT.  When Ulp1 was transformed with a pAA3 plasmid 
containing the yeast wild-type Ulp1 under the control of its own promoter (ScUlp1, 
Elmore et al., 2011), growth was restored to 87.4  5.3 % of the wild type phenotype.  
When pAA3 plasmid engineered to carry TgUlp1 (cDNA 2316 bp) under the control of 
the yeast Ulp1 promoter (TgUlp1) was used, complementation by TgUlp1 was achieved.  
Growth was restored to 48.4  3.7 % (1x) and 80.0  4.4 % (2x) as compared to the WT 
(Figure 5.4.). 
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Figure 5.4.  Yeast complementation analysis in Ulp1 strain.  The ability of yeast to 
utilize the T. gondii ortholog of Ulp1 was tested by growth analysis in the conditional 
ScUlp1 KO yeast strain.  Under the ScUlp1 KO conditions, phenotypic growth was only 
restored upon transfection of a Ulp1 expressing plasmid.  (P-values compared to WT 
yeast growth by densitometry from at least three independent trials are ● p≥ 0.01, * p ≤ 
0.01) 
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5.3.4.  TgUlp1 peptidase activity 
To examine the peptidase activity of TgUlp1, we expressed and purified a 
recombinant protein and a SUMOylated recombinant protein substrate for in vitro assays.  
TgUlp1 (85 kDa) was N-terminally tagged with a glutathione S-transferase (GST, 26 
kDa) that would produce a 111 kDa protein.  The peptide of TgSUMO (TGGT1_266460, 
10.3 kDa) was joined to the N-terminus of GFP that carries a C-terminal His tag (6x) to 
give a 45 kDa protein substrate (Figure 5.5a).  Equal amounts (4 M) of purified GST-
TgUlp1 enzyme and TgSUMO-GFP substrate were combined and incubated at 37 C for 
30 minutes.  In the presence of GST-TgUlp1 (+), the amount of TgSUMO-GFP substrate 
decreased to 57  6.9 % when compared to no enzyme (-) (Figure 5.5a).  A GFP product 
at 34.7 kDa was also detected (Figure 5.5a).  This indicates TgUlp1 is able to recognize 
and hydrolyze the peptide bond from a SUMO conjugated protein. 
Separate parasite lysates (~25 g) were prepared 48-hours post-transfection 
without or with the miR-60a inhibitor and combined with purified TgSUMO-GFP 
substrate. First, mock (no inhibitor) parasite lysates displayed a substrate cleavage rate of 
0.21 nM·min
-1
·µg
-1
 (Figure 5.5b).  Second, the introduction of 5, 10, and 20 µg of 
inhibitor increased substrate cleavage rates to 0.58, 0.77 and 1.10 nM·min
-1
·µg
-1
, 
respectively (Figure 5.5b).  These data suggest the presence of the miR-60a inhibitor can 
increase TgUlp1 activity in parasite lysates. 
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Figure 5.5.  TgUlp1 peptidase activity.   A. Purified GST-TgUlp1 can remove TgSUMO 
from a recombinant protein substrate, TgSUMO-GFP. B.  Total TgSUMO-GFP levels 
were analyzed by western blot and an anti-GFP antisera within parasite lysates.  Parasites 
were transfected with the miR-670a inhibitor and allowed to grow for 48 hours.  
Extracellular parasites were lysed in reaction buffer (see section 5.2.9.1.) and incubated 
with purified TgSUMO-GFP.  Activity was calculated by the total amount of TgSUMO-
GFP substrate present at each time point.  (A, p-value compared to GFP signal without 
GST-TgUlp1 is p≤ 0.005, B, p-value for all substrate cleavage rates are p ≤ 0.0001 
calculated by densitometry from at least three independent trials) 
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5.3.5.  TgUlp1 localization 
To monitor TgUlp1 at the protein level, we generated a tagged version of TgUlp1 
by a genetic knock-in strategy.  The nucleotides encoding for a Strep/Flag (SF) tag were 
introduced immediately before the stop codon for TgUlp1 cDNA to create a ~93 kDa 
protein (85 kDa TgUlp1, ~8 kDa SF) (Huynh and Carruthers, 2009).  To ensure proper 
integration of the SF tag to the TgUlp1 locus, PCR analysis was performed (Figure 5.6a).  
Primer set b-b’ spans 1298 bps in exons 10-13 of TgUlp1 and was present in both the 
parental (Ku80) and transgenic TgUlp1-SF parasites (Figure 5.6a).  Primer set b-e’, spans 
1798 bps in exon 10 to the Flag tag sequence and was only present in the TgUlp1-SF 
parasites (Figure 5.6a). 
SUMOylation could be important for parasite invasion and cyst formation, as 
TgSUMO localizes to specific areas during these events (Braun et al., 2010).  
Localization of TgUlp1 could suggest its involvement in similar events.  Within 
intracellular tachyzoites, TgUlp1 localization is mainly dispersed throughout the 
cytoplasm, however, in extracellular tachyzoites, TgUlp1 localizes to distinct structures 
in the apical and basal ends of the parasite (Figure 5.6b).  Under bradyzoite conditions 
(Dolichos stain for cyst walls not shown), the distinct structures do not appear to change 
(Figure 5.6b). 
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Figure 5.6.  Endogenously tagged TgUlp1 localization.  A. PCR confirmation of 
generation of TgUlp1-SF transgenic parasites by genetic knock-in.  B.  TgUlp1 
localization changes throughout the different stages of the lytic cycle.  Within 
intracellular parasites, TgUlp1 localization is found within the cytoplasm, which changes 
to distinct structures in the apical and basal ends of the parasite in extracellular parasites.  
Under bradyzoite conditions the distinct structures become more prevalent.  (Hz, 
Hoechst,  micrometer represents 5 µm.) 
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5.3.6. Physiological function of TgUlp1 
To determine the function of TgUlp1, we attempted to generate a knockout 
parasite strain by using the CRISPR/Cas9 mythology in type I parasites.  Two guide 
RNAs were designed to target and cleave in the genomic sequence of TgUlp1 at 
nucleotide 4162 in exon 6 and nucleotide 7023 in exon 12 to remove a 2880 bp region 
that encodes for the catalytic domain of TgUlp1.  Using homologous recombination, a 
3640 bp DHFR (dihydrofolate reductase) selectable marker was inserted at the cut sites.  
Upon selection pressure, transfected parasites would begin to grow normally with an 
average of 8 parasites per vacuole at 24-hours post-invasion (data not shown).  However, 
we noticed at 48-hours post-invasion, vacuole morphology would appear somewhat 
abnormal and the parasites remained intracellular (Figure 5.7., vacuole indicated by red 
triangle).  Generally under our culturing conditions at 48-hours post- invasion, parasites 
would require a fresh monolayer of host cells to invade.  As the parasites were allowed to 
growth further (up to 5 days), vacuole morphology continued to look abnormal and 
worsened in appearance and size (Figure 5.7.).  A lack in host cell destruction or debris 
due to parasite egress, or exit, of the host cell was also observed.  The abnormal vacuole 
morphology was noted to be similar in parasites with an inability to egress (Heaslip et al., 
2011). The inability to create a stable TgUlp1 KO parasite strain may indicate TgUlp1 is 
as an essential gene and may be involved in parasite egress. 
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Figure 5.7.  Effects of TgUlp1 knockout by CRISPR/Cas9 methodology.  After 48-hours 
post-infection, TgUlp1KO parasites display abnormal vacuole morphology (indicated by 
red triangle).  By 72 hours post-infection, parasites display an inability to egress and 
remained intracellular. 
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5.3.7. Effects of TgUlp1 expression on SUMOylation 
The effects of TgUlp1 on total SUMOylated substrates in parasite lysates was 
tested by alteration of TgUlp1 expression accomplished by using the miR-60a inhibitor 
and in vitro synthesized 710 nt antisense RNA (710as).  Extracellular TgUlp1-SF 
parasites were transfected with 20 g of miR-60a inhibitor, 710 antisense RNA (710as), 
or a mixture of miR-60a inhibitor and 710as.  TgUlp1-SF expression was detected by an 
anti-Flag antisera.  Densitometry values were calculated based on the expression of an 
alpha-tubulin loading control.  At 48 hours post-transfection the presence of miR-60a 
inhibitor increased Ulp1-SF expression to 232 ± 17 % when compared to WT (Figure 
5.8.).  Introduction of 20 g of the 710as RNA decreased TgUlp1 expression to 65 ± 
13%.  When equal amounts of miR-60a inhibitor and 710as RNA were mixed and 
introduced to the parasites, TgUlp1 expression was 129 ± 10% (Figure 5.8.). 
Subsequent lysates were also analyzed for total SUMOylated substrates with an 
anti-SUMO antisera.  The SUMO antisera would recognizes free SUMO and 
SUMOylated protein substrates.  The presences of the miR-60a inhibitor increased total 
SUMOylated proteins levels to 266 ± 13 % when compared to WT (Figure 5.8.).  Total 
SUMOylated proteins levels decreased to 47 ± 4.1 % in the presences of 710as RNA.  
Combined miR-60a inhibitor and 710as RNA restored total SUMO levels to 129 ± 17 %.  
Selected individual SUMOylated proteins (A, B, C, and D) were also monitored for an 
alteration of expression in the presence of the effector RNAs (Figure 5.8). 
 
155 
 
 
  
156 
 
Figure 5.8.  Alteration of TgUlp1 expression affects total SUMOylation levels.   A.  
Representation of immunoblot for analysis at 48-hours post-transfection with or without 
effector RNA molecules.  B. TgUlp1-SF parasites were transfected with an effector RNA 
or combined effector RNAs and allowed to grow for 48 hours.  Changes in protein 
expression of TgUlp1-SF and total SUMOylated proteins were observed in the presence 
of the miR-60a inhibitor and 710 antisense RNA (710as) when tested independently. (p-
values were  calculated by densitometry from at least three independent trials compared 
to WT expression relative to Tubulin expression,* p ≤ 0.01) 
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5.4.   Discussion 
 
For the identification of the most probable target for miR-60a, we used miRNA 
target binding criteria based on plant miRNAs, which contain a perfect to near perfect 
complementary binding.  The identified near perfect miR-60a binding site is located in 
intron 7 of the pre-mRNA.  Two other putative miR-60a binding sites with only a seed 
match complementarity (6 nt) were found in intron 2 (Table 5.1., Figure 5.2a).  Since 
these three sites were identified in the introns of TgUlp1 pre-mRNA, we sought to 
identify possible miR-60a binding sites on the mRNA based on mammalian miRNA 
binding criteria.  Mammalian miRNAs need as few as 6-nt complementary to bind target 
mRNA and can contain a 1 nt mismatch in the miRNA seed sequence (Seok et al., 2016).  
Either strand of a miRNA can be used as the “guide” strand therefore we sought to 
analyze both the lower and upper strand of miR-60a to target TgUlp1 mRNA.  Only the 
guide strand sequence of miR-60a has been reported, therefore we used two predicted 
upper strands from miR-60b as reported by Braun et al., (2010).  These miRNAs come 
from the same miRNA family (miR-60), contain the same seed sequence and should 
target the same mRNAs.  Using these criteria, we identified ten putative binding sites for 
Tg-miR-60.  Table 5.3. indicates the sequence of the miR-60 strand (lower or upper +) 
and their predicted base pair interactions (indicated by *) and location on the TgUlp1 
mRNA.  The predicted seed sequence base pairing is highlighted.  Using the lower strand 
of miR-60a, eight putative binding sites were identified.  Two of the binding sites are 
located in the predicted 5’ UTR, four in the coding region, and one in the predicted 3’ 
UTR.   The miR-60b upper 1 strand has a binding site in the predicted 5’ UTR and exon 6 
while miR-60b upper 2 would bind once in the predicted 5’ UTR. 
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Table 5.3.  Predicted miR-60a binding site on TgUlp1 mRNA based on mammalian 
miRNA binding.  Seed sequence is highlighted in orange and target sequence is red. 
Predicted base pairing is indicated by * (+ indicates upper strand of pridicited miR60). 
 
Predicted base pairing 
Location on mRNA 
(nt) 
 
5’ UCCCCCCGUUGGAAUUUUCCCUUCU  3’   mRNA 
               *   * *******      
3’ GUACAUCGUGUAUAUCAUGGGAAGA  5’   miR60b+ 
 
Predicted 5’ UTR 
-364 to -339 
 
5’ CCGCUGUUCGUGGUGUCUAAUCGAG  3’   mRNA 
         *       *  ***** * 
3’    CUGAUUUCAGUCGUAUUAGUUAA 5’   miR60b+ 
  
Predicted 5’ UTR 
-322 to -297 
 
5’  AAUCGAGGGCGACUUCGCGUCUGUU  3’  mRNA 
          **    * *  ** ****  
3’   UCAUACCUAAAGCAUGGCUGACACA 5’  miR60a 
 
Predicted 5’ UTR 
-304 to -279 
 
5’  GAGCUUCUGUACACCCACGAGUGUA  3’  mRNA 
     **  *   *       *** *** 
3’   UCAUACCUAAAGCAUGGCUGACACA 5’  miR60a 
 
Predicted 5’ UTR 
-68 to -43 
 
5’   GAGGAAGGAUUCGAGAGACGGUGUC 3’  mRNA 
     *        *   *  *** **** 
3’  TCATACCTAAAGCATGGCTGACACA 5’   miR60a 
 
 
Exon 1 
681 to 705 
 
5’  CGUCCUGGACACAAGGACGACUAUCU 3’  mRNA 
         ****        ***** * * 
3’   UCAUACCUAAAGCAUGGCUGACACA 5’  miR60a 
 
Exon 2 
1165 to 1189 
 
5’  CAGGCCCGUCAAGCGACGAUUGUGC 3’   mRNA 
            *   *   *** ****            
3’  UCAUACCUAAAGCAUGGCUGACACA 5’   miR60a 
 
Exon 2 
1348 to 1373 
 
5’ CUGGCUGAACGACGAAGUUAUCAAC  3’   mRNA 
      *   ** * *    * *****    
3’    CUGAUUUCAGUCGUAUUAGUUAA 5’   miR60b+ 
 
Exon 6 
1710 to 1735 
 
5’  AGUGGUGCAUCCCCGACGACUUUGC 3’   mRNA 
    ***   *  * *    ***** **       
3’  UCAUACCUAAAGCAUGGCUGACACA 5’   miR60a 
 
Exon 11 
2120 to 2145 
 
5’ UGCCAUGCAUGGAAAGAAAUGUGUG 3’    mRNA 
            * * *   * *****        
3 UCAUACCUAAAGCAUGGCUGACACA  5’    miR60a 
 
Predicted 3’ UTR 
2700 to 2725 
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TgUlp1 was identified as the most probable target for miR-60a.  The expression 
of TgUlp1 mRNA and protein levels can be effected by the introduction of a miR-60a 
inhibitor indicating miR-60a acts upon TgUlp1.  Antisense RNA produced from the 
TgUlp1 locus, which contains a possible miR-60a guide sequence, is able to down 
regulated Rnluc activity when the transcript carries miR-60a binding sites and decrease 
TgUlp1 protein expression.  Based on this data, the locus of TgUlp1 has other regions 
that would require investigation.  The pre-mRNA of TgUlp1 could be a source of miR-
60a mirtrons.  Upon splicing, introns 2, 7, and 12 might produce a structure that 
resembles a mirtron with sequences similar to miR-60a.  These regions would also need 
to be tested for their ability to induce gene silencing. 
TgUlp1 locus is on chromosome X and composed of 13 exons and 12 introns that 
span 7432 bp.  The coding sequence is 2316 nucleotides (Gajria et al., 2008).   Pairwise 
sequence alignment of TgUlp1 from three archetype strains revealed 8 SNPs (Type I, 
GT1, Type II, ME49 and type III, Veg) in the N-terminal variable region.  Each SNP 
results in an amino acid change, but are conservative substitutes. Reported gene 
expression profile of TgUlp1 indicates an overall low expression (40
th
 percentile) in the 
three strains (Bahl, et al., 2010).   Overall, this indicates that TgUlp1 would have the 
same function and activity among the parasite archetypes (type I, II, and III). 
The amino acid sequence alignment of TgUlp1 (TGGT1_214470) with reported 
homologs, showed a C-terminal cysteine peptidase domain that contains a canonical 
catalytic triad, His-Asp-Cys.  TgUlp1 sequence also contains a conserved Gln that is 
important for stabilizing the acyl intermediate that forms during catalysis (Supplemental 
Figure 5.1a).  The global sequence similarity among TgUlp1 (771 amino acids), H. 
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sapiens SENP2 (589 amino acids), C. elegan Ulp1 (697 amino acids), and S. cerevisiae 
Ulp1 (621 amino acids) is, 31.9, 35.5, and 30.2 %, respectively.  The catalytic domains 
alone have a 57, 50.6, and 47.4% sequence similarity respectively (accession; SENP2, 
NP_067640.2, C. elegan Ulp1, NP_498095.3, yeast Ulp1, GenBank:KZV07496.1). 
Global phylogenic tree analysis revealed TgUlp1 to be more closely related to human 
SENP2 and C. elegan Ulp1 rather than P. falciparum Ulp1, another Apicomplexan 
(Supplemental Figure 5.1b).  Therefore, we would expect TgUlp1 to have similar 
function and activity to these identified homologs. 
TgUlp1 was only able to complement the growth of yeast to ~50 % (Figure 5.4.).  
The level of rescue observed could be due to the longer N-terminal domain of TgUlp1 
compared to yeast Ulp1 (~150 amino acids) or the lower sequence similarity between the 
functional peptidase domains (47.4 %).  The N-terminal domain of yeast Ulp1 has been 
shown to be important for nuclear localization (Li et al., 2003), therefore, the differences 
in length, tertiary structure and amino acids may have an impact on the ability of TgUlp1 
to localize and function in the yeast nucleus.  Furthermore, these differences may also 
hinder the ability of TgUlp1 to interact with and cleave yeast SUMO-1 and SUMOylated 
products. 
A recent study used the CRISPR/Cas9 system to perform a genome-wide 
screening of T. gondii genes by knockout (Sidik et al., 2016).  After three lytic cycles, 
parasites were analyzed for their ability to grow and given a score based on their fitness.  
Any gene with a negative score was considered to contribute to parasite fitness and 
identified as an indispensable gene.  Under these criteria, TgUlp1 KO was found to have 
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Supplemental Figure 5.1.  Amino acid analysis and phylogenic tree for TgUlp1.  A.  
Sequence alignment of Toxoplasma (TgUlp1) with C. elegan (CsUlp1), H. sapiens 
(HsSENP2), and S. cerevisiae (CsUlp1).  Catalytic domain in gray while catalytic triad, 
H-D-C is highlighted in red (*), conserved Q in purple (#).   B.  Phylogenic tress analysis 
of full length Ulp1 orthologs. 
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a score of -2.73 (Sidik et al., 2016).   Combining our inability to produce a stable TgUlp1 
KO parasite indicates that TgUlp1 is an essential gene. 
TgUlp1 has been identified as the first gene target of miR-60a and could be self-
regulating gene.  TgUlp1 KO and alteration of expression by the miR-60a inhibitor 
suggests a tight regulation of TgUlp1 expression is necessary for parasite cell biology.   
Overall, these data show the importance of an RNA induced gene silencing mechanism in 
T. gondii. 
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CHAPTER 6 
Toxoplasma gondii Argonaute: A core protein of RNA-induced silencing complex 
6.1.  Introduction 
RNA-directed gene silencing mechanisms play a critical role in the control of 
gene expression at the transcriptional, post-transcriptional and chromatin remodeling 
levels in eukaryotes.  Argonaute (Ago) is the core protein found in the RNA-induced 
silencing complex (RISC) (Fire et al., 1998, Shabalian and Koonin, 2008, Carthew and 
Sontheimer, 2009, Siomo and Siomi, 2009).  A member of the Argonaute family is 
responsible for guiding small RNAs (siRNAs and miRNAs) to their regulatory target 
mRNAs.  Subsequent RISC assembly leads to (i) degradation of mRNA target, (ii) 
translational repression or (iii) causing chromatin modifications.  The Ago protein family 
was first identified in plants (Bohmert at al., 1998). Ago proteins were named after a 
phenotype of a knockout in Arabidopsis thaliana, as it resembles the tentacles of the 
octopus, Argonaute argo (Bohmert at al., 1998).  Originally, Ago was called “Slicer” 
based on its nuclease activity to hydrolyze phosphodiester bonds of messenger RNA 
(mRNA). Based on sequence homology, Ago proteins have been divided into three 
subfamilies; (i) Ago subfamily, which resembles A. thaliana Ago1, (ii) Piwi subfamily 
(P-element induced wimpy testis) that is related to Drosophila melanogaster Piwi protein 
and (iii) WAGO which are specific to C. elegans.  Piwi subfamily members only contain 
the Piwi domain that includes the canonical catalytic triad, DDH/E and are generally ~40 
kDa in size.  Members of the Ago subfamily on the other hand, contain two conserved 
domains called PAZ (Piwi-Argonaute-Zwille) and Piwi and are typically ~100 kDa in 
size. Among species an organism can contain one or many paralogs of Ago.  Fission 
yeast (Schizosaccharomyces pombe) and budding yeast (Saccharomyces castellii) both 
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harbor one gene coding for Argonaute, while fruit fly  (Drosophila melongaster), humans 
(Homo sapiens), and worm (Caenorhabditis elegans), contain five, eight and 27 paralogs, 
respectively. Generally, multiple paralogs of Argonaute within an organism function 
within distinct locations (i.e. nucleus or cytosol), vary in nuclease activity or interact with 
a specific form of non-coding RNA molecule (siRNAs and miRNAs vs. piRNA).  In 
organisms that contain a single Argonaute gene, the protein can be found within the 
nucleus and cytosol and, participate in transcriptional and post-transcriptional gene 
regulation mechanisms (Azlan et al., 2016).  Not every eukaryote contains an Argonaute 
gene, for example, baker’s yeast (Saccharomyces cerevisiae, Jinek and Doudna, 2009). 
Among parasitic protozoans, Trypanosoma brucei has two genes that code for 
Argonaute while Toxoplasma gondii, Giardia spp., Entamoeba spp. and Trypanosoma. 
congolense are predicted to have only one.  The presence of Argonaute and small non-
coding RNAs amongst these organisms led to interest in developing a genetic tool to 
target and develop new drugs against parasitic infection (Ullu 2004 and Kolev 2011). 
Trypanosoma cruzi, Leishmania major, Leishmania donovani, and Plasmodium 
falciparum on the other hand, do not harbor Argonaute coding genes (Ullu 2004 and 
Kolev 2011). 
Our focus is the Apicomplexa parasite T. gondii which has infected up to one 
third of the world’s population.  Infection in humans and mammals often leads to 
blindness, encephalitis, severe brain dysfunctions and miscarriages (Kim and Weiss, 
2004).  The study by Al-Riyahi et al. (2006) showed that T. gondii has one Argonaute 
coding gene with a conserved Piwi domain and a partial PAZ domain (Al-Riyahi et al., 
2006).  Using RNA Ligase-Mediated Rapid Amplification of cDNA (RLM-RACE), 
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analysis in type I parasites, TgAgo was found to be encoded by a 2265 nucleotide mRNA 
which spans five exons that could produce a 58.5 kDa protein.  Southern blot analysis 
determined a single locus for the expression of TgArgonaute.  Immunofluorescence 
assays showed that TgAgo localizes to the cytosol.  Despite the smaller size, it was 
shown that TgAgo is required for double-stranded RNA induced gene silencing even 
though it lacks a canonical catalytic triad (DDH/E) (Al-Riyahi et al., 2006). 
In a later study, Braun et al. (2010) identified a larger TgAgo protein in type II 
parasites that was predicted to contain additional domains called MID and RGG, and the 
protein is ~98 kDa (Braun et al., 2010).  A full-length HA-Flag-tagged TgAgo 
overexpression construct composed of the ~7.5 kb genomic sequence was used for the 
study.  They found that HA-Flag-TgAgo had an affinity for small RNAs and polysomes 
by chromatin immuno-precipitation and chromatographic polyribosome fractionation 
analysis, respectively.  Immunoprecipitation of HA-Flag-TgAgo and mass spectrometry 
identified several TgAgo interacting proteins involved in RNA metabolism and 
chromatin-repression complexes, indicating that TgAgo may play a role in translational 
and transcriptional regulation.  HA-Flag-TgAgo was also found to interact with a Tudor-
SN (tudor staphylococcal nuclease) and a PRMT1 (arginine methyltransferase), which 
have been found in the RISC complex of C. elegans and D. melanogaster (Caudy et al., 
2003). 
Another study by Musiyenko et al. (2012) investigated the roles of TgAgo in 
RNA cleavage by antisense guide RNA.   A tachyzoite cDNA library from type I T. 
gondii parasites (provided by the AIDS reagent bank), was used as starting material for 
generating cDNA (2841 nt) used to overexpress an N-terminally Myc-tagged TgAgo.  
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The construct produced a ~100 kDa Myc-TgAgo.  Since TgAgo does not contain the 
canonical DDH/E catalytic triad, the roles of the interacting proteins TgTSN and 
TgPRMT1 were investigated in target mRNA cleavage.  In vitro assays determined that 
purified Myc-TgAgo alone displayed a weak nuclease activity.  When purified Myc-
TgAgo and Myc-TgTSN were combined, a greater target mRNA cleavage was achieved 
(Musiyenko et al., 2012).  By in vitro methylation assays, it was discovered that 
TgPRMT1 is required for methylation of the RGG domain of TgAgo, which is used for 
protein stabilization in addition to recruitment of TgTSN. 
The three versions of TgAgo protein are reported in the NCBI protein database 
(GenBank: ACZ73654.1, ABA70456.1 and ABB05350.1) predicting three possible 
translational starts sites.  Gene ACZ73654.1 identified by Braun et al (2010), contains the 
first predicted translational start codon in exon 1 (Figure 6.1., ATG1).  The predicted 
coding region spans 7 exons and would produce a ~100 kDa protein which would contain 
a RGG, PAZ and PIWI domain (protein 1).  The second predicted TgAgo, ABA70456.1 
identified by Andrews, et al. (2006), has a start codon in exon 3 (ATG 2).  Protein 2 
would span 5 exons and produce a ~ 82 kDa protein and would contain a PAZ and PIWI 
domain (Figure 6.1.).  The third predicted TgAgo, ABB05350.1 identified by Al-Riyahi 
et al. (2006) has a start codon in exon 6 (ATG 3).  Protein 3 would span 2 exons and 
produce a ~58 kDa protein and only contain the PIWI domain (Figure 6.1.).  The 
discrepancy could be due to the methodologies used; genomic expression (TgAgo1), a 
cDNA library (TgAgo2) and RLM-RACE (TgAgo3) or the parasite strains (type I for 
TgAgo 2 and 3 and type II). 
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Figure 6.1.  TgAgo isoforms could be expressed by multiple start codons to produce three 
different TgAgo proteins of different sizes. 
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for TgAgo 1).  This study was initiated in an attempt to resolve these discrepancies by 
determining the expression of the three isoforms of TgAgo and their roles in gene 
silencing. The role of each TgAgo in gene silencing and the small RNAs they would 
interact with, could be suggested by the unique domains they contain. 
6.2.  Materials and Methods 
6.2.1.  Cell cultures 
6.2.1.1.  Mammalian cell cultures 
Human foreskin fibroblasts (HFF; ATCC, #1041) were grown in Dulbecco’s 
Modified Eagle Media with high D-glucose and L-glutamine (DMEM; Invitrogen, 
#12100046) supplemented with 10% v/v Cosmic Calf Serum (Hyclone, #H3008704N) 
and 0.5x Antibiotic–Antimycotic (Invitrogen, #15240-062).  Cultures were maintained at 
37 C in 5% CO2. 
6.2.1.2.  Toxoplasma gondii culture 
RHHX, T. gondii type I strain, was obtained from NIH AIDS Research and 
Reference Reagent Program (#2857); Δku80 strain, which is an RHΔHX-derived strain, 
was obtained from Dr. Vern B. Carruthers (University of Michigan). Unless stated 
otherwise, both strains were maintained in HFF using Minimum Essential Medium 
(MEM, Invitrogen, #61100061) supplemented with 1% v/v dialyzed fetal bovine serum 
(ThermoFisher Scientific, Hyclone, #SH3007903) and diluted (0.5x) Antibiotic-
Antimycotic and maintained at 37 C in 5% CO2.  Selection of transgenic parasites was 
grown in culture media containing either, mycophenolic acid (25 μg/mL) and xanthine 
(50 μg/mL) or pyrimethamine (1 M), for hypoxanthine-xanthine-guanine 
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phosphoribosyltransferase (HXGPRT) or dihydrofolate reductase (DHFR) resistance, 
respectively. 
6.2.2.  Plasmid construction 
Transforming plasmids were constructed using pSF-TAP-LIC-HX and pChFP-
TAP-LIC-DHFR (obtained from Dr. Vern B. Carruthers, University of Michigan). Each 
plasmid was linearized by PacI digestion prior to the treatment with T4 DNA polymerase 
to create compatible ends in the presence of dGTP for a ligation-independent cloning 
procedure as described by Huynh and Carruthers (2009).  TgAgo (1565 bp) amplicon was 
prepared using gene specific primer pair of TgAgoLICFw/TgAgoLICRv (Table 6.1.), and 
purified prior to the treatment with T4 DNA polymerase to create compatible ends in the 
presence of dCTP. Equimolar concentrations of the prepared plasmid and insert were 
allowed to anneal and subsequently used in bacterial transformations. The resultant 
plasmids, pAgo-SF-TAP-LIC-Hx and pAgo-ChFP-TAP-LIC-DHFR were analyzed to 
confirm their sequences via restriction endonuclease digestions. The plasmids were then 
used in the transformation of T. gondii. Transgenic parasites were selected and grown in 
culturing media containing mycophenolic acid (25 μg/mL) and xanthine (50 μg/mL) or 
pyrimethamine (1M). 
 
6.2.3.  Dual luciferase assay 
For dual luciferase assays, 48 hours post-transfection with 20 g of Ago 
expression plasmid, freshly lysed parasites were harvested and lysed with 100 μL of 1x 
Passive Lysis Buffer (Promega, #E1531) and incubated for 10 minutes at room 
temperature. Lysates were cleared of debris by centrifugation (10,000 xg for 1 minute), 
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Table 6.1.  Oligonucleotide primers used in the study of TgAgo.  Lower case nucleotides 
were used for LIC cloning. 
 Nucleotide sequence 
TgAgoLICFw tacttccaatccaatttaatgcCTCCCCGAAATCGCGTGG 
TgAgoLICRv tcctccacttccaattttagcACAGAACACCATCGGGGTCACC 
a ATCTGGTATTCCG 
a’ CGAACACCATCGG 
b ATGGCGTCCAAACCCATTGAA 
b’ ACCGGTGTCGACGTCCTC 
c ATGGAGGGATACCAAATGTTCC 
c’ CGG GGC TGAATGTCCCTG 
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and the supernatant was kept on ice and used in the dual luciferase assay, which was 
carried out in a 2-step fashion as previously described by Crater et al. (2015). 
Luminescence signals were measured with a 20/20n Luminometer (Turner Biosystems).  
Rnluc signals were normalized to Ffluc signals for a direct comparison among different 
independent experiments. The measurement of the dual luciferase expression was tested 
under at least three independently trials. 
6.2.4.  Western blot analysis 
Cell-free lysates were prepared by the addition of RIPA buffer to collected 
parasites and sonicated for 30 seconds (x3).  Protein concentration was measured using 
the RC DC Protein Assay according to manufacturer’s instructions (Bio-Rad 
Laboratories, #500-0119). Approximately 20 μg was used for the analysis, of which the 
lysates were denatured using 6x SDS protein loading buffer and resolved on a 10% SDS-
PAGE. The primary antibodies used were α-Flag mouse antisera (1:5,000, Applied 
Biological Materials Inc., Richmond, B.C, Canada, #G191).  The signals were revealed 
using secondary antibodies: horseradish peroxidase (HRP) conjugated goat anti-mouse 
antisera (Rockland Immunochemicals Inc., #610-1319) at a 1:10,000 dilution, and a 
Chemiluminescent HRP Substrate Kit (Millipore, #WBKLS0500). 
6.2.5.  Immunocytochemistry 
 
HFF monolayers were cultured on coverslips until confluent, infected with ~1 x 
10
6
 freshly lysed parasites and incubated at 37 °C and 5% CO2. Infected monolayers on 
the cover slips were rinsed three times with 1x phosphate buffer saline (PBS), fixed with 
3% paraformaldehyde for 5 minutes. Cells were then incubated with Hoechst staining 
solution (10 μM) at room temperature for 5 minutes, washed twice with 1x PBS and 
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mounted on glass slides. Image acquisition was carried out using a Leica DMI 6000B 
inverted fluorescent microscope using HCX PL Apo 100×/1.40–0.70 objective and a 
Leica DFC 360FX camera with Leica Advanced Fluorescence Application Software 
V.2.3.0. Post-acquisition image processing was performed with Adobe Photoshop 7.0. 
6.2.6.  Statistical analysis 
Statistical analysis for TgAgoKO gene silencing rescue was completed by the 
paired student t-test methodology assuming a null hypothesis.  All values were calculated 
from at least three independent tests. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
175 
 
6.3.  Results 
6.3.1.  Multiple proteins from one locus 
 
 To begin our investigation whether T. gondii expresses multiple TgAgo 
proteins, we generated transgenic parasites by homologous recombination to have the C-
terminus of TgAgo linked to a Strep/Flag (SF) epitope or a cherry fluorescent protein 
(ChFP).  These parasite lines would express TgAgo at the endogenous level and at its 
natural regulation.  To verify TgAgo-SF expression and identify multiple isoforms, SF-
tagged parasites were monitored by western blot analysis using anti-Flag antisera (Figure 
6.2a).  TgAgo-SF expression was monitored over culturing passages to ensure only 
transgenic parasites were studied.  At passages one and two post-transfection with 
pTgAgo-SF-TAP-LIC-Hx, a band appears at ~58 kDa as reported by Al Riyahi et al. 
(2006).  By passage three another band at ~97 kDa appears, as reported by Braun et al. 
(2010).  A band also appears at ~34 kDa in all passages and in WT parasite lysates 
(Figure 6.2a).  The 58 and 97 kDa proteins are not revealed in WT lysates, which 
suggests two forms of TgAgo-SF could be produced from the same locus.  Localization 
of TgAgo-ChFP, after at least three passages, was found to be primarily cytosolic, which 
was in agreement with previous reports (Figure 6.2b.  Al Riyahi et al., 2006, Braun et al., 
2010, Musiyenko, et al., 2012). 
6.3.2.  TgAgo is required for gene silencing 
 
 To study the effects of TgAgo in gene silencing mechanism, a TgAgo knockout 
parasite strain from Dr. JC Boothroyd (Stanford University School of Medicine, Stanford, 
California) was used.  The coding region of TgAgo was replaced with the hypoxanthine-
xanthine-guanine-phosphoribosyltransferase (HXGPRT) gene, and selected for by 
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Figure 6.2.  Multiple TgAgo proteins.  A) Western blot analysis of TgAgo-SF expression 
at progressive culturing passages (p).  Total parasite lysates were analyzed for Flag 
expression up to 6 days post-transfection. B) TgAgoChFP localization in intracellular 
parasites. (Hz, Hoechst, Texas red for cherry fluorescent protein.  Micrometer bar 
represents 5 m.) 
 
177 
 
mycophenolic acid (25 μg/mL) and xanthine (50 μg/mL).  Gene replacement was 
confirmed by PCR analysis using primers in Table 6.1.  Based on their annealing sites, 
primer sets, a-b’, b-a’, and b-b’ would only produce a PCR product if the HXGPRT gene 
was properly integrated into the TgAgo locus at 1, 1.4, and 0.5 kb, respectively.  Primer 
set c-c’ would anneal within the coding region of TgAgo and was only present in WT 
parasites (Figure 6.3.). 
We used our dual luciferase assay where binding sites for the endogenous miR-4a 
were located in the 3’ UTR of the Rnluc transcript, as described by Crater et al., 2015.  
Three perfect match sites to miR-4a were used in reactions labeled A, while three 
mismatch sites were used in reactions labeled B.   Rnluc activity decreased to (A) 39  
2.0 and (B) 35  4.0 % when normalized to Rnluc activity without binding sites in WT 
parasites.  The same reactions were carried out in TgAgoKO parasites, Rnluc activity was 
(A) 110  11 and (B) 70  4.0 % (Figure 6.4).   Plasmids that could express an Ago 
protein were introduced via electroporation with the dual luciferase plasmids in an 
attempt to decrease Rnluc activity within the TgAgoKO parasites.  When human Ago 2 
(HsAgo2) was introduced, Rnluc activity decreased to (A) 67  4.0 and (B) 36  9.0%.  
Transfection of the plasmid that would express the 58 kDa, (TgAgo1) decreased Rnluc 
activity to (A) 87  5.0 and (B) 70  6.0 %.  Upon transfection with the construct that 
contained the genomic sequence of TgAgo (TgAgo2) slightly deceased Rnluc activity to  
(A) 69  11 and (B) 67  6.0 %.  As a control to ensure the decrease in Rnluc activity 
was due to the introduced plasmid, a GFP expressing plasmid was also tested, Rnluc 
activity was (A) 110  9.0 and (B) 92  7.0 % (Figure 6.4.). 
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Figure 6.3.  Confirmation of TgAgo knockout parasite strain.  The coding region of 
TgAgo was replaced with the HXGPRT gene.  Proper gene replacement was confirmed 
by genomic RNA PCR analysis in TgAgoKO parasites compared to wild-type (WT). 
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Figure 6.4.  Argonaute gene silencing rescue.  TgAgo silencing capability was tested with 
a dual luciferase reporter assay within WT and TgAgoKO parasites.  The Rnluc 
transcripts tested would carry either a perfect match (A) or mismatch (B) interaction for 
miR-4a (Crater et al., 2015).  Rnluc activity in TgAgoKO parasites remained unchanged 
when compared to Rnluc activity when no miRNA binding sites were tested.  A rescue of 
a silencing effect was observed upon transfection of a plasmid that would express the 
catalytic active human Ago2 (HsAgo2).  When any of the TgAgo expressing plasmids 
were tested (TgAgo1, TgAgo3), a decrease of Rnluc activity was achieved. A plasmid 
that would express GFP did not affect Rnluc activity in TgAgoKO parasites. (p-values 
are the change in TgAgoKO silencing when complemented by a form of Ago for each 
miRNA binding format from three independent trials,  * p ≤ 0.01 and ** p ≤ 0.02) 
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6.4.  Discussion 
Argonaute is a central protein for which RNA directed gene regulation occurs.  It 
has the ability to confer gene regulation at the transcriptional and post-transcriptional 
level.  Within T. gondii, the roles and functions of TgAgo have yet to be fully eluded.  
Previously, our lab tested the TgAgoKO parasite line for its ability to (i) convert to 
bradyzoites, (ii) its effects on RNAseIII protein expression and (iii) knockdown a gene of 
interest (Liwak, 2009).  First, TgAgoKO parasites were grown under alkaline conditions 
for 5 days to induce bradyzoite formation.  The cyst walls were detected by 
immunofluorescence with a Dolichols-FITC antibody and at least 100 random vacuoles 
were counted.  Under these conditions, ~70 % of the TgAgoKO parasites formed cysts 
while only ~14 % of the WT (RH) parasites formed cysts.  This suggests TgAgo may 
play a role in tachyzoite to bradyzoite interconversion.   Using an anti-RNAseIII antisera 
and western blot analysis, it was found that the expression of RNAseIII containing 
proteins was decreased in the TgAgoKO parasites when compared to WT.  Finally, 
dsRNA for the gene UPRT (uracil phosphoribosyltransferase) was used to test the gene 
silencing ability in WT and TgAgoKO parasites.  UPRT is responsible for the uptake of 
uracil in the parasites; therefore a radio labeled uracil was used to detect UPRT activity.  
In WT parasites, the maximal amount of knockdown was ~60 %, however, the TgAgoKO 
parasites showed no ability to knockdown UPRT.  Overexpression of TgAgo3 in these 
parasites was unable to rescue a knockdown effect (Liwak, 2009).  The inability to rescue 
a gene silencing effect in the TgAgoKO parasites may be related to the type of dsRNA 
used as an effector.  In these experiments the dsRNA was ~ 600 bp.  As previously 
described in Chapter 2, the amount of an induced gene silencing effect could be related to 
the length or type of RNA.  Although a gene silencing effect can be achieved with long 
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dsRNA, a greater silencing effect was observed when a small dsRNA with a mismatch 
interaction to the mRNA target was used (Crater at al., 2012). 
The presence of two forms of Ago expressed from the same locus in T. gondii 
suggests TgAgo1 and TgAgo3 may be the result of two translational start sites.  To 
determine if ATG1 and ATG3 are translational start codons, we could first use the 
CRISPR/Cas9 methodology to disrupt each predicted start codon separately in TgAgo-SF 
parasites.  TgAgo-SF expression could be determined by western blot analysis.  If ATG1 
and ATG3 are bona fide translational start sites, we would expect to see only one isoform 
expressed (from the site that was not disrupted).  An increase in protein expression from 
the TgAgo isoform could also be possible under these conditions.  Next, we could use our 
dual luciferase reporter system with Tg-miRNA binding sites to monitor gene silencing 
by (i) Rnluc activity and (ii) qRT-PCR analysis.  TgAgo expressed from ATG1 would 
have the RGG domain required for TSN association.  Upon TSN association to TgAgo, 
we would expect gene silencing to occur by mRNA degradation.  TgAgo expressed from 
ATG3 has only a PIWI domain and we would expect gene silencing to occur by 
translational repression. 
Overall, these data are the first to suggest that T. gondii expresses at least two 
isoforms of Ago that could be required for gene silencing.  The mode of gene silencing, 
mRNA degradation or translational repression, could be determined by the TgAgo 
isoform.  Further investigations into the roles of TgAgo are thereby necessary to 
understand this unique gene. 
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CHAPTER 7 
Discussion and Future goals 
7.1.  Mechanism of RNA induced gene silencing 
7.1.1.  Roles and mechanism of miRNAs 
These studies have been conducted to understand RNA directed gene regulation 
mechanism in Toxoplasma.  The effectiveness of endogenous miRNA is directly related 
to (i) the abundance of miRNA and (ii) the number of miRNA binding sites within a 
target transcript.  The mode of regulation appears to vary among miRNA families.  The 
miR60 family causes mRNA degradation, while the miR-4 family causes translational 
repression.  Gene expression can also be manipulated by the use of a miRNA inhibitor or 
mimic.  This work shows that miRNA-induced gene silencing could also become a 
valuable tool in the study of Toxoplasma.  By using a combination of known genetic 
methodologies, we took advantage of homologous recombination system offered by the 
ΔKU80 strain that lack non-homologous end joining (NHEJ) capability to place miR-60a 
binding sites within the 3’ UTR of an essential (LDH1) and nonessential (HoDI) gene to 
down regulate their expression and monitor the effects.  With the use of the miRNA 
inhibitors and mimics the gene silencing capabilities of miR-60a could be altered and the 
effects evaluated. 
In order to further elucidate the mechanism for RNA induced silencing in 
Toxoplasma, we would need to also investigate the factors involved and underlying 
mechanism.  The presences of putative Dicer and RdRp gene have been predicted in 
Toxoplasma (Braun et al., 2010). The silencing activities of Argonaute, Tudor and 
PMRT1 have been studied (Musiyenko et al., 2012). However, the interactions among 
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these proteins, small effector RNAs (siRNA and/or miRNA) and target transcripts 
collective roles and functions have not yet been studied.  Since protein-protein and RNA-
protein interactions are vital for a functional gene silencing mechanism, we could employ 
a BioID and RNA aptamer methodology to examine these factors.  BioID is a method to 
identify proximal and direct protein-protein interactions in a cell system.  This is 
accomplished by the fusion of a biotin ligase enzyme (BirA) to a protein of interest to 
either the N- or C-terminus.  Addition of excess biotin to the cell system leads to 
biotinyation of proteins either adjacent or directly interacting with the protein of interest 
(Kim et al., 2016).  Biotinyated proteins are then purified on streptavidin-conjugated 
agarose beads.  Interacting and proximal proteins can be identified via fluorescence 
microcopy, western blot analysis or by mass spectrometry (Fairhead and Howarth, 2015). 
A methodology to study protein-RNA interactions is by use of the MS2 RNA 
aptamer to purify RNA-protein complexes (Slobodin and Gerst, 2010). A transcript that 
contains two MS2 loop repeats would bind to a recombinantly expressed coat protein 
(CP).  The MS2-CP is linked to a streptavidin binding protein that would bind to 
streptavidin-conjugated beads (Figure 7.1.) similarly to the BioID method, interacting 
proteins could be identified via mass spectroscopy.  Since previous results indicate that 
miR-4a causes translational repression, this methodology could be used with the Rnluc 
transcripts that contain the different miRNA binding formats (perfect vs. mismatch).  
This would also allow for us to compare the possible different or similar proteins 
involved in silencing when a perfect match or mismatch interaction is involved.  We 
could expect to find translational machinery proteins as well as RISC components such as 
TgAgo.  Since target mRNA cleavage is not the cause of silencing we would not expect 
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Figure 7.1.  A possible approach for determining RNA induced gene-silencing factors by 
MS2 RNA aptamer.  The Rnluc transcript would contain the sequence for the MS2 loop 
following three Toxoplasma miRNA binding sites (miR-60a or miR-4a) in the 3’ UTR.  
The secondary structure of the MS2 loops would bind to a MS2 coat protein linked to a 
streptavidin binding protein that would allow for complex purification by streptavidin-
conjugated beads. 
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to find TgTudor interactions as it appears to be involved in transcript degradation 
(Musiyenko et al., 2012).  Furthermore, the isoform of TgAgo involved could also be 
identified.  As TgTudor is not expected to be involved in translational repression we 
would expect the smaller isoform of TgAgo to be involved as it does not possess the 
RGG domain required for TgTudor interaction (Al Riyahi et al., 2006). One possible 
limitation of the MS2 aptamer would be to elude the proteins involved in mRNA 
degradation.  The transcripts may not be sustained long enough to purify the interacting 
complex.  To test this, we could use the Rnluc transcript that contains miR-60a binding 
sites as previous reports indicate target mRNA degradation occurs for this interaction. 
7.1.2.  Self-regulating genes and TgUlp1 
The most well defined example of a self-regulating gene is the Xist gene involved 
in cellular differentiation in female mammalians.  Tsix is the non-coding RNA gene that 
is transcribed antisense to the Xist RNA to induce random x inactivation by binding to 
Xist RNA (Chow et al., 2005).  Another example is the hok/sok system in E. coli during 
cell division.  Expression of the hok gene creates a toxic protein that causes cell death by 
depolarization of the cell membrane.  To prevent accumulation of this deadly protein 
the sok RNA is transcribed from antisense strand to the hok gene.  Sok regulates hok 
expression by binding within the hok transcript open rereading frame to induce 
translational repression.  The subsequent RNA duplex is recognized by an RNAseIII 
enzyme and is degraded (Gerdes et al., 1990).  These examples of self-regulating genes 
are both important for cellular differentiation and development.   Self-regulating genes 
are also advantageous when a fast response to external signals is required during stress 
response (Shimoni et al., 2007).   Most self-regulating genes are regulated by a 
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transcription factor by either a negative or positive feedback loop.  For example, human 
miR-483 has been shown to activate its expression via promoter activation through the 
up-regulation of a transcription factor, USF1 (Emmerling et al., 2016).  Self-regulating 
genes by non-coding RNAs has been observed in other Apicomplexans.  For example, 
the var gene family in Plasmodium, which is responsible for host cell immune evasion, is 
regulated by an RNA transcribed from the antisense strand of a conserved intron within 
the var genes (Amit-Avaham et al., 2015).  However, at the time of this dissertation, no 
reports of self-regulating genes by miRNAs have been identified in Apicomplexans.  As 
a self-regulating gene, and as evident by the parasite’s inability to complete its lytic cycle 
asexually, suggests TgUlp1 is likely also important for parasite development and immune 
response. 
7.1.3.   Alternative translational starts sites of TgAgo 
Initiation of protein translation is initiated by the recruitment of a ribosome at a 
specific nucleotide sequence called the ribosomal-binding site (RBS).  RBS recruitment 
can be mediated by the 5’ cap of mRNAs or in a cap independent mediated mechanism 
via internal ribosome entry sites (IRES).  In eukaryotes, the region upstream of the start 
codon on the mRNA has a consensus sequence (ACCAUGG) called the Kozak sequence.  
Multiple adenines upstream of the RBS can also enhance ribosomal recruitment (Hellen 
and Sarnow, 2001, Laursen et al., 2005).  Alternative translational start sites within a 
single transcript can contribute to proteome diversity.  Preferential translation is 
attributed to longer 5’ UTRs that are enriched for transcription factors and leaky mRNA 
scanning.  Although the functional significance for alternative start sites is controversial, 
this mechanism can lead to the production of N-terminal protein variants to promote 
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diversity in higher eukaryotes (Bazykin and Kochetov, 2011).  For example in A. 
thaliana, the mitochondrial and nuclear form of the DNA ligase 1 (AtLIG1) are both 
translated from a single mRNA from two in-frame start codons (AUG).  Similarly, 
mitochondrial and cytoplasmic isoforms of proteins have been observed in rat with the 
ornithine decarboxylase-antizyme (Gandre et al., 2003), and the human insulin-degrading 
enzyme (Leissring et al., 2004) and neuropeptide Y (Kaipio et al., 2005). 
The expression of multiple Ago proteins in higher eukaryotes (i. e. human, fruit 
fly and worm) function within distinct locations (i.e. nucleus or cytosol), vary in nuclease 
activity or interact with a specific form of non-coding RNA molecule (Azlan et al., 
2016).  Organisms that contain a single Ago (baker’s yeast) can participate in 
transcriptional and post-transcriptional regulation within the nucleus and cytosol (Jinek 
and Doudna, 2009).  Although three versions of TgAgo can be found within the NCBI 
protein database, the expression of only two forms has been experimentally identified 
(GenBank: ACZ73654.1 and ABB05350.1).  A ~100 kDa protein that would contain the 
RGG, PAZ and PIWI domain and ~58 kDa protein that only contains the PIWI domain 
(Braun et al., 2010 and Al Riyahi et al., 2006). 
Toxoplasma contains a Kozak-like sequence (gncAaaATGg, Seeber, 1997).   
Upon investigation of the TgAgo locus for possible RBS locations, six possible locations 
were identified with 4 locations within the predicted exons and 2 in the predicated introns 
(Table 7.1.).  Based on sequence similarities and location of the predicted sites, the 
identified site on exon 6 is the most likely to be a translational start site and corresponds 
to the ATG3 start site.  The protein that would be produced from this site corresponds to 
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Table 7.1.  Toxoplasma Kozak-like sequence and possible translational start site on the 
TgAgo locus.  Nucleotide numbers are based on the reported ATG1 start site.  Upper case 
indicates essential nucleotides for RBS recruitment and translation.  Perfect match 
nucleotides to the Toxoplasma Kozak-like sequence are indicated by *. 
 
Toxoplasma Kozak-like sequence gncAaaATGg 
Location on TgAgo locus 
(TGGT1_310160) 
Sequence 
Exon 1 
-6-4 
tctcttATGa 
*    *** 
Intron 4 
2418-2428 
acgAaaATGg 
* ******* 
Exon 6 
3490-3500 
gccAaaATGt 
********* 
Intron 6 
4313-4323 
gatAaaATGt 
** ****** 
Exon 7 
4593-4603 
ggaAatATGg 
** ** **** 
Exon 7 
5058-5068 
cgcgacATGg 
** * **** 
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TgAgo3 at ~ 58 kDa.  The first predicted start site (ATG1) has the lowest sequence 
similarity to the Kozak-like sequence and is the least likely possible start site (Table 7.1.).  
Although western blot analysis indicates the presence of two isoforms of TgAgo, 
predicted translational start sites indicate one likely start site in exon 6.  Taken together, 
these findings could suggest Toxoplasma contains a leaky translation mechanism that 
produces two forms of TgAgo where one could function within the nucleus and the other 
in the cytosol. 
7.2.  MiRNAs as an anti-Toxoplasma therapeutic 
During host cell invasion by Toxoplasma, parasite specific secretory organelles 
(micronemes and rhoptries) inject effector molecules into the host.  These effectors have 
been shown to interfere with host cell signaling to block apoptosis and progression of the 
host’s cell cycle.  Additionally infected host cell expression profiling has shown 15 % of 
host mRNAs display an alteration (Blader et al, 2001, Nelson et al., 2008).  A study used 
microarray profiling to analyze the change in host cell miRNA expression upon 
Toxoplasma infection.  Primary transcripts for miR-17~92 and miR-106b~25 display an 
increased abundance in infected human foreskin fibroblasts.  The mature miRNAs 
derived from these primary transcripts target mRNAs that encode for pro-apoptotic 
factors and negative regulators of the cell cycle (Zeiner et al., 2010).  Furthermore, a 
study showed an increase in miRNAs that target immune response factors in Toxoplasma 
infected mouse brains (Cannella et al., 2014).  The exact mechanism for this change is 
not fully understood however, a study by Zeiner et al., (2010) showed the increase the 
miR-17 ~ 92 primary transcripts is likely due to an increase in promoter activity.  The 
fact that parasite or host miRNAs have not been found locationally different may not 
infer an exchange of host-parasite miRNAs is not occurring, but the level of change or 
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location is not currently detectable. 
Although systematic siRNA therapies have been used in the clinic treatment of 
cancer, many different barriers can inhibit their delivery due to unfavorable 
physicochemical properties and instability of the siRNA (Roberts 2016).  To prevent 
rapid degradation of the siRNA, modified backbones such as those like locked nucleic 
acids, morpholinos and antagmers are preferred.  Non-viral delivery of siRNAs is 
preferred to prevent potential toxicities associated with viral vectors.  Non-viral siRNA 
vectors involve complexing the siRNA with a positively charge polymer or lipid, 
conjugation of the siRNA to small molecules such as cholesterol and lipids or 
encapsulating the siRNA in a nanoparticle (Roberts et al., 2016, Wang et al., 2010).  The 
administration depends on the organs targeted.  Generally, locoreginal delivery, such as 
inhalation is preferred as it has fewer barriers to overcome when compared to systemic 
delivery, such as intravenous injection (Wang et al., 2011). 
Similar methodologies have been utilized to treat intracellular tachyzoites and 
bradyzoites in vitro and in vivo. A transductive peptide conjugated to a 
phosphorodiamidate morpholino oligomer (PMO) was used sequence specifically to 
inhibit the expression of Toxoplasma dihydrofolate reductase (DHFR) and enoyl-ACP 
reducatase (ENR) enzymes, which are involved in folate and fatty acid synthesis, 
respectively.  Intracellular parasite replication was slowed when either of the mentioned 
genes was targeted by the peptide-conjugated morpholino (PPMO) in cell culture.  The 
methodology also showed parasite burden was reduced in infected mice that were treated 
with the DHFR-specific PPMO (Lai et al., 2012).  As another possible treatment for anti-
Toxoplasma therapeutics, it would be interesting to investigate the use of the Toxoplasma 
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specific miRNAs or inhibitors with this methodology.  The experiments discussed found 
a maximal amount of miRNA mimic or inhibitor required for an alerted silencing effect 
was 20 μg, which translates to 1.23 and 2.35 mM respectively.  However, the maximal 
concentration of the PPMOs discussed earlier was 5 μM indicating treatment by PPMO 
may have a greater effect at lower concentrations, which would be more advantages to 
eliminate toxicity and off-targeting effects (Lai et al., 2012). Toxoplasma miRNAs have 
no reported mRNA targets or sequence homology to host miRNAs therefore we would 
not expect to find an alteration in host gene expression. 
7.3.  Conclusion and significance 
This research has been dedicated to studying the underlying mechanism of RNA 
induced gene silencing in Toxoplasma.  Gene regulation is vital for our understanding of 
the biological processes required for Toxoplasma survival and opportunistic life.  The 
first goal was to determine the effectiveness of different effector RNA molecules to 
induce gene silencing. Next, the roles and effectiveness of endogenous miRNA in 
Toxoplasma were examined.  The best gene silencing effect was observed based on the 
abundance of miRNA present or the number of binding sites on a target transcript.  
Lastly, TgUlp1 was chosen as a model gene to study the underlying gene silencing 
mechanism and the biological roles of Tg-miRNAs.  In fact, TgUlp1 has proven an 
excellent model gene to study RNA induced gene silencing.  The locus of TgUlp1 
contains the highest number of miR-60a binding sites and contains possible precursor 
miR-60a. It is very likely that TgUlp1 is a self-regulating gene.  Furthermore, the 
expression of TgUlp1 is critical for SUMOylation and parasite egress.  Overall, this 
dissertation has revealed the importance of proper gene regulation by miRNAs in 
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Toxoplasma.  An alteration in gene expression can be detrimental to the parasite.  With 
these studies, exanimation of genes for quick functional analysis for the development of 
drugs or use of the Tg-miRNA mimics and inhibitors alone as a drug treatment for 
Toxoplasma infection could be within reach. 
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APPENDICES 
A1.  Dual luciferase plasmids for Chapter 2. 
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A2.  Dual luciferase plasmids with miR-4a binding sites for Chapter 3. 
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A3.  LIC plasmid for miR-60a binding sites for Chapter 3 
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A4.  LIC plasmids to create HoDI-SF and HodI-SF-miR60a sites for Chapter 3 
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A5.  LIC plasmids to generate LDH1-SF and LDH1-SF-miR-60a sites for Chapter 3 
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A6.  Genomic and cDNA sequences for TgUlp1 (TGGT1_214470) for Chapter 5. 
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A7. Plasmids for generation of GST-Ulp1 for Chapter 5. 
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A8.  pET28b TgSumoeGFP for Chapter 5 as substrate for TgUlp1 activity assay. 
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A9.  Plasmids used to create TgUlp1 KO for Chapter 5. 
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A10. Genomic representation of TgUlp1 KO with DHFR selectable marker insert for 
Chapter 5. 
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A11. pScUlp1PromoterTgUlp1-GFP/LEU2 used for yeast complementation assays for 
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